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Summary 
Many inflammatory diseases are characterised by persistent and inappropriate neutrophil 
activation, systemic or localised hypoxia and bacterial colonisation.  Hypoxia represents an 
important regulator of inflammatory responses since it inhibits neutrophil apoptosis, a process 
central to timely resolution of inflammation.  Furthermore, the oxygen sensing transcription 
factor, HIF-1α is a critical regulator of myeloid cell function and neutrophil survival in hypoxia.  
I show that HIF-2α has a distinct role from HIF-1α in regulating survival of inflammatory 
neutrophils.  Specifically, HIF-2α was expressed in neutrophils from patients with chronic 
inflammatory diseases and was upregulated by inflammatory stimuli and in a mouse model of 
acute lung inflammation.  Overexpression of HIF-2α inhibited constitutive apoptosis of human 
neutrophils in vitro and delayed resolution of inflammation in an in vivo model of zebrafish 
tailfin injury.  By contrast, myeloid-specific deficiency of HIF-2α enhanced resolution of 
inflammation in a murine model of lung inflammation but did not impair essential neutrophil 
antimicrobial functions in vitro or in vivo.  These findings implicate HIF-2α as a potential target 
for treating neutrophilic inflammation.   
Infections frequently cause or complicate illnesses associated with arterial hypoxaemia and 
local tissue hypoxia.  I investigated the effect of systemic hypoxia on host-pathogen 
interactions using a subcutaneous infection model in mice.  Surprisingly ambient hypoxia 
transformed the local bacterial challenge into a phenotype of sickness behaviour and 
hypothermia.  The mechanism responsible for this phenotype was not discovered but I found 
no evidence of bacteraemia, excessive cytokine production or lung injury in the hypoxic 
infected mice.  However, there was significant circulatory dysfunction, with hypotension, 
bradycardia and impaired left ventricular function.  These findings imply that hypoxia may 
adversely alter the host response to a minor bacterial challenge, leading to profound systemic 
illness.  Interestingly, myeloid-cell deficiency of HIF-2α protected mice from the adverse 
systemic phenotype in this model, further supporting the potential utility of targeting HIF-2α in 
inflammatory disease.  
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1 Introduction 
1.1 Hypoxia 
Oxygen is fundamentally important to living organisms.  A shortage of oxygen, hypoxia, can 
occur systemically and at tissue or cellular levels.  The millions of people who travel to high 
altitude each year experience whole body hypoxia as a consequence of the reduction in 
barometric pressure.  The reduction in ambient oxygen tension feeds down the oxygen 
cascade as shown in Figure 1.1-1 resulting in lower levels of oxygen in body tissues.  Even in 
health, oxygen tension at a tissue level varies depending upon the metabolic requirements of 
the tissue and the distance from the vascular supply (Arteel et al., 1995; Maxwell et al., 1989).  
Tissue values measured by microelectrode in rats breathing room air revealed mean values of 
1.7 kPa of oxygen in the liver, 3.0 kPa in subcutaneous tissue and 4.9 kPa in the brain 
(Jamieson and van den Brenk, 1965).  Indeed, relative hypoxia is often a physiological signal 
guiding important processes such as angiogenesis in wound healing (Knighton et al., 1983) and 
maintaining pulmonary vasoconstriction in utero (Cassin et al., 1964). 
However, for most cells and tissues, severe or prolonged hypoxia will result in damage.  The 
brain tolerates hypoxia poorly with neuronal damage occurring after 5 to 10 minutes of 
ischemic injury (Levy et al., 1975).  This is in part due to the high neuronal requirement for 
adenosine triphosphate (ATP), but hypoxic cellular injury is not only a result of cellular energy 
depletion but also due to cellular acidosis and the generation of damaging free radicals (Chen 
et al., 2011; Erecińska and Silver, 2001; Perlman, 2007).  
In disease, oxygen tensions in tissue can fall substantially.  For example, lung disease leads to 
systemic hypoxaemia through impaired gas exchange and inadequate arterial oxygenation 
while vascular disease interrupts normal blood supply and results in local tissue ischemia 
(Agusti et al., 2003).  Furthermore, increased demand for oxygen will occur in infected or 
inflamed tissue (Kempf et al., 2005).   
10 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1-1. The oxygen cascade. 
A diagram showing oxygen tensions at each step of the oxygen cascade from ambient oxygen 
tension to mixed venous blood oxygen tension. With ascent to altitude, barometric pressure 
decreases and ambient partial pressure of oxygen falls.  This diagram shows calculated oxygen 
tensions at 5200 m and sea level.  At 5200 m the ambient partial pressure of oxygen is 
approximately 11 kPa, compared to that at sea level where the ambient oxygen tension is 21 
kPa.  Adaptation to hypoxia increases ventilation, reducing the effect of dead space ventilation 
thus increasing the alveolar oxygen tension.   Cardiac output also increases, maximising arterial 
oxygen tension.   
The calculator used to draw this cascade was authored by JK Baillie and is available at 
www.altitude.org,  
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1.1.1 Hypoxia and disease 
In the context of human disease, hypoxia is an important factor in the pathogenesis and 
prognosis of many conditions.  
1.1.1.1 Altitude 
In otherwise healthy humans resident at sea level, acute ascent to an altitude of 5200 m, with 
the corresponding drop in oxygen tensions shown in Figure 1.1-1,  results in an incidence of 
acute mountain sickness (AMS) that approaches 60% (Dorward et al., 2007).  AMS is a self-
limiting disorder characterised by headache and non-specific symptoms of fatigue, nausea and 
dizziness (Hackett and Roach, 2001).  However, life-threatening pathologies such as high 
altitude pulmonary oedema (HAPE) and high altitude cerebral oedema (HACE) may also occur 
following acute ascent, with HAPE having a reported incidence of up to 2% at 4000 m (Hackett 
and Roach, 2001; Schoene, 2008).  The pathogenesis of these disorders is incompletely 
understood but adequate acclimatisation effectively ameliorates the risk of these conditions 
(Bartsch, 1999; Basnyat and Murdoch, 2003).  Such a strategy cannot be employed to prevent 
the hypoxic complications of sea level diseases. 
1.1.1.2 Lung disease 
Chronic respiratory conditions were reported by 6.4% of UK adults in 2004, with an estimated 
3 million patients in the UK having chronic obstructive pulmonary disease (BTS, 2006; 
HealthcareCommission, 2006).  Lung disease may lead to alveolar hypoxia through 
hypoventilation or increased dead space and arterial hypoxia through a reduction in the 
diffusing capacity for oxygen (Wagner and West, 2005). Indeed patients with advanced chronic 
obstructive pulmonary disease (COPD) frequently have arterial oxygen tensions less than 7.3 
kPa, evidenced by the 865,000 prescriptions for oxygen issued in primary care in 2004 (BTS, 
2006).  This threshold of arterial oxygen tension used as an indication for long term oxygen 
treatment was extrapolated from data acquired during two major trials of domiciliary oxygen 
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treatment.  The MRC trial of domiciliary oxygen use demonstrated a reduction in mortality in 
hypoxaemic patients receiving oxygen treatment for more than 15 hours per day (MRC, 1981) 
and in a similar cohort of patients the NOTT trial showed a significant mortality benefit from 
continuous rather than nocturnal oxygen therapy (NOTT, 1980).  Interestingly, the 
physiological benefits of receiving this supplemental oxygen were not clear but reductions in 
haematocrit and improvements in pulmonary haemodynamic measurements were 
demonstrated (MRC, 1981; NOTT, 1980). Other studies have shown that low arterial oxygen 
tension and mixed venous oxygen saturation in COPD patients predict poor outcome and risk 
of acute exacerbation requiring hospitalization (Kawakami et al., 1983; Kessler et al., 1999).   
COPD and other chronic lung conditions such as cystic fibrosis may also predispose to areas of 
local tissue hypoxia within the lung (Hamedani et al., 2011). Airway obstruction, mucus 
hypersecretion and bacterial colonization will reduce oxygen tension. Indeed, pO2 
measurements as low as 0.33 kPa were reported in infected mucopurulent collections in the 
airways of patients with cystic fibrosis (Hamedani et al., 2011; Worlitzsch et al., 2002).   
1.1.1.3 Critical care 
Acute or chronic lung diseases are often contributing factors in the hypoxaemia frequently 
evident in critically ill patients (Simpson et al., 2005). Patients with acute respiratory distress 
syndrome (ARDS) or pneumonia may be hypoxaemic despite aggressive ventilation, with 
ventilation potentially perpetuating lung injury (ARDSN, 2000; Matthay and Zemans, 2011).  
Sepsis, the presence of the systemic inflammatory response syndrome (SIRS) due to infection 
(Bone et al., 1992), is another important cause of admissions to critical care.  Due to the high 
prevalence of respiratory infection underlying the diagnosis of sepsis and the frequency of 
respiratory failure associated with it, hypoxaemia is common in this disorder (Alberti et al., 
2002; Martin et al., 2003; Stearns-Kurosawa et al., 2011). In sepsis, tissue hypoxia in sepsis 
may result from impaired oxygen extraction and abnormalities of the microcirculation even 
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with normal arterial oxygenation (Anning et al., 1999; Spronk et al., 2004).  Importantly, in the 
context of severe sepsis, respiratory failure was an independent predictor of mortality (Guidet 
et al., 2005). 
1.1.1.4 Local hypoxia 
While causes of systemic hypoxaemia may result in widespread tissue hypoxia, more localised 
reductions in oxygen tension are also found in the context of infection, inflammation and 
cancer and have been implicated in disease pathogenesis and severity.  In a rabbit model of 
empyema, oxygen tensions of less than 3kPa were found in the infected empyema cavity 
(Shohet et al., 1987) while in a mouse model of inflammatory bowel disease the gut 
epithelium, which is relatively hypoxic in health, displays evidence of significantly greater 
hypoxia when inflamed (Karhausen et al., 2004).  Synovial fluid from inflamed human joints 
had oxygen tensions of less than 3kPa (Ng et al., 2010).  Interestingly, the study by Ng et al. 
found a direct correlation between synovitis and oxygen tension and higher levels of 
inflammatory cytokines in hypoxic synovial fluid (Ng et al., 2010).  Tumours often have necrotic 
centres with penumbral hypoxia and hypoxia has been implicated in cancer metastasis, poor 
prognosis and resistance to radiotherapy (Brahimi-Horn et al.; Vaupel, 2004; Vaupel et al., 
1991; Welsh and Powis, 2003).  
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1.1.2 Adaptation to hypoxia 
Over the course of evolution, mechanisms of compensating for oxygen deprivation have 
developed.  In humans, hypoxia rapidly induces an increase in heart rate and ventilation to 
maintain oxygen delivery (Honig and Tenney, 1957; Keys et al., 1943; Rahn and Otis, 1949).  If 
hypoxia is sustained for days, erythropoesis will occur.  Indeed the erythropoetic effect of high 
altitude, first observed by Viault, is perhaps the best known adaptation to systemic hypoxia 
(Viault, 1890). After 23 days at 4392 m, with an ambient oxygen tension equivalent to 60 % of 
that at sea level, he found a rise of 3 million red cells per cubic millimetre of his blood (Viault, 
1890). Investigation of the regulation of erythropoietin (EPO), the hormone responsible for 
Viault’s observation, led to the discovery of one of the key regulators of cellular adaptation to 
hypoxia, the nuclear transcription factor, hypoxia inducible factor (HIF) (Semenza and Wang, 
1992).  HIF and the regulatory components of the HIF pathway are not unique to mammals. 
Homologs of HIF have been found in corals, nematodes, beetles and flies, demonstrating the 
importance of this ancient pathway in oxygen sensing across diverse species and habitats 
(Hampton-Smith and Peet, 2009; Taylor and McElwain, 2010).   
In mammals, HIF is a heterodimeric protein consisting of α and β subunits (Wang and 
Semenza, 1995). The β subunit, the aryl hydrocarbon receptor nuclear transporter (ARNT), is 
constitutively expressed while the α subunits are regulated by a family of oxygen-sensitive 
enzymes (Bruick and McKnight, 2001; Epstein et al., 2001; Wang et al., 1995)  Under hypoxic 
conditions these enzymes are inhibited, HIF-α subunits accumulate, translocate to the nucleus 
and dimerize with ARNT.  HIF dimers bind to genes that contain the core DNA sequence, 5’-
RCGTG-3’, known as the hypoxic response element (HRE) (Semenza et al., 1996). HIF target 
genes have a broad range of functions, but many aim to preserve cell survival or restore 
oxygen delivery (Kaelin and Ratcliffe, 2008).    
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1.1.3 Hypoxia and the innate immune system 
Of the three known HIF-α subunits, HIF-1α has been studied in most detail and its role extends 
far beyond controlling cellular adaptation to hypoxia. Cramer et al. showed that HIF-1α is a 
critical regulator of the innate immune system (Cramer et al., 2003).  Although sites of 
inflammation are often hypoxic, HIF-1α can be stabilised in myeloid cells activated by bacterial 
stimuli independent of oxygen tension (Peyssonnaux et al., 2005) .  
I will now discuss the importance of hypoxia and oxygen-sensing pathways in the innate 
immune system, specifically focussing on neutrophils.  These short-lived effector cells   
undergo apoptosis to safely dispose of their potent cytotoxic armaments, but if neutrophil 
survival is prolonged, resolution of inflammation is delayed resulting in damage to surrounding 
tissues (Dransfield and Rossi, 2004; Rossi et al., 2006; Savill, 1997).  Hypoxia, in contrast to its 
effects on many other cells, is a profound neutrophil survival stimulus (Walmsley et al., 2005). 
However, the effects of hypoxia on neutrophil pro-inflammatory functions are not well 
characterised.  HIF-1α has been implicated in the control of neutrophil survival and function 
but the role of the structurally related transcription factor, HIF-2α, is not known (Walmsley et 
al., 2005).  I will therefore discuss the biology of HIF-2α and the evidence that it has a role 
distinct from HIF-1α will be explored.   The wider interactions between hypoxia and the host 
response to bacterial infection will also be considered and I will conclude this chapter with a 
description of the aims of the experimental work in this thesis. 
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1.2 Neutrophilic inflammation 
Neutrophils are vital components of the innate immune system and the first cells to migrate to 
sites of inflammation or tissue damage.  They are recruited by the release of chemoattractants 
from activated macrophages, epithelial cells and bacteria, and transmigrate across the 
capillary epithelium to enter the injured or infected tissue (Kelly et al., 2007; Nourshargh and 
Williams, 1995).  Neutrophils have impressive cytotoxic abilities including phagocytosis, the 
respiratory burst and the release of granule proteases (Borregaard et al., 2007; Dinauer, 2005; 
Dransfield and Rossi, 2004). Furthermore, through the secretion of inflammatory mediators, 
neutrophils are capable of modulating the immune response (Borregaard et al., 2007; 
Dransfield and Rossi, 2004). Neutrophils are short-lived and undergo constitutive apoptosis 
(Savill et al., 1989).  Apoptosis allows neutrophils to retain their granule contents and reduces 
chemotaxis, phagocytosis and the respiratory burst (Whyte et al., 1993). Apoptosis also 
promotes recognition and removal of neutrophils by macrophages which then restore normal 
tissue homeostasis (Savill et al., 1989).  Inhibition of apoptosis will therefore impair the 
resolution of inflammation and may result in tissue damage (see Figure 1.2-1) (Rossi et al., 
2006; Savill, 1997; Vissers and Wilkie, 2007). Indeed, persistent neutrophilic inflammation has 
been implicated in numerous disease processes including COPD (Quint and Wedzicha, 2007), 
asthma (Barnes, 2007), lung fibrosis (Gharaee-Kermani et al., 2007), cystic fibrosis (Elizur et al., 
2008), inflammatory bowel disease (Taylor and Colgan, 2007), inflammatory arthritis (Cross et 
al., 2006) and atherosclerosis (Zernecke et al., 2008). 
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Figure 1.2-1. Neutrophilic inflammation. 
A diagram showing the phases of neutrophilic inflammation.  Following an injurious stimulus, 
neutrophils are recruited and perform their anti-microbial and immunomodulatory functions.  
In the top panel the resolution of this acute inflammatory response requires timely neutrophil 
apoptosis followed by clearance by macrophages and the restoration of normal tissue 
homeostasis.  The bottom panel depicts delayed apoptosis favouring persistence of 
neutrophils and leading to chronic inflammation.  This schematic was based on a diagram from 
Serhan et al. (2007).  
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1.2.1 Neutrophil apoptosis  
Timely neutrophil death and clearance are essential for the resolution of inflammation and 
safe disposal of the neutrophils’ potentially damaging contents (Haslett, 1999).  Neutrophils 
are inherently short-lived being genetically programmed to undergo spontaneous apoptosis 
even at sites of inflammation (Savill et al., 1989). Apoptotic neutrophils display characteristic 
morphological features such as nuclear fragmentation, chromatin condensation and cell 
shrinkage and biochemical changes such as the exposure of phosphatidylserine on the outer 
plasma membrane and cleavage of DNA and chromatin (Martin et al., 1995; Savill et al., 1989).  
Apoptosis is thus clearly distinct from necrosis, which is characterised by increased cell 
volume, loss of membrane integrity and cell lysis (Wyllie et al., 1980). 
Neutrophil apoptosis is not only triggered by classical intrinsic and extrinsic pathways, but the 
involvement of reactive oxygen species and granule proteases has also been demonstrated.   
The intrinsic pathway is characterised by mitochondrial outer membrane permeabilisation 
resulting in release of cytochrome C and leading to assembly of the apoptosome with 
subsequent caspase 9 activation (Green and Kroemer, 2004).  The integrity of the 
mitochondrial outer membrane is controlled by the BCL-2 family of proteins.  Neutrophils 
express both anti-apoptotic (MCL-1, BCL-XL, A1) and pro-apoptotic (BAX, BAK) members of this 
family (Bianchi et al., 2006; Witko-Sarsat et al., 2011).  The apoptosis inducers, BAX and BAK, 
insert into the mitochondrial membrane but are inhibited when in complex with anti-apoptotic 
BCL-2 family members.   Interestingly, the expression of anti-apoptotic BCL-2 family members 
is lower in mature neutrophils than in neutrophil precursors (Geering and Simon, 2011; 
Theilgaard-Monch et al., 2005).  Thus this pathway is implicated in the control of constitutive 
apoptosis characteristic of mature neutrophils. 
Extrinsic signals triggering apoptosis are typified by death receptor pathway signalling.  
Ligation of receptors by Fas ligand (FasL), TNF-related apoptosis inducing ligand (TRAIL) and, 
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under certain conditions, tumour necrosis factor (TNF)-α induce neutrophil apoptosis via the 
generation of a death-induced signalling complex (DISC) and subsequent caspase 8 activation. 
Importantly, inflammatory neutrophils retain susceptibility to apoptosis triggered by extrinsic 
stimuli (Renshaw et al., 2000). Both intrinsic and extrinsic pathways culminate in downstream 
activation of effector caspases which lead to apoptosis (Kothakota et al., 1997). 
An important feature of neutrophil anti-bacterial function is their capacity to produce reactive 
oxygen species (ROS).  ROS have been implicated in the activation of the intrinsic apoptosis 
pathway (Arruda et al., 2006) and they may also activate the extrinsic pathway independently 
of receptor ligation (Scheel-Toellner et al., 2004).  ROS may also directly lead to neutrophil 
apoptosis by damaging DNA and activating the pro-apoptotic p53 pathway (Ye et al., 1999).  
Evidence of their role in spontaneous neutrophil apoptosis comes from experiments using 
antioxidants, which delay constitutive apoptosis, but importantly also from patients with 
chronic granulomatous disease (Kasahara et al., 1997).  These patients have defects in NADPH-
oxidase that lead to impaired or absent ROS production and, as a result, increased 
susceptibility to bacterial and fungal infections (Dinauer, 2005).  Neutrophils from these 
patients have significantly lower rates of constitutive apoptosis (Kasahara et al., 1997).  
While neutrophils undergo apoptosis constitutively, numerous stimuli prolong their lifespan.  
Inflammatory stimuli are key mediators of delayed neutrophil apoptosis.  As neutrophils 
migrate into inflamed or infected tissue bacterial and viral stimuli, signalling via toll-like 
receptors, promote neutrophil survival (Francois et al., 2005).  Furthermore, inflammatory 
cytokines including IL-1β, IFN-γ, G-CSF and GM-CSF also delay neutrophil apoptosis (Colotta et 
al., 1992; Maianski et al., 2004b).  Signals from the local inflammatory microenvironment are 
therefore of critical importance in the regulation of neutrophil persistence.  Another such 
signal, characteristic of inflammatory sites, is hypoxia.     
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1.2.2 Hypoxia enhances neutrophil survival 
Hypoxia is a characteristic feature of inflammatory sites and many tumours (Bertout et al., 
2008; Brahimi-Horn et al., 2007).  Neutrophils need to function at these hypoxic sites and are 
well adapted for this purpose by relying mainly on glycolysis to generate ATP (Levene and 
Meyer, 1912; Maianski et al., 2004a; Sbarra and Karnovsky, 1959). Indeed, in contrast to its 
effects on many other cell types, hypoxia is a profound neutrophil survival stimulus (Hannah et 
al., 1995). 
 
1.2.3 Neutrophil survival in hypoxia requires HIF-1α 
Walmsley et al. demonstrated that HIF-1α was necessary for inhibition of neutrophil apoptosis 
by hypoxia (Walmsley et al., 2005).  HIF-1α deficient bone marrow-derived neutrophils showed 
markedly reduced survival in anoxia, while the HIF stabiliser, dimethyloxalylglycine (DMOG) 
promoted survival (Walmsley et al., 2005).  Supernatant transfer experiments also 
demonstrated hypoxic induction of a pro-survival factor, identified as macrophage 
inflammatory protein-1β (Walmsley et al., 2005). In contrast to the direct survival effect of 
hypoxia, this transferrable effect was dependent on phosphoinositide 3-kinase signalling.  
 
1.2.4 Neutrophil function in hypoxia 
The effects of hypoxia on neutrophil function have been less well characterised.  Experimental 
conditions in published studies have varied widely making conclusions difficult.  This is because 
the method of neutrophil isolation and even the anticoagulant used influences neutrophil 
function and must always be considered when interpreting ex vivo data (Dransfield and Rossi, 
2004; Engstad et al., 1997; Freitas et al., 2008; Haslett et al., 1985).  
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Existing data suggest that neutrophil function is preserved and possibly enhanced by hypoxia. 
Neutrophils isolated from the blood of healthy volunteers following an acute episode of 
systemic hypoxaemia (arterial oxygen saturation <70%) showed enhanced elastase release in 
response to the bacterial peptide, N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMLP) 
(Tamura et al., 2002).  Wang et al. exposed subjects to normobaric hypoxia for 2 hours and 
found, using ex vivo assays, that 12% oxygen resulted in enhanced chemotaxis, respiratory 
burst and phagocytosis (Wang and Liu, 2009). However, in theory the effects observed in both 
of these studies could have been due to reoxygenation of the neutrophils during isolation.  
1.2.4.1 Phagocytosis 
Neutrophils cultured in hypoxic conditions (PO2 in media ≈3kPa), for 1 hour demonstrated 
increased phagocytosis of heat-inactivated Streptococcus pneumoniae compared to those 
cultured in normoxia (PO2 ≈20kPa) (Walmsley et al., 2006). Similar findings were reported 
when whole blood was rendered hypoxaemic in vitro (PO2 <2kPa) (Simms and D'Amico, 1994). 
The percentage of neutrophils positive for opsonised fluorescent microspheres was 
significantly greater than in normoxic venous blood (PO2 8-10kPa) (Simms and D'Amico, 1994).  
1.2.4.2 Chemotaxis and transmigration 
Previous studies on the effect of hypoxia on neutrophil chemotaxis have yielded conflicting 
results.  Studies using Boyden chambers suggested that neutrophil chemotaxis was inhibited at 
oxygen tensions of around 3kPa but Wang et al. found that chemotaxis was enhanced 
following systemic exposure to hypoxia (Rotstein et al., 1988; Wang and Liu, 2009).  
Differences in the experimental protocols and chemoattractant used may explain these 
differences. For example Wang et al. isolated neutrophils from subjects exposed to hypoxia 
and used fMLP as the chemoattractant, but the assay was carried out in normoxic conditions 
(Wang and Liu, 2009).  More recent data revealed no difference in chemotaxis of human 
neutrophils through a 5 µm filter under hypoxic conditions (PO2 in media ≈3kPa) (McGovern et 
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al., 2011).  Furthermore hypoxia had no effect on the expression of chemokine receptors or on 
the capacity for neutrophils to undergo shape change (McGovern et al., 2011).   However, 
hypoxia led to the upregulation of the adhesion molecule CD11b and has been shown to 
enhance transmigration across the endothelium of blood vessels through both neutrophil and 
endothelial cell receptor regulation (Colgan et al., 1996; Kong et al., 2004; Meyer et al., 2007).  
Consistent with hypoxia enhancing the mechanisms responsible for transmigration, culture in 
hypoxia for 4 hours enhanced elastase release from primed neutrophils stimulated with fMLP 
(McGovern et al., 2011; Tamura et al., 2002).  While enhanced elastase release may facilitate 
tissue infiltration and elastase is important for host defence in gram negative sepsis, it also has 
the potential to damage healthy tissue and has been implicated in the pathogenesis of lung 
injury (Belaaouaj et al., 1998; Kaynar et al., 2008; Lee and Downey, 2001).  
1.2.4.3 Respiratory burst 
While phagocytosis and chemotaxis appear to be preserved in hypoxic conditions, defects in 
neutrophil respiratory burst have been observed. The respiratory burst is the chemical 
generation of free radicals by the multi-component phagocyte NADPH oxidase enzyme and is 
an important anti-microbial function of neutrophils (Roos et al., 2003). McGovern et al. 
demonstrated that extracellular superoxide generation by primed neutrophils in response to 
stimulation with fMLP was reduced in hypoxia.  Neutrophils stimulated with phorbol 12-
myristate 13-acetate (PMA) also had impaired generation of extracellular superoxide and 
intracellular oxidant generation was significantly reduced with either PMA or opsonized 
zymosan stimulation (McGovern et al., 2011).  Importantly, the profound impairment of 
respiratory burst was not associated with a reduction in NADPH-oxidase components in 
hypoxia (McGovern et al., 2011). Pyocyanin, a phenazine pigment exotoxin secreted by 
Pseudomonas aeruginosa, induces an accumulation of intracellular oxidants independent of 
NADPH-oxidase but involving direct oxidation of NADPH and NADH (Muller et al., 1989; 
O'Malley et al., 2004; Prince et al., 2008; Reszka et al., 2004). ROS generation in response to 
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pyocyanin was significantly inhibited in hypoxia indicating that impaired ROS production in 
hypoxia was independent of NADPH-oxidase (McGovern et al., 2011).  This and the fact that 
restoration of oxygen tension to normoxic levels reinstated the ability of neutrophils to 
produce ROS suggest it is the lack of molecular oxygen that leads to deficiency of ROS 
production in hypoxia.  Critically, hypoxia impaired the ability of neutrophils to kill certain 
bacteria.  Killing of Staphylococcus aureus, but not Escherichia coli, was impaired in hypoxia 
(McGovern et al., 2011).  The selective defect in killing of S. aureus was mirrored by NADPH-
oxidase inhibition, suggesting that while killing of S. aureus requires intact ROS generation, 
other ROS-independent mechanisms are sufficient for effective killing of E. coli (McGovern et 
al., 2011).   
 
1.2.5 HIF-1α is a key regulator of myeloid cell function  
Although the effect of hypoxia on neutrophil function requires further study, the oxygen 
sensing transcription factor HIF-1α has been shown to be a key regulator of myeloid cell 
function and survival.  As discussed above, Walmsley et al. showed that HIF-1α was essential 
for neutrophil survival in hypoxia (Walmsley et al., 2005). Furthermore, using mice with 
targeted deletion of the HIF-1α or VHL genes in myeloid cells (macrophages and neutrophils), 
Randall Johnson’s group elegantly demonstrated that HIF-1α is vital to the innate immune 
response.   
Cramer et al. showed that HIF-1α deficient myeloid cells had reduced levels of intracellular ATP 
in normoxic culture (Cramer et al., 2003). Functions dependent on ATP generation such as 
macrophage motility and invasion were significantly inhibited (Cramer et al., 2003). Although 
macrophage phagocytosis was not affected, bactericidal capacity was markedly reduced 
(Cramer et al., 2003).  HIF-1α deficiency did not impair neutrophil transmigration across a 
pulmonary endothelial cell monolayer or respiratory burst but significant reductions in granule 
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protease production and levels of cathelecidin-related antimicrobial peptide were 
demonstrated (Peyssonnaux et al., 2005). These studies also demonstrated that bacteria and 
LPS led to stabilisation of HIF-1α protein in macrophages independent of oxygen tension 
(Peyssonnaux et al., 2005). A summary of myeloid cell functions dependent upon HIF-1α is 
shown in Figure 1.2-2.  
Importantly, these in vitro findings were substantiated by in vivo models of infection and 
inflammation.  Cutaneous myeloid cell infiltration and tissue oedema in an in vivo model of 
acute inflammation was greatly reduced in HIF-1α deficient mice, but was increased in VHL 
deficient mice (Cramer et al., 2003). Group A streptococcal skin infection was also more severe 
in HIF-1α deficient mice, with larger necrotic lesions and greater weight loss than wild-type 
mice (Peyssonnaux et al., 2005).  Interestingly, HIF-1α deficient mice were less susceptible to 
LPS-induced sepsis with less clinical evidence of haemodynamic compromise and reduced 
mortality (Peyssonnaux et al., 2007).  HIF-1α deficient mice in this model produced lower 
levels of the inflammatory cytokines, tumour necrosis factor-α (TNF-α) and interleukin-6 
(Peyssonnaux et al., 2007).  
Other groups have also shown that HIF-1α activation modifies the immune response.  Vissers 
et al. isolated neutrophils from mice lacking ascorbate oxidase (Vissers and Wilkie, 2007). 
These ascorbate deficient neutrophils had elevated levels of HIF-1α and, consistent with the 
findings in hypoxia, had delayed rates of apoptosis (Vissers and Wilkie, 2007). Furthermore, 
ascorbate deficient neutrophils aged in vitro were not phagocytosed by macrophages and an in 
vivo model suggested that resolution of inflammation was delayed (Vissers and Wilkie, 2007).  
The mechanism by which HIF-1α regulates innate immune cell function may extend beyond its 
direct ability to modulate gene expression. For example, there is also evidence of important 
cross-talk between HIF-1α and another transcription factor, nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-ĸB)(Rius et al., 2008; Taylor, 2008). NF-ĸB is itself a master-
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regulator of inflammation and is implicated in the control of neutrophil apoptosis and function 
(Hsu et al., 2011; Ward et al., 1999).  As will be discussed later, NF-ĸB regulates HIF-1α 
transcription and may itself be regulated by HIF-1α (van Uden et al., 2008; Walmsley et al., 
2005).   
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Figure 1.2-2. HIF-1α is a key regulator of myeloid cell function. 
Bacterial stimuli, hypoxia or both lead to stabilization of HIF-1α subunits in innate immune 
cells. As a result transcription of hypoxia responsive genes is upregulated and in turn glycolytic 
activity of the cells is enhanced.  Studies have shown increases in a range of myeloid cell 
functions listed on the right hand side of the figure.  
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Furthermore patients with activation of HIF-pathways, for example patients with heterozygous 
mutation of the VHL gene (encoding the von Hippel Lindau protein responsible for HIF-α 
degradation) have been shown to exhibit a distinct neutrophil phenotype compared to healthy 
controls with delayed rates of constitutive apoptosis and enhanced phagocytic capacity 
(Walmsley et al., 2006). This provides direct evidence that the HIF pathway influences human 
neutrophil survival and function.   
 
1.2.6 Evidence of a distinct role for HIF-2α in myeloid cells 
Recent evidence has emerged that suggests that another HIF-α subunit, HIF-2α has a distinct 
role from HIF-1α in controlling nitric oxide (NO) homeostasis in macrophages. Takeda et al. 
showed that murine bone marrow derived macrophages (BMDMs) polarised to the M1 
phenotype (or classically activated) using lipopolysaccharide or Th1 cytokines such as 
interferon-gamma upregulated HIF-1α expression (Takeda et al., 2010).  On the other hand, 
BMDMs polarised to the M2 phenotype (or alternatively activated) using Th2 cytokines such as 
interleukin-4 or interleukin-13 upregulated HIF-2α expression.  Interestingly, this differential 
activation of the HIF-α subunits led to differences in NO synthesis.  Inducible nitric oxide 
synthase (iNOS), the enzyme responsible for NO synthesis from L-arginine and a known HIF-1α 
target gene (Peyssonnaux et al., 2005), was upregulated in M1 polarised macrophages while 
arginase-1, an enzyme which competes for L-arginine, was upregulated in M2 polarised 
macrophages under the regulation of HIF-2α (Takeda et al., 2010).  
Given the importance of the HIF pathway in myeloid cells and emerging evidence of a distinct 
role for the structurally similar HIF-2α subunit, the biology of the HIF-α subunits will be 
discussed and known differences between HIF-1α and HIF-2α reviewed.   
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1.3 HIF-α subunits – regulation and roles 
Three HIF-α subunits have been identified and while the most studied to date has been HIF-1α, 
emerging evidence has a distinct role for the structurally similar HIF-2α subunit.     HIF-2α, also 
known as EPAS-1, HIF-1α-like factor (HLF), HIF-related factor (HRF) and member of PAS 
superfamily 2 (MOP2), was identified by several groups searching for novel proteins similar to 
HIF-1α (Ema et al., 1997; Flamme et al., 1997; Tian et al., 1997). The structure of the HIF-α and 
β subunits is shown in Figure 1.3-1. 
 
1.3.1 Regulation of HIF-α subunits 
HIF-α subunits are predominantly regulated at the protein level by a family of hydroxylase 
enzymes (HIF-hydroxylases) which require oxygen, 2-oxoglutarate, iron (Fe(II)) and for maximal 
activity, ascorbate (Bruick and McKnight, 2001; Knowles et al., 2003; Lando et al., 2002). The 
concentration of oxygen required for half-maximal activity of these enzymes (KM 90-230 µM) 
is well above that in human tissues (10-30 µM), so the activity of the HIF-hydroxylases will 
fluctuate across the physiological range of oxygen tension in vivo (Ehrismann et al., 2007; 
Tuckerman et al., 2004). However, as the expression of HIF-α subunits varies in different cell 
types even when oxygen is available, activity of the HIF-hydroxylases at a given oxygen tension 
may be limited by other factors. 
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Figure 1.3-1. Structure of HIF-α and HIF-β subunits. 
A schematic drawing of the structures of HIF-1α, HIF-2α and HIF-β subunits.  HIF-3α is not 
included.  HIF-α subunits contain basic-helix-loop-helix (bHLH) and period-ARNT-sim (PAS) 
domains and their amino acid sequences display a high degree of homology (Hu et al., 2003; 
Tian et al., 1997).  In humans, the bHLH DNA binding domain of HIF-2α is 85% similar to HIF-1α 
and the PAS domains, important for dimerization with ARNT, are 70% similar (Hu et al., 2003). 
HIF-α subunits have two transcriptional activation domains (TADs) termed the N-terminal TAD 
(N-TAD) and C-terminal TAD (C-TAD) (O'Rourke et al., 1999; Patel and Simon, 2008). The inset 
shows the conservation across species of the asparaginyl (Asn) and prolyl (Pro) residues on 
HIF-2α that are hydroxylated by factor inhibiting-HIF (FIH) and the prolyl hydroxylase (PHD) 
enzymes respectively.    
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1.3.1.1 The prolyl hydroxylases (PHDs) 
Hydroxylation of highly conserved prolyl residues (see Figure 1.3-1) by prolyl hydroxylase 
domain-containing enzymes (PHDs) allows HIF-α subunits to bind to the von Hippel Lindau 
protein (pVHL) (Ivan et al., 2001; Jaakkola et al., 2001; Masson et al., 2001). The pVHL forms 
part of an E3 ubiquitin ligase complex and binding of this complex leads to ubiquitination of 
the HIF-α subunit, marking it for proteasomal destruction; see Figure 1.3-2 (Maxwell et al., 
1999). Four PHD enzymes have been identified (PHD1-4) (Bruick and McKnight, 2001; Epstein 
et al., 2001; Koivunen et al., 2007). They are widely expressed but for each enzyme levels of 
RNA may vary considerably according to cell type and the pattern of localisation within a cell is 
distinct (Kaelin and Ratcliffe, 2008; Lieb et al., 2002; Metzen et al., 2003). In vitro experiments 
have suggested that PHD-2 is the main regulator of HIF-1α, but this may be because PHD-2 is 
the most abundant PHD in most cells under normoxic culture conditions (Appelhoff et al., 
2004; Berra et al., 2003).  
Importantly, differences in substrate specificity of the PHD enzymes have been described. For 
example, data suggest that PHD-3 preferentially degrades HIF-2α (Appelhoff et al., 2004). In 
normoxic conditions, suppression of PHD-3 stabilised HIF-2α to a greater extent than HIF-1α 
and suppression of PHD-2 did not prevent degradation of HIF-2α following re-oxygenation of 
hypoxic cells (Appelhoff et al., 2004). Thus, as the PHD enzymes catalyse only the forward 
reaction, the relative abundance of the different enzymes within a cell may be a key 
mechanism by which differential regulation of the HIF-α subunits occurs.   
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Figure 1.3-2. Post-translational regulation of HIF-α subunits. 
In normoxia, HIF-α subunits are subject to hydroxylation by prolyl hydroxylase (PHD) enzymes 
and factor inhibiting-HIF (FIH).  These enzymes require oxygen (O2) and 2-oxolglutarate (2-Oxo) 
as substrates and their activity also depends on availability of iron (Fe2+) and ascorbate. PHD 
enzymes hydroxylate prolyl (Pro) residues allowing the von Hippel Lindau protein (pVHL) to 
bind to the HIF-α subunits. An E3 ligase complex then forms leading to ubiquitination (Ub) and 
subsequently degradation by the proteasome.  FIH hydroxylates (OH) an asparaginyl (Asn) 
residue in the C-terminal transactivation domain (CTAD), preventing recruitment of the co-
activators CBP/p300 and thus inhibiting transcription of HIF-target genes. In hypoxia, the HIF-
hydroxylases are less active allowing stable HIF-α subunits to dimerize with HIF-β, bind to 
hypoxic response elements (HRE), recruit the co-activators and upregulate transcription. 
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1.3.1.2 Factor inhibiting HIF (FIH) 
One asparaginyl hydroxylase has been identified in humans, factor-inhibiting HIF (FIH) (Lando 
et al., 2002). Hydroxylation of a conserved asparaginyl residue in the CTAD prevents 
interaction with the co-activators, creb-binding protein (CBP)/p300 and therefore deactivates 
HIF-mediated transcription; see Figure 1.3-2 (Lando et al., 2002). 
FIH hydroxylates ankyrin repeat domains, which exist in many proteins (Cockman et al., 2009). 
FIH may therefore be competitively inhibited by these proteins depending upon their 
hydroxylation status (Cockman et al., 2009; Webb et al., 2009). However, FIH may play a less 
important role in HIF-2α regulation as its CTAD has been shown in vitro to be more resistant to 
the effect of FIH than the CTAD of HIF-1α (Bracken et al., 2006; Yan et al., 2007). 
1.3.1.3 Regulation of the HIF-hydroxylases 
The finding of stable HIF-α subunits in cells where oxygen is readily available suggests other 
factors involved in HIF-hydroxylase activity may become limiting (Maxwell, 2005; Schofield and 
Ratcliffe, 2004). For example, iron chelation is known to limit HIF-hydroxylase activity, but 
more recent data have shown that non-hypoxic stabilisation of HIF-1α in a myeloid cell line 
was associated with changes in the intracellular labile iron pool and could be suppressed with 
iron supplementation (Epstein et al., 2001; Knowles et al., 2006; Knowles et al., 2003). 
Ascorbate supplementation also de-stabilised HIF-1α in this context and in a number of 
normoxic tumour cell lines in which HIF-1α was stable (Knowles et al., 2003).  
Negative feedback occurs through HIF-dependent expression of PHD-2 and PHD-3. This 
dampens the HIF pathway in chronic hypoxia and enables rapid deactivation of HIF-α when 
normoxic conditions are restored (Appelhoff et al., 2004; Aprelikova et al., 2006; D'Angelo et 
al., 2003). Succinate (a product of the hydroxylase reaction) can competitively compete with 
the substrate, 2-oxoglutarate, reducing HIF-hydroxylase activity (Selak et al., 2005). Thus 
disorders of succinate metabolism, such as the mutations in the succinate dehydrogenase 
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gene found in some types of cancer, may explain the activation of HIF-α subunits in those 
tumours (Mole, 2009; Selak et al., 2005).  
Nitric oxide (NO) may inhibit HIF-hydroxylase activity by competing with oxygen to bind to 
Fe(II).  However, the role of NO is complex as it has paradoxical effects on HIF-α subunit 
stability which depend on NO dose, ambient oxygen concentration and interaction with 
reactive oxygen species (Berchner-Pfannschmidt et al., 2010).  
1.3.1.4 Hydroxylase-independent regulation of HIF-α subunit stability 
Multiple HIF-hydroxylase independent mechanisms control HIF-α stability.  Firstly, de-
ubiquitination of hydroxylated HIF-1α subunits by the pVHL-interacting deubiquitinating 
enzyme, VDU2, may rescue them from degradation (Li et al., 2005).  Secondly, conjugation 
with small ubiquitin-like modifier (SUMO) may regulate HIF-α subunits. This process, known as 
SUMOylation, is not fully understood.  On the one hand reports have suggested SUMOylation 
of HIF-1α leads to its stabilisation while on the other hand several studies have shown 
enhanced degradation (Bae et al., 2004; Cheng et al., 2007).    Thirdly, receptor of activated 
protein kinase C (RACK-1) mediated recruitment of the E3 ligase complex and finally, 
phosphorylation by glycogen synthase kinase 3 (GSK3) both lead to proteasomal degradation 
of HIF-1α (Flugel et al., 2007; Liu et al., 2007).  
None of the above studies showed whether these additional methods of regulation are 
important for HIF-2α, but three novel mechanisms resulting in differential regulation of the 
two α subunits have been recently identified. Firstly, binding of heat shock protein 70 (Hsp70) 
to the HIF-1α subunit, led to its degradation in a process independent of pVHL but involving 
recruitment of the E3 ubiquitin ligase, carboxyl terminus of Hsc70-interacting protein (CHIP) 
(Luo et al., 2009). In these in vitro experiments, HIF-2α levels were not affected by 
overexpression or knockdown of Hsp70 or CHIP (Luo et al., 2009). Secondly, hypoxia-
associated factor (HAF), another E3 ubiquitin ligase, also selectively regulated HIF-1α subunits 
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but not HIF-2α (Nakayama et al., 2004). Finally, the integration site 6 (Int6) protein has been 
shown to regulate HIF-2α but not HIF-1α in a pVHL and oxygen independent manner (Chen et 
al., 2007).  
1.3.1.5 Reactive oxygen species (ROS) 
Many studies have demonstrated that changes in ROS levels within cells can alter HIF-α 
protein levels (Acker et al., 2006; Guzy et al., 2005; Hagen et al., 2003; Mansfield et al., 2005). 
However the exact role of ROS, particularly in hypoxia, remains controversial with apparent 
inconsistencies in experimental findings. For example, inhibition of ROS production by the 
mitochondrial transport chain has been shown to prevent HIF-1α and HIF-2α stabilisation while 
others found no effect (Doege et al., 2005; Guzy et al., 2005; Mansfield et al., 2005; Maxwell et 
al., 1999). As ambient oxygen tension influenced the results, a proposed explanation was that 
when oxygen was in short supply, mitochondrial inhibition led to a redistribution of oxygen 
within the cell and resulted in increased oxygen availability for the PHD enzymes (Doege et al., 
2005; Hagen et al., 2003). However, Bell et al. used cells with a defect in complex III of the 
mitochondrial transport chain that prevented utilisation of oxygen but permitted generation of 
ROS in hypoxic conditions (Bell et al., 2007). HIF-1α stabilisation occurred in these 
circumstances but could be prevented by antioxidants.  These results argue against the 
redistribution of intracellular oxygen levels and suggest ROS may be acting via other 
mechanisms.  For example, ROS may influence available levels of Fe(II) and thus limit PHD 
enzyme activity (Mole, 2009). 
1.3.1.6 Transcription and translation 
If protein synthesis were to overwhelm the post-translational eliminatory mechanisms or if 
oxygen-sensitive enzyme activity was limited, transcription and translation could play a role in 
HIF-α regulation (Schofield and Ratcliffe, 2004).  
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One important factor implicated in the control of HIF-1α transcription, and a key player in the 
inflammatory response, is the oxygen sensitive transcription factor, NFκB (Rius et al., 2008). In 
vitro studies have shown that HIF-1α mRNA levels are regulated by members of the NFκB 
pathway via binding of NFκB to the HIF-1α promoter (Belaiba et al., 2007; van Uden et al., 
2008). A recent study showed that IKKβ, a component of the NFκB signalling pathway, is 
necessary in vitro and in vivo for HIF-1α mRNA expression (Rius et al., 2008). Furthermore 
lipopolysaccharide, an activator of NFκB, upregulated HIF-1α protein levels in hypoxic 
macrophages (Rius et al., 2008). Interestingly, Rius et al. found no regulatory effect of IKKβ on 
HIF-2α.  In HIF-1α deficient neutrophils, hypoxic induction of NFκB mRNA was markedly 
reduced, suggesting that HIF-1α also exerts control on the NFκB pathway (Walmsley et al., 
2005).  
Protein synthesis is usually inhibited in hypoxia but HIF-α subunits are in a minority of essential 
proteins whose production is preserved (Fahling, 2009; Lang et al., 2002; Nakayama et al., 
2004). Increased translation of HIF-1α has been reported as a method of increasing levels of 
the transcription factor in hypoxic and normoxic conditions, while Sanchez et al. showed that 
inhibition of HIF-2α synthesis can occur via binding of iron-regulatory proteins (IRPs) to an iron 
response element in the 5’-untranslated region of HIF-2α mRNA (Laughner et al., 2001; Pore et 
al., 2006; Sanchez et al., 2007). 
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1.3.2 Roles of HIF-1α and HIF-2α   
Despite the similarities in their structure and regulation, HIF-2α has a distinct role from HIF-1α.  
Some differences in post-translational regulation have been described above and there are 
notable differences in expression, target genes, transcriptional regulation and function. 
1.3.2.1 Expression 
Ema et al. showed HIF-2α mRNA expression in most major organs of mice, most abundantly in 
the lung, heart and brain (Ema et al., 1997). In situ hybridization studies confirmed expression 
in alveolar epithelial cells, cardiomyocytes and vascular endothelial cells (Ema et al., 1997; 
Flamme et al., 1997; Tian et al., 1997). Wiesener et al. examined protein expression and 
immunoblotting revealed low or undetectable HIF-2α in tissues isolated from normoxic rats 
(Wiesener et al., 2003). However, marked widespread upregulation of HIF-2α expression 
occurred following exposure of the animals to normobaric hypoxia (8%) or carbon monoxide.  
The induction of HIF-2α varied between tissues and interestingly, even within tissues.  For 
example, in the liver, increased staining for HIF-2α was seen in hepatocytes closest to the 
central vein compared to staining around the portal triad, consistent with known in vivo 
oxygen gradients (Wiesener et al., 2003).  
In contrast with these in vivo data, some studies have shown expression of HIF-2α protein in 
normoxia. Primary cultures of human pulmonary artery fibroblasts and several cell lines 
including bovine arterial endothelial cells and human mammary epithelial cells expressed HIF-
2α (Ban et al., 1994; Eul et al., 2006; Wiesener et al., 1998).  Rius et al. showed presence of 
HIF-2α in murine BMDMs but Fang et al. did not find normoxic expression in human monocyte-
derived macrophages (Fang et al., 2009; Rius et al., 2008). Recent evidence suggests that the 
method of isolation is important in determining HIF-2α expression in mononuclear cells but 
whether there is a true species difference in expression is as yet unknown (Takeda et al., 
2010).  
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Key differences between HIF-1α and HIF-2α expression have been identified.  Firstly, in the 
kidney and brain, HIF-1α and HIF-2α were expressed in different cell populations following 
hypoxic exposure (Wiesener et al., 2003).  Secondly, in vitro and in vivo studies showed that 
HIF-2α protein was stabilised at higher oxygen concentrations than HIF-1α (Stroka et al., 2001; 
Wiesener et al., 2003; Wiesener et al., 1998). Thirdly, hypoxic induction of HIF-2α was 
sustained for longer than HIF-1α (Stroka et al., 2001; Wiesener et al., 2003).  Indeed, more 
recently these differences have been mirrored in the stability of HIF1A and HIF2A mRNA, with 
HIF2A mRNA being more stable than that of HIF1A (Takeda et al., 2010). Finally, the cellular 
localisation of the two transcription factors was different, with HIF-2α only being observed in 
cell nuclei but HIF-1α being found in both cytoplasm and nucleus (Stroka et al., 2001; Wiesener 
et al., 2003).  
1.3.2.2 Target genes 
More than 600 DNA binding sites for HIF-α subunits have been identified in the genome (Mole 
et al., 2009). The majority bound only HIF-1α but a significant number also bound both α 
subunits with a minority binding only HIF-2α (Mole et al., 2009). Other studies using gene array 
analysis also showed that HIF-1α regulates substantially more genes than HIF-2α in hypoxia or 
in response to iron chelation (Elvidge et al., 2006; Wiesener et al., 2003).  Furthermore, despite 
high affinity binding to HREs, several studies have suggested that HIF-2α does not always 
activate transcription (Hu et al., 2006; Mole et al., 2009).  Nonetheless, compelling data 
suggest HIF-2α is the key regulator of several genes.   
Among the genes that HIF-2α has been shown to preferentially regulate are transforming 
growth factor-α; the stem cell factor, Oct-4; the iron transporter, divalent metal transporter-1 
(DMT-1); and the adenosine A2A receptor (Ahmad et al., 2009; Covello et al., 2006; 
Mastrogiannaki et al., 2009).  HIF-1α uniquely regulates carbonic anhydrase-9; PHD-2; and 
glycolytic enzymes, such as hexokinase-2, phosphoglycerate kinase and lactate 
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dehydrogenase-A (Aprelikova et al., 2006; Hu et al., 2003; Raval et al., 2005). Both HIF-1α and 
HIF-2α have been shown to play a role in the regulation of PHD-3; adrenomedullin; vascular 
endothelial growth factor (VEGF); and glucose transporter-1 (Aprelikova et al., 2006; Hu et al., 
2003).  
Recent data suggest that HIF-2α is the dominant regulator of EPO in vivo (Gruber et al., 2007). 
In postembryonic mice deletion of HIF-2α using a conditional knockout system led to anaemia 
and decreased levels of circulating EPO while deletion of HIF-1α had no effect (Gruber et al., 
2007)). Evidence does suggest that HIF-1α plays a role in EPO regulation during development 
(Yoon et al., 2006).  
Although predominance of one α subunit over another has been demonstrated for certain 
target genes, this preferential regulation may be context-dependent (Holmquist-Mengelbier et 
al., 2006). For example, in neuroblastoma cells VEGF was regulated by HIF-1α after acute 
exposure to 1% oxygen, but following more prolonged and milder (5%) hypoxia, HIF-2α was 
the main inducer of VEGF (Holmquist-Mengelbier et al., 2006). Differential regulation may also 
occur. In renal cell carcinoma cells deficient in pVHL, the pro-apoptotic protein, BNIP3 was 
upregulated by augmenting expression of HIF-1α but downregulated by HIF-2α (Raval et al., 
2005).  
Further cell-type specific differences between HIF-1α and HIF-2α were demonstrated in mouse 
embryo fibroblasts (Park et al., 2003). These cells expressed HIF-2α protein in normoxia but it 
did not activate known target genes, even in hypoxic conditions, unless ectopically 
overexpressed (Park et al., 2003).  Experiments revealed that HIF-2α could not translocate to 
the nucleus, but the reason for this was not elucidated (Park et al., 2003).  
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1.3.2.3 Factors affecting HIF-2α target gene specificity 
Experiments using mutant HIF-α proteins have shown that it is not the DNA-binding region 
that confers target gene specificity.  Interestingly, replacement of the N-TAD of HIF-2α with 
that of HIF-1α can switch target gene specificity but both C-TAD and N-TAD regions are needed 
for full transcriptional activity (Hu et al., 2003; Lau et al., 2007).  
Multiple co-activators have been implicated in the control of transcriptional activity of both 
HIF-1α and HIF-2α including CREB-binding protein (CBP)/p300 and steroid receptor co-
activator (SRC1), but other transcription factors may determine target gene specificity (Carrero 
et al., 2000). Binding sites for members of the E-twenty six (ETS) family of transcription factors 
have been identified on genes preferentially regulated by HIF-2α (Aprelikova et al., 2006). 
Using siRNA to knockdown ELK-1, an ETS family member, prevented hypoxic induction of some 
but not all HIF-2α target genes (Aprelikova et al., 2006; Hu et al., 2007).  
Bracken et al. showed that HIF-2α but not HIF-1α interacts with IKK-gamma, also known as 
NFκB essential modulator (NEMO) (Bracken et al., 2005).  In normoxic human embryonic 
kidney cells, overexpression of NEMO resulted in enhanced HIF-2α transcriptional activity and 
conversely knockdown of NEMO reduced activity (Bracken et al., 2005).  
1.3.2.4 Function  
Key roles for HIF-2α in catecholamine homeostasis, lung maturation and vascular remodelling 
have been demonstrated by a variety of transgenic animal models, while roles in 
tumourigenesis and erythrocytosis are evident not only from experimental models but from 
human diseases. 
1.3.2.4.1 HIF-2α in embryogenesis    
Mice with homozygous deletion of HIF-2α (HIF2-α-/-) die either in utero or shortly after birth 
(Compernolle et al., 2002; Tian et al., 1998).  Embryonic lethality is thought to result from a 
deficiency of foetal catecholamines leading to circulatory failure (Tian et al., 1998).  However, 
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mice with a different genetic background displayed vascular disorganisation, particularly in the 
yolk sac (Peng et al., 2000). Endothelial-specific expression of HIF-2α in this model restored 
vascular development, but embryonic mortality remained high (Peng et al., 2000). A third 
group investigated HIF-2α-/- mice that survived to term (Compernolle et al., 2002).  These pups 
died of respiratory failure within a few hours due to insufficient surfactant and immature lungs 
(Compernolle et al., 2002).  These findings contrast with HIF-1α-/- mice, which die during mid-
gestation due to abnormal vascularisation (Ryan et al., 1998).  
1.3.2.4.2 Tumourigenesis 
HIF-α subunits are stable in many tumours but there are marked differences in the function of 
HIF-2α compared to HIF-1α.  In the tumour syndrome, von Hippel Lindau (VHL) disease, 
mutations in the pVHL gene are associated with the development of clear-cell renal cell 
carcinomas, haemangioblastomas and pheochromocytomas (Mole and Ratcliffe, 2008).  Loss 
of functional pVHL leads to accumulation of both α subunits, but HIF-2α has been implicated in 
the promotion of renal cell tumour growth while HIF-1α overexpression in renal cancer 
xenografts actually inhibited growth (Holmquist-Mengelbier et al., 2006; Patel and Simon, 
2008; Raval et al., 2005). Consistent with these findings, HIF-2α expression in other types of 
cancer (breast cancer, non-small cell lung cancer, neuroblastoma and teratomas) correlated 
with advanced stage or an aggressive phenotype (Covello et al., 2006; Holmquist-Mengelbier 
et al., 2006; Kim et al., 2009). Furthermore, inhibition of HIF-2α in lung carcinoma and clear 
cell renal cancer cells, led to increased tumour cell death and enhanced the response to 
radiation treatment (Bertout et al., 2008).  In contrast, loss of HIF-2α expression in colon 
tumours was correlated with advanced tumour stage and colon cancer cell xenografts deficient 
in HIF-2α exhibited enhanced growth (Imamura et al., 2009).  
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1.3.2.4.3 Erythrocytosis 
Mutations of several key regulatory components of the HIF pathway lead to the development 
of familial erythrocytosis (Lee, 2008).  For example, a mutation in the VHL gene leads to an 
autosomal recessive form of erythrocytosis that is endemic to Chuvashia, Chuvash 
polycythaemia (Lee, 2008; Sergeyeva et al., 1997)). Affected individuals have a homozygous 
missense mutation in the VHL gene leading to an amino acid substitution (Arg200Trp) that 
impairs interaction between the VHL protein and HIF-α subunits, inhibiting ubiquitination and 
therefore stabilising HIF-α subunits in non-hypoxic conditions (Ang et al., 2002).  
As discussed above (Section 1.3.2.2), evidence has emerged to suggest that HIF-2α is the 
dominant HIF-α subunit regulating EPO production.  Studies of familial erythrocytosis have also 
supported this conclusion.  Percy et al. identified a family with a gain-of-function mutation 
(G1609→T) in the HIF-2α gene (HIF2A)(Percy et al., 2008b).  This mutation led to a replacement 
of glycine by tryptophan at amino acid 537 close to the hydroxylation target, Pro531. 
Hydroxylation of the Gly537→Trp HIF-2α by PHD-2 was reduced but not to the same extent as 
a direct mutation at Pro531 (Percy et al., 2008b).  
 
In summary, I have described the biology of HIF-1α and HIF-2α, providing evidence that they 
may be differentially regulated and have distinct roles in many cell types.  Both transcription 
factors have important roles in innate immune cell function but the role of HIF-2α in 
neutrophils requires further exploration.    
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1.4 Aims of the thesis 
Hypoxia is a common finding at sites of inflammation but also more globally in patients with 
lung disease or critical illness. The oxygen sensing transcription factor, HIF-1α is a critical 
regulator of innate immunity.  Neutrophils are profoundly influenced by this transcription 
factor, depending on it for survival in hypoxia and production of ATP and important 
antimicrobial enzymes and proteins.  Although HIF-α subunits have some similarities, there is 
compelling evidence that HIF-1α and HIF-2α have distinct roles and that these roles vary 
according to cell type or microenvironment. It is unknown whether HIF-2α has a unique role in 
neutrophils.   
Infections frequently cause or complicate illnesses associated with arterial hypoxaemia and 
local tissue hypoxia.  In these contexts, the effects of local versus systemic HIF activation are 
not well characterised.  
Therefore, in this thesis I aim to investigate: 
i) The regulation and expression of HIF-2α in neutrophils 
ii) The functional consequences of HIF-2α overexpression and HIF-2α deficiency in 
neutrophils 
iii) Host-pathogen interactions in hypoxia using a subcutaneous infection model 
iv) The influence of HIF-1α or HIF-2α deficiency on host responses in the context of 
HIF-pathway activation by the combination of bacteria and hypoxia. 
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2 Methods 
2.1 Ethical approval 
The taking of blood samples from healthy volunteers and from patients with inflammatory 
arthritis was approved by the Sheffield Research Ethics Committee.  Volunteers gave full 
informed consent to participate.  Ethical approval to study neutrophils from patients with gain-
of-function mutations in the HIF2A gene was given by the Oxfordshire Clinical Research Ethics 
Committee and use of the human lung tissue was approved by the ethics committee of the 
Helsinki University Central Hospital, Helsinki, Finland.   
 
2.2 Human neutrophil isolation  
Neutrophils were isolated from peripheral blood using dextran sedimentation with 
discontinuous plasma-Percoll gradients. This method causes less activation of neutrophils than 
other methods of isolation (Haslett et al., 1985).  Percoll® (Sigma-Aldrich Company Ltd., 
Gillingham, UK) consists of polyvinylpyrrolidone coated colloidal silica particles ranging in 
diameter from 15-30 nm (23% w/w in water) (Sigma-Aldrich, 1998a). Materials used for 
neutrophil isolation were warmed to 37˚C in a water bath before use and centrifugation was 
carried out at room temperature. Sterile technique was employed throughout within a Class II 
microbiological safety cabinet (Walker, Glossop, UK). 
Peripheral blood was drawn using a 21 gauge needle and decanted into a 50 ml falcon tube 
containing tri-sodium citrate (Martindale Pharmaceuticals, Romford, UK) as an anticoagulant 
(4.4 ml 3.8% tri-sodium citrate for 35.6 ml blood).  Tubes were gently mixed then spun at 1200 
rpm (270 g) for 20 minutes (MSE centrifuge, Sanyo, Loughborough, UK).  The plasma phase 
was aspirated into clean falcon tubes, taking care not to disrupt the buffy coat layer, and spun 
at 2000 rpm (1155g) for 20 minutes to form platelet poor plasma (PPP).  To the lower cell-rich 
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layer remaining after the first spin, 6 ml of 6% dextran (Sigma-Aldrich Company Ltd., 
Gillingham, UK) were added and topped up to 50 ml with sterile 0.9% saline.  This was mixed 
by gently inverting the tubes, air bubbles were removed and the contents were allowed to 
settle for 20-30 minutes allowing red cell sedimentation to occur. 
When a clear interface was achieved, the upper leukocyte-rich layer was transferred to clean 
falcon tubes and spun at 1000 rpm (185 g) for 6 minutes.  Discontinuous plasma-Percoll 
gradients were prepared by overlaying 2 ml of 42% Percoll/58% PPP onto 2 ml of 51% 
Percoll/49% PPP in 15 ml tubes. Leukocytes (from up to 80 ml of blood) were re-suspended in 
1.5 ml PPP and layered on top of the upper phase of the plasma-Percoll gradient.  These tubes 
were immediately spun at 1100 rpm (225 g) for 11 minutes with zero brake.   
Three layers of cells are produced using this method.  Erythrocytes pellet at the bottom of the 
15 ml tubes.  Above this, between the 51% and 42% plasma-Percoll layers, a band of 
neutrophils and eosinophils is formed.  A further band, at the interface of the 42% Percoll and 
plasma layers, contains peripheral blood mononuclear cells (PBMCs). The PBMCs were 
carefully removed using a Pasteur pipette and then the granulocytes were transferred into 
25% PPP (10 ml PPP + 30 ml Hanks buffered salt solution (HBSS) without Ca2+/Mg2+ (Gibco®, 
Invitrogen Ltd., Paisley, UK)), counted using a haemocytometer and spun at 1500 rpm (420 g) 
for 6 minutes.  The supernatant was discarded and the cells were re-suspended to give 5x106 
neutrophils per ml in RPMI 1640 (Gibco®, Invitrogen Ltd., Paisley, UK) containing 1% penicillin 
and streptomycin and 10% foetal bovine serum (FBS). 
Neutrophil purity was measured by examination of cytocentrifuge slides prepared using freshly 
isolated cells (see Section 2.7.1) and was routinely >95% with eosinophils as the main 
contaminating cell type (see Figure 2.2-1). 
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2.2.1 Ultrapure human neutrophils 
To further purify human neutrophils, contaminating cells were removed by magnetic selection 
(Sabroe et al., 2002).  Following density gradient purification, the harvested and counted 
granulocytes were resuspended in 1 ml of column buffer (HBSS containing 2% FBS).  For every 
100x106 granulocytes, 70 µl of a custom antibody cocktail (StemCell Technologies, Grenoble, 
France) containing antibodies to CD36, CD2, CD3, CD19, CD56, and glycophorin A were added 
and the cells were incubated for 15 minutes at room temperature.  Magnetic colloid (50 µl per 
100x106 granulocytes, Miltenyi Biotec Ltd., Bisley, UK) was then added before further 15 
minutes incubation at room temperature, swirling intermittently.  During the incubation a 
MACS® LS column (Miltenyi Biotec Ltd.) was primed with 3 mls column buffer.  The cells were 
then added to the column, collecting the effluent in a falcon tube.  A further 9 mls of column 
buffer were then added to the column in 3 aliquots collecting a total of 10 mls of effluent.  The 
negatively selected cells that passed through the column were then pelleted at 1500 rpm (420 
g) for 6 minutes and resuspended in neutrophil media (RPMI 1640 containing 1% penicillin and 
streptomycin and 10% FBS), counted and diluted in media to a final concentration of 5x106/ml.  
Neutrophil purity following negative magnetic selection was greater than 99% (see Figure 2.2-
1). 
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Figure 2.2-1. Human neutrophil isolation. 
(A) Photographic image of freshly isolated human neutrophils on a cytocentrifugation slide. 
Original magnification x1000. (B) Representative side scatter (SSC) versus forward scatter (FSC) 
flow cytometry plot of an ultrapure neutrophil isolation. The plot shows 10,000 events with 
gate indicating contaminating PBMCs which represented 0.08% of the total population. Debris 
to the left of the diagonal black line was excluded.   
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2.3 Human neutrophil culture 
Human neutrophils were cultured at a concentration of 5x106/ml on 96-well non-tissue culture 
treated polyvinyl chloride plates (BD Falcon™, BD Biosciences, Becton Dickinson Ltd., Oxford, 
UK).  Normoxic cell culture was carried out at 37°C in a humidified incubator with 5% 
supplemental CO2 (Sanyo Electric Co Ltd., Japan). Hypoxic cell culture was established by re-
suspending cells in media that had been pre-equilibrated in 1% O2, 5% CO2 using an Invivo2 400 
hypoxic work station (Ruskinn, Bridgend, UK).  The PO2, PCO2 and pH of the hypoxic media 
were measured weekly using a blood gas analyser (ABL5, Radiometer, Copenhagen, Denmark) 
to confirm the delivery of a consistent hypoxic environment (see Table 2.3-1).  Neutrophils 
were cultured in the presence or absence of 10 ng/ml LPS from E coli. (Serotype R515(RE), 
TLRgrade™, Alexis® biochemicals, Lausen, Switzerland), the hydroxylase inhibitor, 
dimethyloxalylglycine (DMOG 1-1000 µM, Frontier Scientific Europe, Carnforth, UK), heat killed 
Staphylococcus aureus (SH1000, kind gift from Professor Simon Foster, University of Sheffield) 
or Streptococcus pneumoniae (serotype 2 strain D39, NCTC 7466, Health Protection Agency 
Culture Collections, Salisbury, UK).   
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Table 2.3-1. Gas tensions in culture media. 
Gas tension and pH values in neutrophil culture media equilibrated in either normoxia 
(atmospheric oxygen, 5% CO2) or hypoxia (1% O2, 5% CO2).   Data are mean and SEM.    
  
 pH PO2 (kPa) PCO2 (kPa) 
 
Normoxia 
n=4 
 
7.37 +/- 0.03 
 
19.02 +/-0.17 
 
4.66 +/- 0.16 
 
Hypoxia 
n=10 
 
7.34 +/- 0.01 
 
3.54 +/- 0.15 
 
4.55 +/- 0.07 
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2.4 Human neutrophil RNA preparation  
Neutrophils (5x106) were lysed with 750 µl of TRI® reagent (Sigma-Aldrich Company Ltd., 
Gillingham, UK). To isolate RNA, 200 µl of chloroform was added and after 15 minutes 
incubation at room temperature the sample was centrifuged at 14,000 g for 15 minutes at 4 oC 
(Eppendorf 5417R, Hamburg, Germany).  The clear aqueous RNA layer was transferred to a 
clean eppendorf tube and 500 µl of isopropanol were added.  Following 10 minutes incubation 
at room temperature the sample was again centrifuged at 14,000 g for 15 minutes at 4 oC.  The 
supernatant was discarded and 1 ml of 75% ethanol was added before centrifugation at 9000 g 
for 5 minutes at 4oC.  The supernatant was discarded and the pellet air-dried before being re-
suspended in 10 µl of RNase-free water.  A NanoDrop™ 1000 spectrophotometer (Fisher 
Scientific UK Ltd., Loughborough, UK) was used to assess RNA quantity and purity.  
2.4.1 DNase treatment of RNA 
Contaminating genomic DNA was removed from RNA samples using a DNase digestion kit 
(DNA-free™, Ambion, Huntingdon, UK).  RNA samples were diluted to achieve a nucleic acid 
concentration of approximately 200 ng/µl.  DNase I buffer (10x) was added to the RNA samples 
at a 1 in 10 dilution then 1 µl of DNase I enzyme was added for every 10 µg of nucleic acid.  
Samples were incubated for 30 minutes at 37˚C before addition of DNase inactivation reagent.  
A minimum of 2 µl or 0.1 volumes of inactivation reagent were added to the RNA samples 
which were then spun at 10,000g for 90 seconds to pellet the inactivation beads. A 
NanoDrop™ 1000 spectrophotometer (Fisher Scientific UK Ltd., Loughborough, UK) was used 
to again assess RNA quantity and purity. 
2.4.2 Random hexamer cDNA synthesis from human RNA aliquots 
Avian myeloblastosis virus (AMV) reverse transcriptase and random primers were used to 
generate cDNA from the RNA aliquots.  Every 1 µg RNA was made up to 12.4 µl with RNase-
free water and a cocktail of primers, enzyme and dNTP was added (see Appendix I).  Samples 
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were run on a DNA Engine™(PTC-200, MJ Research, Watertown, USA) at 23 oC for 5 minutes, 
then 42 oC for 2 hours, followed by 99 oC for 2 minutes to heat inactivate the enzyme and 
stored at –20 oC until required. 
2.4.3 Polymerase chain reaction 
Custom primers were designed for HIF2A (see Appendix II). These were used to amplify human 
neutrophil cDNA in polymerase chain reactions using GoTaq® Flexi DNA Polymerase (Promega 
UK, Southampton).  The components of the mastermix for these reactions and the cycling 
conditions are shown in Appendix III.  Negative controls with H2O in place of sample were 
performed routinely.    
2.4.4 Sequencing 
PCR products were run at 100 volts (PowerPac 300, Bio-Rad Laboratories) on 1.5% agarose 
gels.  Gels were prepared using electrophoresis grade agarose (Melford Laboratories Ltd., 
Ipswich, UK) and TAE buffer (40 mM Tris-base (Fisher Bioreagents, Fisher Scientific, New 
Jersey, USA), 20 mM acetic acid (Fisher Scientific), 1mM EDTA (Sigma-Aldrich Ltd.)) and heated 
in a microwave to dissolve.  Ethidium bromide (1 µl per 50 ml) was added to the liquid 
agarose/TAE before pouring into a gel tank and allowing to set. A 100 bp ladder (Hyperladder 
IV™, Bioline Reagents Ltd., London, UK) was used to confirm the size of the resulting product 
and this was localized using an ultraviolet transilluminator (UVP Chromato-Vue, San Gabriel, 
USA) or imaging system (ChemiDoc XRS+, Bio-Rad Laboratories Ltd., Hemel Hempstead, UK).  
The PCR product was subsequently extracted from the agarose gel with a scalpel and purified 
using a QIAquick PCR purification kit (QIAGEN, Crawley, UK). Sequencing was performed by the 
genetics core facility (University of Sheffield) using BigDye® 3.1 sequencing kits on a 3730 DNA 
Analyser (Applied Biosystems, Foster, USA).  Sequences were visualized using Finch TV 
software (Version 1.4.0, Geospiza Inc.) and alignment with known mRNA sequences analysed 
by NCBI nucleotide BLAST (http://blast.ncbi.nlm.nih.gov/).   
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2.4.5 Real-time polymerase chain reaction (RT-PCR) 
Real-time PCR allows detection and quantification of specific sequences in a sample of DNA.  
TaqMan® oligonucleotide probes use a high energy reporter dye at the 5’-end and a quencher 
molecule at the 3’-end.  The probe is designed to anneal to a specific sequence between the 
forward and reverse primers and is cleaved when the DNA polymerase starts to copy the 
cDNA.  This releases the fluorophore from the quencher molecule and fluorescent resonance 
energy transfer (FRET) is detected in real time. Identification of the exponential phase of the 
PCR reaction enables accurate quantification and comparison of samples.  
2.4.6 TaqMan® protocol 
TaqMan® gene expression assays (Applied Biosystems, Foster, USA) were used for target assay 
and endogenous control assay reactions.  Each product contained sequence-specific primers 
and a 6-FAM dye-labelled probe.  Beta-actin was selected as the endogenous control as it is 
highly expressed and expression is not altered by hypoxia. This enabled relative quantification 
following RT-PCR reactions.  When commercially available assays were not available (HIF2A, 
PHD3), probes and primers were designed and then manufactured by Sigma-Aldrich.  Primer 
and probe sequences for each assay are shown in Appendix II.  
Pre-optimised cDNA samples were diluted to give standards in order to create a standard 
curve for each gene of interest.  On the same 384-well plate, 1 µl of cDNA samples and 
standards were added in duplicate to 19 µl of master mix (see Appendix I). The thermal cycler 
conditions used were 2 minutes at 50 oC, 10 minutes at 95 oC then each of 40 cycles 15 
seconds at 95oC to denature and 1 minute at 60oC to anneal and extend.   
Average threshold cycle values were obtained for each sample using SDS2.2.1 software 
(Applied Biosystems).  Standards curves were plotted using an arbitrary value of 10000 for the 
top standard followed by the appropriate dilution series against average threshold cycle 
values.  Samples were then quantified using the standard curve.  The values obtained were 
52 
normalised to values for beta-actin expression in the same samples using the following 
equation: Normalised value = Gene-of-interest expression / beta-actin expression  
 
 
2.5 Western blotting 
2.5.1 Preparation of human neutrophil lysates for protein separation 
Following culture for the appropriate time period, neutrophils were gently harvested from the 
culture plates and spun at 2000 rpm for 2 minutes.  Hypoxic samples were harvested into 
eppendorf tubes within the hypoxic workstation and maintained on ice for the duration of the 
lysis protocol to minimise degradation of oxygen-sensitive proteins.  The cells were washed in 
ice cold phosphate buffered saline (PBS) (Gibco®, Invitrogen Ltd., Paisley, UK) before being 
washed in 1ml of sonication lysis buffer (see Appendix IV).  The supernatant was discarded and 
cells re-suspended in 100 µl of sonication lysis buffer and incubated on ice for 10 minutes.  
Cells were then sonicated in a Bioruptor™ iced water bath (Diagenode Europe SA, Liège, 
Belgium) using 30 second on-off high power cycles for 10 minutes.  The whole cell lysates were 
centrifuged at 12,000 g for 10 minutes at 4°C.  The supernatant was removed into fresh 1.5ml 
tubes and an equal volume of 2X SDS lysis buffer was added to each aliquot (see Appendix IV).  
Samples were boiled for 5 minutes at 100°C then stored at -80°C. 
2.5.2 Protein separation 
Proteins were separated by sodium dodecyl sulphate polyacrylamide electrophoresis (SDS-
PAGE) using the Bio-Rad mini PROTEAN®II electrophoresis cell system (Bio-Rad laboratories, 
Hemel Hempstead, UK). Glass plates were cleaned with distilled water and 70% industrial 
methylated spirits, before being assembled in a horizontal casting stand 1.5 mm apart. 
Resolving gels (8% for HIF-alpha western blots) were prepared (See Appendix V), and 
transferred to the casts using a Pasteur pipette.  The resolving gel was overlaid with 
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isopropanol to prevent evaporation until set. The isopropanol was then decanted and the gel 
washed with distilled water. A 5% stacking gel was poured on top of the resolving gel and a 10-
well 1.5 mm thick comb carefully inserted to avoid air bubbles.  After the stacking gel had set 
the comb was carefully removed and the glass plates were placed in a gel running tank and 
immersed with SDS-PAGE running buffer (See Appendix V). Neutrophil cell lysates were heated 
to 100°C for 2-5 minutes before being loaded into individual lanes with one or two lanes 
containing rainbow markers (Bio-Rad Laboratories). The gel was run at 180 volts (PowerPac 
300, Bio-Rad Laboratories) until the blue dye front reached the bottom of the gel. 
2.5.3 Protein Transfer 
Following separation by SDS-PAGE as described above, the gel apparatus was disassembled. 
The glass plates were carefully separated and the stacking gel was removed.  Using flat-ended 
tweezers, the resolving gel was lifted off the glass and placed onto blotting paper soaked in 
transfer buffer (see Appendix V). 
 A piece of PVDF Immobilon-P transfer membrane (Millipore, Bedford, USA) was activated by 
soaking in methanol for 2 minutes and then placed in transfer buffer.  In a tray containing 
transfer buffer, a gel-holding transfer cassette was opened and a fibre pad soaked in transfer 
buffer was placed on the black side of the cassette.   Two pieces of blotting paper (Whatman® 
3mm chromatography paper, Whatman International, Maidstone, UK) were then placed on 
top of this followed by the resolving gel and then the activated membrane.  Two further pieces 
of blotting paper and another fibre pad were applied on top before the gel holding cassette 
was closed and placed in a tank filled with ice-cold transfer buffer.  Transfer of protein to the 
membrane was performed using a Bio-Rad Mini Trans-Blot® cell at 100 volts for 70 minutes. 
Loading and transfer success was assessed by Ponceau S solution staining (Sigma-Aldrich 
Company Ltd., Gillingham, UK).  Membranes were stained for 30 seconds, before rinsing in 
distilled water. 
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2.5.4 Immunoblotting and Detection 
After transfer, the membrane was blocked in blocking buffer (see Appendix V) for 1 hour on an 
orbital shaker.  This minimised non-specific binding of antibodies to the membrane.  The 
membrane was transferred to a 50 ml tube and the primary antibody, diluted in 4 ml of 
blocking buffer, was added.  The dilutions at which the antibodies were used are shown in 
Appendix VI. The membrane was incubated overnight at 4˚C on a rolling platform.  After 
incubation with the primary antibody, the membrane was washed for 30 minutes in Tris-
buffered saline supplemented with Tween 20 (see Appendix V) before being incubated for one 
hour at room temperature with the appropriate HRP-conjugated secondary antibody diluted in 
4 ml of blocking buffer. The membrane was then washed again as before.  Labelled proteins 
were detected using the Enhanced Chemi-Luminescent™ (ECL) system (EZ-ECL, Geneflow Ltd., 
Fradley, UK). The ECL-treated membranes were placed between two pieces of acetate.  Air 
bubbles and excess ECL were removed before the membrane was placed in a developing 
cassette (Amersham Hypercassette™, GE Healthcare Ltd. Little Chalfont, UK) and exposed to X-
ray film (Amersham Hyperfilm™) in a dark room. Exposed x-ray films were developed, washed 
and air-dried.   
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2.6 Immunohistochemistry 
Lung tissue sections were from non-smokers and patients with COPD undergoing resection of 
hamartomas and kindly provided by Professor Vuokko Kinnula (Department of Medicine and 
Pathology, Helsinki University Central Hospital, Finland).  Immunohistochemistry was kindly 
performed by Yvonne Stephenson.   
2.6.1 Staining of tissue sections  
Slides were dewaxed twice in xylene, leaving slides in the xylene for 5 minutes each time. 
Slides were then placed in 95% ethanol for 2 minutes followed by 70% ethanol for 2 minutes 
before being washed well in water. Endogenous peroxidases were quenched by adding 3% 
H2O2 in methanol for 20 minutes then slides were washed again with water. Non-specific 
antibody binding was blocked by incubating in Power Block™ (Biogenex, Fremont, USA) for 10 
minutes. Slides were washed 3 times in water then incubated in primary antibody for 30 
minutes.  The primary antibodies were diluted in TBST (see Appendix IX for dilutions).  An 
appropriate isotype control antibody was used alongside each primary antibody. Following 3 
washes in TBST, slides were incubated with ImmPRESS™ reagent (ImmPRESS™ universal 
polymer detection kit, Vector Laboratories Ltd, Peterborough, UK).  The ImmPRESS™ reagent 
consists of a peroxidase coupled to anti-mouse and anti-rabbit IgG secondary antibodies. Slides 
were washed 3 times in TBST before adding diaminobenzidine (DAB) substrate from the DAB 
peroxidase substrate kit (Vector Laboratories Ltd.).  The peroxidase in the ImmPRESS™ kit 
reacts with the DAB substrate producing a dark brown reaction product. This reaction was 
allowed to proceed for up to 10 minutes. Sections were rinsed in running water and then 
counterstained with Gill’s haematoxylin for 30 seconds.  After a further wash, Scott’s tap water 
was added for 10 seconds before washing in running water.  Finally, the slides were 
dehydrated by immersion in an ascending series of ethanol concentrations and mounted using 
VectaMount™ (Vector Laboratories Ltd.).  
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2.7 Detection of human neutrophil apoptosis 
2.7.1 Preparation of cytocentrifugation slides 
Cytocentrifuge slides allow the long-term preservation of neutrophil morphology and 
therefore assessment of the morphological changes observed during apoptosis.  Neutrophils 
(100 µl of 5x106/ml) were removed from culture and added to the chamber of the cytospin 
apparatus. This consisted of slide holder, microscope slide, filter paper and cytospin chamber.  
Cells were spun at 300 rpm for 3 minutes in a Cytospin 3 cytocentrifuge (Shandon Life Sciences 
International Ltd, Runcorn, UK).  Slides were allowed to dry before methanol was applied to fix 
the cells.  The cells were then stained with Reastain Quick-Diff (Reagena Ltd, Toivala, Finland), 
a modified Wright-Geimsa stain.  Once dry, slides were cover-slipped and viewed using oil 
immersion light microscopy (see Figure 2.7-1). 
  
57 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7-1.  Apoptotic neutrophils.  
Photomicrograph of human neutrophils after 8 hours of culture in normoxic conditions.  
Neutrophils were spun onto cytocentrifugation slides, fixed with methanol and stained with 
Reastain Quick-Diff.  Grey arrows indicate morphologically apoptotic cells, black arrow 
indicates an eosinophil. Original magnification x1000.  
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2.8 Assessment of human neutrophil function 
2.8.1 Neutrophil phagocytosis 
2.8.1.1 Phagocytosis of opsonized zymosan A 
Zymosan A is prepared from the cell wall of Saccharomyces cerevisiae (Sigma-Aldrich).  Before 
use, 1 g zymosan should be boiled in 200 ml of sterile PBS for 30 minutes then allowed to cool. 
Aliquots of this mixture were centrifuged (1200 rpm for 10 minutes at 4˚C) and washed three 
times with sterile PBS.  The zymosan was then pooled into a final volume of 20 ml of sterile 
PBS and aliquots transferred into eppendorf tubes.  These aliquots were spun at 3000 rpm for 
5 minutes and the supernatant discarded before storing at -20˚C.  On the day of use the 
zymosan was opsonized by adding 1 ml of foetal bovine serum to 10 mg of zymosan and 
agitating for 1 hour at 37°C.  Particles were then washed three times in PBS before re-
suspending in PBS to give a stock suspension of 50 mg/ml.  Prepared in this way zymosan 
forms a fine suspension of particles around 3 µm in diameter.   
Neutrophils were incubated with 0.2 mg/ml or 1 mg/ml of opsonized zymosan A particles for 
15 minutes at 37°C.  Cytocentrifuge slides were then prepared and uptake of the yeast 
particles by neutrophils assessed.  Phagocytic index (PI) was calculated as follows: 
PI = (Mean number of particles per neutrophil) x (% of neutrophils containing particles)  
2.8.1.2 Phagocytosis of Escherichia coli 
Neutrophils were incubated with heat-inactivated fluorescein isothiocyanate-conjugated 
Escherichia coli (Sigma-Aldrich Company Ltd., Gillingham, UK) at a multiplicity of infection of 1 
for 30 minutes at 37°C.  The cells were then placed on ice to stop phagocytosis, washed in PBS 
and re-suspended in fluorescence-activated cell sorting (FACS) buffer (PBS without Ca2+/Mg2+, 
0.25% bovine serum albumin, 0.1 mM HEPES, pH 7.4, filter-sterilized).  Samples were 
processed using a flow cytometer (BD FACSCalibur™, BD Biosciences, Becton Dickinson Ltd., 
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Oxford, UK).  Results in the FL-1 channel were analysed using FlowJo software (version 9.0, 
Tree Star Inc., Ashland, US). 
2.8.2 Respiratory burst  
Intracellular reactive oxygen species production was assessed using 2’,7’-dichlorofluorescein 
diacetate (DCF)(Sigma-Aldrich Company Ltd., Gillingham, UK). This cell-permeable compound 
fluoresces upon reaction with oxidants (Hempel et al., 1999). Cells were pre-equilibrated for 1 
hour then treated with 3% DCF.  After 30 minutes cells were stimulated with 100 nM formyl-
methionyl-leucyl-phenylalanine (fMLP) or 0.2 mg/ml opsonised zymosan A for a further 30 
minutes.  After washing in PBS, the fluorescence of the cells from the FL-1 channel was 
recorded by a flow cytometer (BD FACSCalibur™, BD Biosciences, Becton Dickinson Ltd., 
Oxford, UK) and geometric mean fluorescence was subsequently calculated using FlowJo 
software (version 9.0, Tree Star Inc., Ashland, US). 
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2.9 Fish husbandry 
The neutrophil specific fluorescent zebrafish line Tg(mpx:GFP)i114 (Renshaw et al., 2006) was 
used, subsequently referred to as mpx:GFP. Zebrafish were maintained according to standard 
protocols (Nusslein-Volhard, 2002). Adult fish were maintained on a 14 hour light and 10 hour 
dark cycle at 28°C in UK Home Office approved facilities in the MRC CDBG aquaria at the 
University of Sheffield.  Fish experiments were kindly performed by Dr Phil Elks.  
2.9.1  Inflammation assay 
Inflammatory responses were elicited in zebrafish embryos by tail transection as previously 
described using the neutrophil specific line mpx:GFP (Elks et al., 2011; Renshaw et al., 2006). 
Two days post-fertilization (dpf) embryos were anesthetized by immersion in 0.168 mg/ml 
Tricaine (Sigma-Aldrich) and transection of the tail was performed as previously described (Elks 
et al., 2011). Neutrophils were counted at the site of transection at 6, 24 and 48 hpi using a 
fluorescent dissecting stereomicroscope (Leica Microsystems GmbH, Wetzlar, Germany). 
Counting was performed blind to experimental conditions.  
2.9.2 Zebrafish neutrophil apoptosis assay 
Rates of apoptosis were assessed using TUNEL/TSA, by blinded assessors, and by anti-active 
caspase-3/TSA staining, as previously described (Elks et al., 2011). Apoptotic neutrophils were 
identified in the tail transection region, imaged on an UltraVIEWVoX spinning disk confocal 
microscope (Perkin Elmer Inc.) and quantified by the percentage of neutrophils co-labelled 
with TUNEL. 
2.9.3 Wild-type and mutant epas1 cloning 
Zebrafish 2dpf RNA purified using TRIzol (Invitrogen) was used for RT-PCR cloning of zebrafish 
the HIF2A homologue epas1a (primer details in Appendix VII) using Pfusion polymerase 
(Finnzymes, Espoo, Finland). These were initially cloned into the TOPOBlunt vector (Invitrogen) 
and were subsequently subcloned into the pCS2+ vector (Invitrogen) for RNA synthesis. 
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Dominant active forms of epas1a were generated by successive rounds of site-directed 
mutagenesis. In each round one of the hydroxylation sites (P347A, P481G, N753A) was 
mutated into non-hydroxylatable amino acids as previously described in zebrafish hif1a (Elks et 
al., 2011). Additionally, the corresponding zebrafish amino acid to the human HIF-2α G537R 
and G537W was mutated in the same fashion.  Dominant active RNAs were transcribed 
(mMessageMachine, Ambion, Life Technologies Corp., Carlsbad, CA) and micro-injected into 
zebrafish embryos at the one cell stage as previously described (Elks et al., 2011).   
2.9.4 Determination of epas1a signalling activity 
To assess the function of overexpressed G487 mutant constructs, phd3 in situ hybridization 
was performed using previously described methods 24 hours following injection of G487R, 
G487W or dominant active epas1a at the 1 cell stage (Thisse and Thisse, 2008).  A dominant 
negative form of epas1a was generated using primers amplifying DNA corresponding to amino 
acids 1-330 of human HIF-2α (Elks et al., 2011; Manotham et al., 2005).  
2.9.5 Morpholino knockdown of arnt-1.  
The arnt-1 morpholino (Genetools, Philomath, OR) was used as previously reported (Prasch et 
al., 2006). A standard control morpholino (5' CCTCTTACCTCAGTTACAATTTATA 3') (Genetools) 
was used as a negative control. 
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2.10 Murine colonies 
A tissue specific Cre-loxP system was used to delete Hif1a or Hif2a. Lysozyme M-driven Cre 
recombinase (LysMCre) was used to target Hif1a (Hif1aflox/flox;LysMCre+/-) or Hif2a 
(Hif2aflox/flox;LysMCre+/-) in myeloid lineage cells. Animals were back crossed to a C57BL/6 
background (Cramer et al., 2003; Takeda et al., 2010). Breeding pairs of these mice, 
homozygous for the floxed alleles, were kindly provided by Professor Randall Johnson 
(University of California, San Diego; now at University of Cambridge, UK) and Professor Celeste 
Simon (University of Pennsylvania, Philadelphia).  C57BL/6 mice (Harlan, Oxon, UK) or 
littermate Hif2aflox/flox;LysMCre-/-  mice were used as controls.  All animal experiments were 
conducted in accordance with the Home Office Animals (Scientific Procedures) Act of 1986 with 
local ethics approval. 
2.10.1 Extraction of murine DNA 
Ear clippings were put into 1.5 ml eppendorf tubes before 180 µl of buffer ATL (Qiagen DNeasy 
kit, Qiagen Ltd. Crawley, UK) and 20 µl of proteinase K (Qiagen Ltd.) were added to each 
sample. Samples were then vortexed and placed in a shaking water bath at 56˚C overnight. 
Following lysis, the samples were vortexed followed by the addition of 200 µl of buffer AL and 
200 µl of ethanol.  After thorough mixing, each sample was added to a DNeasy mini spin 
column (Qiagen Ltd.) and spun at 8000 rpm for 1 minute. The flow through was discarded and 
the column was washed using 500 µl AW1.  After spinning at 800 rpm for 1 minute, the wash 
was repeated with 500 µl buffer AW2 and the samples were spun at 13,400 rpm to dry the 
column membrane. DNA was then eluted into a fresh collection tube with 100 µl H2O.   
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2.10.2 Genotyping of murine colonies 
Genotyping of the mice was performed by Ian Phillips (Bioserv UK Ltd, Sheffield, UK) using 
primers, mastermix and cycling conditions detailed in Appendix VIII.  An example of the 
genotyping results for animals from these colonies are shown in Figure 2.10-1. 
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Figure 2.10-1. Genotyping of murine colonies. 
(A & C) Representative images of PCR gels performed to detect murine genotypes.
extracted from ear clips of mice and amplified using primers to detect wild
Hif1a or (C) Hif2a alleles.  Wild type and floxed allele bands are labelled in each panel. H
wild-type DNA (Wt) were used as controls.  (B) A schematic showing the use of 3 primers for 
Hif2a genotyping.  This allowed detection of wild
the multiplex PCR detected the 1
lysozyme M driven Cre transgene (lanes indicated by *).  This phenomenon is reported in other 
tissue-specific Cre-loxP systems 
transgene was confirmed by a further PCR reaction in all animals. 
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2.11 Murine neutrophil isolation 
Peripheral blood or bone marrow murine neutrophils were isolated by negative magnetic 
selection using commercially available kits. Following leukocyte preparation (described in 
sections 2.11.1 and 2.11.2), the EasySep® ‘neutrophil enrichment kit’ from StemCell 
technologies produced a better yield of neutrophils than the Miltenyi MACS® ‘untouched 
neutrophil isolation kit’ and was therefore used as the standard method of isolation for 
peripheral blood neutrophils.  However, when isolating neutrophils for RNA work or from bone 
marrow, better purity was obtained using the Miltenyi neutrophil isolation kit (see Figure 2.11-
1).   The standard (EasySep®) neutrophil isolation is described in section 2.11.3 and the highly 
pure (Miltenyi MACS®) neutrophil isolation is described in section 2.11.4.  
2.11.1 Murine peripheral blood leukocyte preparation 
Mice were anesthetised using a mixture of xylazine hydrochloride (10 mg/kg, Rompun® 2%, 
Bayer HealthCare, Kiel, Germany), atropine sulphate (0.02 mg/kg, Atrocare®, Animalcare Ltd., 
York, UK) and ketamine (200 mg/kg, Ketaset®, Fort Dodge Animal Health Ltd., Southampton, 
UK).  Once adequately anaesthetised, a laparotomy was performed and the inferior vena cava 
exposed by blunt dissection.  Blood was collected using a 23G needle (BD Microlance™3, 
Becton Dickinson, Fraga, Spain) and 1 ml syringe (BD Plastipak™).  Between 0.5 and 1 ml of 
blood were obtained per mouse and this was transferred into labelled 15 ml falcon tubes.  
Mice were culled by cervical dislocation following venesection.  The erythrocytes were lysed 
using 9 parts of an ammonium chloride lysis solution (StemCell technologies) to every 1 part 
blood.  The blood and lysis solution were incubated together for 10 minutes at room 
temperature and out of direct light.  The leukocytes were pelleted at 300 g for 10 minutes at 
4˚C and the supernatant removed.  Pellets were resuspended in 10 ml of a PBS buffer solution 
containing 2% foetal bovine serum and 5 mM EDTA (RoboSep™ buffer, StemCell technologies) 
and spun again at 300 g for 10 minutes at 4˚C.  Typically leukocytes from 2 or 3 mice were 
pooled to obtain sufficient numbers for neutrophil isolation. 
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Figure 2.11-1. Isolation of murine neutrophils from peripheral blood and 
bone marrow. 
(A) Purity of peripheral blood neutrophils isolated using either Miltenyi negative selection kit 
and MACS® LD columns or the EasySep® neutrophil isolation kit with Easyplate® magnet.  (B) 
Yield of neutrophils from peripheral blood using the Miltenyi or EasySep isolation methods 
expressed as 106 cells per mouse. (C & D) Photographs of freshly isolated murine (C) peripheral 
blood or (D) bone marrow derived neutrophils. Original magnification 1000x.   (E) Photograph 
of a cytocentrifuge slide showing contaminating leukocytes in murine peripheral blood 
neutrophil isolations. N = neutrophil; M = monocyte; L = lymphocyte. Original magnification 
1000x.   
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2.11.2 Murine bone marrow leukocyte isolation 
Mice were killed by cervical dislocation following venesection (2.11.1) and the hind legs de-
gloved and removed by cutting at ankle and hip joint. Femurs and tibias were carefully 
dissected from the surrounding muscle and placed in ice cold HBSS with 0.5% bovine serum 
albumin (Sigma-Aldrich).  Bones were cannulated with 25G needles (BD Microlance™) and the 
marrow was flushed into falcon tubes using 10 mls of HBSS plus BSA.  This cell suspension was 
passed over a 40 µm cell strainer (BD Falcon™) to remove clumps and other tissue before the 
cells were pelleted at 350 g for 6 minutes at 4˚C.  The supernatant was discarded and the cells 
were resuspended in 20 mls of PBS plus 0.5% BSA.  A haemocytometer count was performed 
before the cells were pelleted again, ready to proceed to negative magnetic selection as 
described in 2.11.4.  Typically 50 x 106 leukocytes were obtained per mouse.   
2.11.3 Standard murine peripheral blood neutrophil isolation - EasySep® kit 
Following peripheral blood leukocyte preparation, leukocyte pellets were resuspended in 150 
µl of RoboSep™ buffer and transferred into a 96-well non-tissue culture treated U-bottom 
plate (BD Falcon Microtest™).  The EasySep® neutrophil enrichment antibody cocktail labels a 
maximum concentration of leukocytes of 100 x 106 per ml or 15 million cells per well.  Typically 
blood from 3 mice yielded less than 15 million leukocytes and therefore leukocytes from a 
maximum of 3 mice were pooled per well.  Rat serum (7.5 µl per 150 µl sample) and neutrophil 
enrichment cocktail (7.5 µl per 150 µl sample) were added and the plate incubated at 4˚C for 
15 minutes. RoboSep™ buffer (100 µl) was then added to each sample and the plates 
centrifuged at 300 g for 7 minutes.  The supernatant was aspirated and the cell pellets 
resuspended in 150 µl of RoboSep™ buffer.  A biotin selection cocktail was then added (7.5 µl 
per 150 µl sample) and plates were incubated for a further 15 minutes at 4˚C.  Magnetic 
dextran-coated iron particles (D Particles) were added (20 µl per 150 µl sample) and plates 
incubated for 10 minutes at 4˚C.  RoboSep™  buffer was added to each well to give a total 
volume of 250 µl and the plate was placed on an EasyPlate™ EasySep® magnet (StemCell 
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technologies) for 10 minutes at room temperature.  The tetrameric antibody complexes bound 
to contaminating cells were attracted to the magnet and settled at the bottom of the wells 
leaving unlabelled neutrophils in the supernatant.  This supernatant was carefully transferred 
into 15 ml falcon tubes and topped up with RoboSep™ buffer to a final volume of 500 µl.  A 
haemocytometer count was performed and the cells were washed in 10 mls of PBS before 
being spun at 300 g for 10 minutes.  The cells were then ready to be suspended in media or the 
appropriate lysis solution.   
2.11.4 Highly pure murine neutrophil isolation – Miltenyi MACS® kit 
The volumes of antibody and buffer solutions described for this method apply to the use of the 
MACS® untouched murine neutrophil isolation kit (Miltenyi Biotec Ltd.) with 50x106 or fewer 
leukocytes. If greater than 50x106 leukocytes, buffer and antibody volumes were titrated up 
accordingly, but if less than 50x106 leukocytes the volumes were not reduced.  Murine 
peripheral blood or bone marrow leukocytes were resuspended in 400 µl of a buffer solution 
(PBS plus 0.5% BSA).  Mouse FC receptor blocking reagent (Miltenyi Biotec Ltd.) was added (50 
µl per 50x106 leukocytes) and the cells incubated for 10 minutes at 4˚C. A biotinylated antibody 
cocktail was added (50 µl per 50x106 leukocytes) and cells were incubated for a further 10 
minutes at 4˚C.  Cells were washed in 10 ml of the buffer solution and centrifuged at 300g for 
10 minutes.  The supernatant was removed and cells were resuspended in 400 µl buffer.  Anti-
Biotin MicroBeads (100 µl per 50x106 leukocytes) were added followed by 15 minutes 
incubation at 4˚C. Cells were washed again in 10 ml of buffer and spun at 300 g for 10 minutes. 
The supernatant was removed and cells were resuspended in 500 µl buffer.  During the final 
spin a MACS® LD column, placed in a MidiMACS™ magnet, was primed by rinsing with 2 ml of 
buffer.  The cell suspension was applied to the primed column and unlabelled cells were 
collected in a clean falcon tube.  Once the cells had fully penetrated the column matrix, buffer 
solution (2 x 1 ml aliquots) was used to wash the column.  The enriched neutrophils which had 
passed through the column were washed by topping up the flow through to a total volume of 
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10 mls, pelleted at 300 g for 10 minutes and resuspended in 500 µl of buffer before being 
counted.  The neutrophils were pelleted at 300 g for 10 minutes and were then ready for use.   
 
 
2.12 Murine neutrophil culture 
Murine neutrophils were cultured at a concentration of 1x106/ml on 96-well non-tissue culture 
treated polyvinyl chloride plates (BD Falcon™).  Normoxic and hypoxic cell culture was carried 
as described in section 2.3.  Cells were also cultured in the presence or absence of 10 ng/ml 
LPS from E coli. (Serotype R515(RE), TLRgrade™, Alexis® biochemicals, Lausen, Switzerland) or 
the hydroxylase inhibitor, dimethyloxalylglycine (DMOG 1-1000 µM, Frontier Scientific Europe, 
Carnforth, UK). 
 
 
2.13 Murine neutrophil RNA extraction   
Murine peripheral blood or bone marrow neutrophil RNA was extracted using the mirVana™ 
total RNA isolation protocol (Ambion, Austin, USA).  Cells (1x106 per condition) were lysed in 
300 µl of mirVana lysis/binding buffer and stored at -80 ˚C if not being extracted immediately.  
To extract the RNA, miRNA homogenate (1/10th of the lysate volume) was added to the lysate 
to stabilise the RNA and inactivate RNases.  Samples were vortexed (Vortex Genie®2, Scientific 
Industries, Bohemia, USA) to mix and incubated on ice for 10 minutes. A volume of Acid-
Phenol:Chloroform (Ambion) equivalent to that of the initial lysate was added, mixed well 
using a vortex mixer and spun at 13400 rpm (Eppendorf Mini Spin Hamburg, Germany) for 5 
minutes at room temperature.  The upper aqueous layer was carefully removed and 
transferred to a clean RNase-free 1.5 ml eppendorf tube.  The volume removed was noted to 
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enable 1.25 volumes of ethanol to be added. Samples were vortexed and a maximum of 700 μl 
of this aqueous layer/ethanol mixture was transferred onto a filter cartridge within a labelled 
mirVana kit collection tube. These tubes were spun for 15 seconds at room temperature at 
10000 rpm. The flow through was discarded and any remaining aqueous/ethanol mixture was 
added to the filter cartridge.  Once all the aqueous/ethanol mixture had been spun over the 
cartridge, 700 μl miRNA wash-solution 1 was added to the filter cartridge.  Tubes were again 
spun for 15 seconds at 10000 rpm, the flow through was discarded and washing of the filter 
cartridge was repeated a further two times using 500 μl miRNA wash-solution 2/3, discarding 
the flow through after each wash. After the final wash, the tubes were spun for a further 60 
seconds to dry the filter cartridge.  Cartridges were then placed into a clean labelled collection 
tube and 30 μl of RNase free water pre-heated to 95 °C was added to the filter cartridge.  
Tubes were spun again for 20-30 seconds at 13400 rpm.  The flow through containing the RNA 
was then analysed using a NanoDrop™ 1000 spectrophotometer (Fisher Scientific UK Ltd.). 
cDNA synthesis was performed as per section 2.4.1 but due to the low numbers of murine 
neutrophils and low yield of RNA, 500 ng of RNA were used to make each cDNA sample. 
 
 
2.14 Murine neutrophil protein extraction and immunoblotting   
Murine neutrophil lysates were prepared by adding complete protease inhibitor cocktail (1x106 
cells in 30 µl) to cell pellets and boiling in an equal volume of 2xSDS buffer (see Appendix V).  
Protein separation was performed as described in section 2.5.2 and antibody concentrations 
are indicated in Appendix VI. 
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2.15 Murine neutrophil functional assays 
2.15.1 Neutrophil chemotaxis 
Neutrophil chemotaxis was assessed using Neuro Probe ChemoTx® microplates with a 5 µm 
filter (Neuro Probe, Inc. Receptor Technologies Ltd., Adderbury, UK). Microplate wells were 
filled in duplicate with 29 µl of test solutions containing various concentrations of recombinant 
murine KC (PeproTech EC Ltd., London, UK). A negative control (RPMI 1640) and positive 
control (25 µl of cells at a concentration of 2 x 106/ml) were also added to the microplate. The 
framed filter was firmly applied to the microplate so that the fluid in the wells made contact 
with the filter and no air bubbles were seen.  Cells (25 μl) were added to each site on the filter 
except for over the positive control well and allowed to migrate for 1 hour. A chemokinesis 
control (cells suspended in 10 nM KC with 10 nM KC in the microplate well below) was also 
prepared. After incubation, any remaining cells on the top of the filter were removed using a 
cotton bud and the plates were centrifuged at 350 g for 10 minutes. The filter was carefully 
removed and cells in the microplate wells were counted using a haemocytometer.  The 
number of cells in the microplate wells is expressed as a percentage of the positive control 
minus the percent migration of the chemokinesis control: 
% chemotaxis = no. migrated cells – no. of migrated cells in chemokinesis control     x 100    
no. of cells in positive control well 
 
2.15.2 Neutrophil cell surface receptor expression 
After 4 hours incubation, cells were washed with ice-cold FACS buffer (PBS plus 0.5% BSA) and 
stained with anti-mouse antibodies at 4°C. Cells were single-stained with PE-anti-CD62L (L-
selectin) (8 μg/ml, BD Pharmingen™) and PE-anti-CD11b (8 μg/ml, BD Pharmingen™).  Isotype-
matched controls (PE-IgG2a and PE-IgG2b respectively) were used to set baselines.  Antibody 
binding was detected using a BD FACSCalibur™ flow cytometer (BD Biosciences, Becton 
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Dickinson Ltd., Oxford, UK).  During analysis specific geometric mean fluorescence was 
calculated by obtaining geometric mean fluorescence intensity values for each antibody and 
subtracting the geometric mean fluorescence of the isotype control.  Results were processed 
using FlowJo software (version 9.0, Tree Star Inc., Ashland, US). 
 
 
2.16 In vivo models 
2.16.1 Acute lung injury models 
2.16.1.1 Intratracheal instillation of lipopolysaccharide (LPS) 
Mice were anaesthetised with ketamine (100 mg/kg i.p.; Willows Francis Veterinary, Crawley, 
U.K.) and acepromazine (5 mg/kg i.p.; C-Vet Veterinary Products, Lancashire, UK) before fur 
was shaved from their necks.  A small (<1 cm) midline incision was made and the trachea 
exposed through gentle blunt dissection until it could be cannulated under direct vision with a 
24G cannula (Jelco® radiopaque cannula, Smiths Medical International Ltd. Rossendale, UK).  
LPS from Salmonella minnesota R595 (TLRgrade™, Enzo Life Sciences, Exeter, UK) was directly 
instilled (0.3 µg in 20 µl) via the cannula and the animals recovered for 6 hours in a warmed 
cage in room air (Rowe et al., 2002).  
2.16.1.2 Nebulised lipopolysaccharide  
Awake mice were placed in a plastic container which was connected to an oxygen-driven 
nebuliser.  Oxygen was delivered at 6 litres per minute through 3 mg LPS from Salmonella 
minnesota creating a vapour that was delivered into the container.  Once all the LPS was 
delivered, mice were transferred back into their original cages.   
 
73 
2.16.1.3 Bronchoalveolar lavage, blood and tissue collection 
At specified time points (6, 24, 48 or 72 hours) mice were anaesthetised with 
ketamine/atropine/xylazine (as per section 2.11.1) and exsanguinated.  The chest wall was 
exposed by opening the skin in the midline from the initial neck wound down to the abdomen.  
Pneumothoraces were introduced by carefully puncturing the inferior surface of the 
diaphragm and then the thorax was opened by carefully cutting along the lateral margins of 
the rib cage on each side exposing the untouched lungs and heart.   The trachea was exposed, 
cannulated and secured in place with suture before the lungs were instilled with 3.5 ml of ice 
cold 0.9% saline in 0.5-1.0 ml aliquots. The recovered lavage fluid was maintained on ice 
before haemocytometer counts were performed and samples spun at 1000 g for 5 minutes.  
Cell pellets were resuspended in foetal bovine serum prior to cytocentrifugation or directly 
lysed and RNA extracted using the mirVana™ total RNA isolation protocol (Ambion, Austin, 
USA).  BAL supernatant was stored at -80˚C for cytokine analysis. Cytospins of serum-
suspended BAL cells were stained with Reastain Quick-Diff (see section 2.7.1) for differential 
cell counts and morphologic scoring of apoptosis.   
Blood from mice exposed to LPS was used to generate plasma and to isolate peripheral blood 
neutrophils.  Heparinised blood drawn prior to performing bronchoalveolar lavage was spun at 
3000 rpm for 5 minutes (Eppendorf, Mini Spin) and the plasma carefully removed and stored 
at -80˚C.  Cell pellets were lysed in ammonium chloride as per section 2.11.1 and the 
neutrophils isolated using the standard negative selection protocol described in section 2.11.3.   
For histological sections, lungs which had not been lavaged were fixed via the trachea with 
10% buffered formalin at 20 cm H2O and paraffin-embedded blocks prepared. Following 
deparaffinization, serial sections were stained with anti-HIF-2α (clone ep190b) as described in 
section 2.6. 
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2.16.1.4 Analysis of IgM in bronchoalveolar lavage fluid 
Levels of IgM in bronchoalveolar lavage fluid were determined by enzyme-linked 
immunosorbent assay (ELISA) using a commercially available kit (Mouse IgM ELISA quantitation 
set, Bethyl Laboratories Inc, Montgomery, USA).  High affinity plates (Costar 96-well EIA plates, 
Thermo Fisher Scientific, Loughborough, UK) were coated with 100 µl per well of coating 
antibody diluted 1:100 in coating buffer (see Appendix X). Plates were incubated at room 
temperature for 60 minutes before being washed 5 times with 200 µl per well of wash solution 
(see Appendix X). Blocking buffer (200 µl per well) was added and plates incubated for a 
further 30 minutes at room temperature.  Plates were again washed 5 times before 100 µl of 
neat samples and standards were added in duplicate.  Serial dilutions of mouse reference 
serum were performed to produce a standard curve with an IgM concentration range of 7.8 
ng/ml to 1000 ng/ml in 0.9% saline.  After 1 hour of incubation, the plates were washed 5 
times and 100 µl per well of HRP-conjugated detection antibody, diluted 1: 50,000 in blocking 
solution, was added.  After a further 1 hour of incubation the plates were washed 5 times and 
100 µl of tetramethylbenzidine (TMB) substrate solution (eBioscience Ltd., Hatfield, UK) was 
added to each well.  The plate was developed in the dark for 15 minutes before the reaction 
was stopped by adding 100 µl of 1M sulphuric acid.  Plates were read at 450 nm 
(VarioskanFlash®, Thermo Fisher Scientific) and data were analysed in Microsoft excel.  
2.16.2 Pneumococcal pneumonia model 
Mice were anaesthetised and the trachea cannulated as described in 2.16.1.  Pneumococci  
(Streptococcus pneumoniae, serotype 2, stain D39) were prepared at a concentration of 5x108 
per ml in PBS and 20 µl (1x107 cfu) were instilled via the trachea.   This strain and 
concentration of bacteria leads to established pneumonia, induces neutrophilic lung 
inflammation and is associated with a high rate of mortality in wild-type animals (Dockrell et 
al., 2003). Following intratracheal administration of bacteria, the mice were allowed to recover 
and then monitored closely for 9 days.  Animals which displayed a pre-determined level of 
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morbidity (severely ruffled fur, hunched posture and impaired movement) were culled.  The 
individuals making this assessment were not aware of mouse genotype.   On day 9 surviving 
mice were culled and Kaplan-Meier survival curves plotted.     
 
 
2.17 Analysis of cytokines in plasma and bronchoalveolar lavage fluid. 
Cytokine analysis was performed on plasma and bronchoalveolar lavage fluid from mice 
exposed to LPS using a multiplex analysis kit, the Meso Scale Discovery mouse 
proinflammmatory 7-plex assay ultra-sensitive kit (Meso Scale Discovery®. Gaithersburg, USA).  
This method follows the same principle as enzyme-linked immunosorbent assays (ELISA) but 
each well of the 96-well Multi-Spot® carbon electrode plate surface contained 7 spatially 
distinct spots each coated with antibody for a specific protein.  This allowed multiple proteins 
to be detected in a small volume of the same sample.   
Standards and samples (25 µl) were added to a pre-coated plate and incubated for 2 hours 
with vigorous shaking (600 rpm) at room temperature.  The plates were washed with PBS 
containing 0.05% Tween®-20 (Fisher Scientific) before addition of the detection antibody.  
Plates were incubated for 2 hours with vigorous shaking and then washed again in PBS 
containing Tween (PBS-T).  Read buffer was then added to each well and the plate read using a 
MSD Sector® Imager 2400 (Meso Scale Discovery).  Data were analysed using MSD Discovery 
Workbench® software (Meso Scale Discovery) and exported into Microsoft Excel for 
subsequent analysis.       
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2.18 A model of subcutaneous Staphylococcus aureus infection 
2.18.1 Preparation of live Staphylococcus aureus 
Bacterial work was carried out in a class II microbiological safety cabinet (Walker, Glossop, UK). 
The SH1000 strain of S. aureus, derived from the clinical isolate NCTC 8325, was used 
throughout these experiments. As the NCTC 8325 strain harbours a naturally occurring 
mutation in the rsbU element, the SH1000 strain was generated to restore the lack of this 
virulence factor (Horsburgh et al., 2002; Kullik et al., 1998).  Bacteria were plated on Columbia 
horse blood agar (Oxoid Ltd.. Basingstoke, UK) and grown overnight at 37˚C with 5% CO2.  A 
single colony was used to inoculate 30 mls of brain heart infusion (BHI, Oxoid Ltd.) in a 50 ml 
falcon.  This was cultured for 15 hours at 37˚C to generate bacteria in stationary phase growth 
(Horsburgh et al., 2001).  Bacteria were centrifuged at 5000 g for 10 minutes to pellet the cells 
and were subsequently washed twice with PBS.  Following centrifugation bacteria were 
resuspended in a final volume of 10 mls and the concentration of colony forming units (cfu) in 
this stock was calculated using the Miles and Misra method (Miles et al., 1938).  A 100 µl 
sample of stock was diluted in a ten-fold dilution series in sterile PBS, vortexing samples 
thoroughly between each serial dilution. Three 10 µl drops from each of 7 serial dilutions were 
incubated overnight on blood agar plates. Viable colonies were counted the following day and 
from this the original bacterial concentration calculated.  The stock was stored at -80˚C.  Prior 
to use, stock vials were defrosted, the cells pelleted at 9000 rpm for 3 minutes and washed 
twice in PBS before being resuspended in a volume which yielded an estimated concentration 
of 2 x 109 cfu/ml.  The final bacterial concentration was subsequently confirmed for each 
experiment using the Miles and Misra method. 
2.18.2 Skin lesion model 
Wild-type C57BL/6 mice had the fur on their backs shaved with electric hair trimmers and were 
then injected with 50 µl of SH1000 at a concentration of 2 x 109 cfu/ml.  Mice were weighed 
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and a photograph of the injected area was taken.  Mice were then checked daily for 7 days and 
on each day weights were recorded and a photographic image taken of the back using a ruler 
to indicate scale.  On day 7 mice were sacrificed and the skin lesions dissected, weighed, snap 
frozen in liquid nitrogen and stored at -80˚C.   ImageJ software (version 1.45, National 
Institutes of Health, USA) was used to trace the circumference of abnormal skin in each 
photographic image and skin lesion area was calculated.     
2.18.3 Exposure of animals infected with S. aureus to hypoxia 
Mice were prepared as in section 2.18.2 and injected with 50 µl of SH1000 at a concentration 
of 2 x 109 cfu/ml or PBS as a control and injection sites were marked. Following injection mice 
were either left in room air (normoxia) or placed in a hypoxic chamber (Wolf laboratories, 
York, UK) which delivered 10% oxygen/90% nitrogen.  The oxygen tension in the chamber was 
reduced gradually to the set point of 10% over 1 hour using an oxygen sensing control unit 
(Coy Labs, Grass Lake, Michigan, USA).  Carbon dioxide was removed with soda lime (Sigma 
Aldrich). At indicated time points (3-12 hours) mice were taken out of the chamber to be 
assessed alongside normoxic controls.  Routinely temperature was recorded using a rectal 
thermometer probe (VisualSonics, Toronto, Canada) and sickness severity was assessed (see 
section 2.19).  Following this clinical assessment mice were anaesthetised and exsanguinated 
via the inferior vena cava.  To investigate potential bacterial seeding of organs, spleens and 
kidneys were harvested and stored at -80˚C and a 4 mm punch biopsy (Decree Thermo Ltd, 
Sheffield, UK) of the skin at the injection site was taken to be processed as described in section 
2.20.   
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2.19 Mouse sickness scoring  
Clinical assessment of mouse sickness behaviour was made by two independent observers 
blinded as to which oxygen tension the mice had been exposed.  Two sickness scores (see 
Appendix XI) were used based on existing objective scoring systems (Biswas et al., 2002; Lloyd 
and Wolfensohn, 1999).   Scores provided by each observer were averaged for each animal.  
 
 
2.20 Assessing local response to infection 
2.20.1 Skin sections  
Skin biopsies of the injection site were placed in 10% buffered formalin prior to processing.  
Tissue embedding and sectioning was performed by Yvonne Stephenson.  In brief, tissue was 
removed from the formalin and placed in a cassette before being processed into wax using a 
Leica TP1020 processor (Leica Microsystems, Milton Keynes, UK). Waxed tissue was embedded 
in paraffin blocks before cutting with a microtome (Leica RM2245) and floating onto glass 
slides (Superfrost plus, Thermo Fisher Scientific, Loughborough, UK) in a water bath at 45˚C.  
Slides were dried overnight in an oven at 37˚C.   
2.20.1.1 Haematoxylin and eosin staining 
Slides were dewaxed and rehydrated by immersing in graded descending concentrations of 
ethanol.  Slides were washed in tap water and stained with Gill’s haematoxylin (Leica) for 2 
minutes. After a further wash, the sections were covered in Scott’s tap water (1000 ml water, 
3.5 g sodium bicarbonate, 20 g magnesium sulphate) for 10 seconds before washing and 
staining with 1% aqueous eosin (Leica) for 5 minutes. This was rinsed with tap water and the 
sections were dehydrated through ascending ethanol concentrations until in xylene (VWR 
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International Ltd., Lutterworth, UK) and then mounted using Consul-Mount™ (Thermo Fisher 
Scientific).   
2.20.1.2 Gram’s stain 
To visualise Gram positive bacteria in tissue sections, the Accustain® Gram stain kit was used 
(Sigma Aldrich).  The kit uses a modified method from Gram’s original description (Gram, 
1884).  Sections were dewaxed in xylene and rehydrated to deionised water as described 
above. Slides were flooded with Crystal Violet solution and allowed to stand for 1 minute.  
Slides were washed with water and treated with Gram’s iodine solution for 5 minutes followed 
by a further wash.  Excess water was blotted before slides were dipped twice in ethanol to 
differentiate and checked by light microscopy.  A further dip in ethanol could be performed if 
required.  Following a rinse in deionised water, slides were covered in Safranin O solution for 1 
minute. This was rinsed, slides were blotted and Tartrazine solution was applied for 5 sections.  
Excess stain was immediately blotted and the slides rinsed twice in ethanol. Slides were 
cleared in xylene before mounting.     
2.20.1.3 Immunohistochemistry 
Immunohistochemical staining of mouse skin sections was performed as described in section 
2.6 using an anti-myeloperoxidase antibody.  Antibody dilutions are in Appendix IX.    
2.20.2 Skin myeloperoxidase activity 
Skin biopsies were weighed then immediately frozen in liquid nitrogen and stored at -80˚C for 
subsequent analysis.  Skin was chopped finely with a scalpel blade while defrosting and 
subsequently homogenised.  The chopped skin was placed in 0.5 ml of 5 mg/ml 
hexadecyltrimethylammonium bromide (Sigma Aldrich) containing 50 mM potassium 
phosphate (HTAB buffer) at pH 6.0.  Homogenisation was performed using either a glass pestle 
and mortar or with stainless steel beads in a Bullet Blender® (Next Advance, Averill Park, USA).  
HTAB buffer efficiently extracts myeloperoxidase from skin specimens (Bradley et al., 1982). 
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The samples were sonicated in a Bioruptor™ iced water bath (Diagenode Europe SA, Liège, 
Belgium) for 5 minutes using 30 second on/off high power cycles. Samples were then frozen 
and thawed 4 times before a further 5 minute period of sonication and subsequently 
centrifuged at 14000 g for 30 minutes at 4˚C.  The supernatant was removed and 100 µl of this 
was added to 1.9 ml O-dianisidine solution (0.167 mg/ml O-dianisidine hydrochloride (Sigma 
Aldrich), 0.0005% hydrogen peroxide, 50 mM potassium phosphate).  O-dianisidine 
hydrochloride is a chromogenic oxidase substrate and its reaction with myeloperoxidase under 
the conditions used has been reported to be sensitive enough to detect the myeloperoxidase 
activity of 10,000 neutrophils (Bradley et al., 1982).  Absorbance was read by a 
spectrophotometer (Jenway 6310, Barloworld Scientific Ltd, Dunmow, UK) at a wavelength of 
450 nm.  The absorbance change between 30 seconds and 90 seconds of the reaction time 
gave the relative myeloperoxidase activity.   
2.20.3 Bacterial counts in homogenised skin 
Skin biopsies were weighed then immediately frozen in liquid nitrogen and stored at -80˚C for 
subsequent analysis.  Skin was homogenised as in section 2.20.2 but PBS was used in place of 
the HTAB buffer.   The numbers of colony forming units in skin homogenates were calculated 
using the Miles and Misra method and normalised per gram of skin.   
 
 
2.21 Assessing systemic response to S. aureus infection 
2.21.1 Plasma cytokine analysis 
Blood from mice injected with SH1000 or placebo was harvested at 3, 6 or 12 hours and spun 
at 3000 rpm for 5 minutes to generate plasma.  This was stored at -80˚C until further analysis 
could be performed.  To analyse cytokines, cytometric bead arrays (CBA) were performed by 
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Susan Newton (Flow cytometry core facility, University of Sheffield) on a FACSarray flow 
cytometer (Becton Dickinson Ltd., Oxford, UK) using BD™ CBA flex sets (murine Il-1β, Il-6, Il-10, 
TNF-α, KC, MCP-1) as per manufacturer’s instructions. 
2.21.2 Serum markers of organ dysfunction 
Serum was generated by allowing blood to clot at room temperature before centrifugation at 
5000 rpm for 5 minutes (Mini Spin, Eppendorf).  Serum was then transported on ice to a 
veterinary laboratory (Nationwide Veterinary Laboratories, Leeds) and analysed for makers of 
liver (aspartate transaminase), kidney (creatinine) and pancreatic dysfunction (lipase).   
2.21.3 Assessment of lung injury 
To assess for possible lung injury in animals injected with SH1000 bacteria, animals were 
anaesthetised after 12 hours in hypoxia or normoxia.  Respiratory rate was counted then 
bronchoalveolar lavage was performed, while in other animals lungs were fixed by instillation 
of buffered formalin.  Both methods are described in section 2.16.1.3.  In separate 
experiments lungs were harvested, weighed and maintained in a warm room until fully 
dehydrated.  Lung weights were recorded each day until measurements were stable for more 
than 2 readings giving the dry weight.   
2.21.4 Assessment of brain oedema 
Mice were injected subcutaneously with S. aureus or PBS control and after 12 hours in hypoxia 
or normoxia were terminally anaesthetised with pentobarbital (20% w/v, JM Loveridge PLC, 
Southampton, UK). The brains were carefully removed and placed in a warm room to obtain 
dry weights as described for lungs in Section 2.21.3.  In other experiments, mice were injected 
intraperitoneally with Evan’s blue dye (4 ml/kg of 2%) and subsequently infected and either 
exposed to hypoxia or maintained in normoxia for 12 hours. Mice were then anaesthetised 
and exsanguinated and the circulation flushed from the left ventricle with 10 mls of ice cold 
PBS to remove intravascular dye. The brains were harvested and placed in 500 µl of formamide 
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(Sigma Aldrich) for 48 hours in a dark warm room. The supernatant was then carefully 
harvested and 100 µl added in duplicate to a flat-bottomed 96-well plate.  Plasma collected at 
the same time as the brain tissue was also added to the plate and optical density was analysed 
by spectrophotometry at 630 nm. A standard curve of serial dilutions of Evans blue dye was 
performed and sample concentrations were read against this curve (see Figure 2.21-1). Plasma 
values were checked to ensure equal absorption of dye in each group and to check that no 
values exceeded the maximum binding capacity of plasma proteins for the dye (500 µg/ml) 
(Hafezi-Moghadam et al., 2007; Kakinuma et al., 1998).  
2.21.5 Measurement of blood glucose and bicarbonate 
Blood glucose levels were measured in infected mice after 12 hours in normoxia or hypoxia 
using an Optium Xceed blood glucose meter (Abbott Laboratories Ltd, Maidenhead, UK).  A 
single drop of blood was placed on the measurement strip to obtain the reading. Venous 
bicarbonate levels were obtained from infected mice by drawing 100 µl heparinised blood into 
a syringe and analysing on a blood gas analyser (ABL5, Radiometer, Copenhagen, Denmark). 
2.21.6 Blood pressure and heart rate measurements in awake mice 
To obtain readings in awake mice, animals were trained for 7 days to undergo non-invasive 
blood pressure measurement using a BP-2000 Blood Pressure Analysis System™ (Visitech 
Systems Inc., Apex, USA).  Training involved placing mice in the restraints used by the analysis 
machine each day, followed by 10 or 20 recordings of blood pressure.  This was performed to 
allow animals to become accustomed to the procedure.  After training, these animals were 
then injected with either SH1000 bacteria or PBS (as per section 2.18.3) and exposed to 
hypoxia or normoxia for 12 hours after which time blood pressure and heart rate 
measurements were recorded.  A minimum of 10 readings were attempted on each animal.   
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Figure 2.21-1. Optical density of serial dilutions of Evan’s blue dye. 
A standard curve fitted to values of optical density at 630 nm plotted against the logarithm of 
Evan’s blue dye concentrations.    
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2.21.7 Echocardiography 
Twelve hours after subcutaneous injection of bacteria, hypoxic or normoxic mice were 
anaesthetised with 5% isoflurane supplied in oxygen at 2 l/min and placed on a warming pad.  
Mice were secured on the pad lying flat and supine. The fur on the chest was clipped and hair 
removal cream used to ensure good penetration of ultrasound waves.  
Transthoracic echocardiography was performed by an experienced operator (Dr Abdul 
Hameed, Department of Cardiovascular Sciences, University of Sheffield) using a VisualSonics 
Vevo® 770 Imaging system and RMV707B scanhead (VisualSonics, Toronto, Canada).  Short axis 
view recordings were made in M-mode at the level of the papillary muscles to enable 
measurement of left ventricular diameter at end-systole and end-diastole.  Using these values, 
fractional shortening (FS) and left ventricular end-systolic and end-diastolic volumes were 
calculated allowing subsequent calculation of ejection fraction (EF).  Left ventricular volumes 
were also used to calculate stroke volume and thus cardiac output.  For equations used see 
Table 2.21-1.  Cine (2-D) images in the short axis view were acquired and endocardial area 
traced in systole and diastole from which fractional area change (FAC%) was calculated.  
Another independent measure of contractility used was pulse wave tissue doppler velocities.  
These were manually recorded from the endocardial aspect of the posterior left ventricular 
wall. 
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Table 2.21-1. Echocardiographic calculations.   
Equations used to calculate echocardiographic measurements of left ventricular volume and 
function. Abbreviations are as follows: LVID = left ventricular internal diameter; d = end-
diastole; s = end-systole; EDV = end-diastolic volume; ESV = end-systolic volume; LVAd = left 
ventricular endocardial area in diastole; LVAs = left ventricular endocardial area in systole; HR 
= heart rate.   
Parameter Equation 
 
Fractional shortening  
(%) 
 
((LVIDd – LVIDs)/LVIDd) x 100 
 
Left ventricular volume  
(μl) 
 
(7/(2.4+LVID)) x LIVD3 
 
Ejection fraction 
(%) 
((EDV – ESV)/EDV) x 100 
 
Fractional area change  
(%) 
((LVAd – LVAs)/LVAd) x 100 
 
Stroke volume (SV) 
(µl) 
EDV – ESV 
Cardiac output 
(ml/min) 
SV x HR / 1000 
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2.21.8 Nitric oxide measurements 
Frozen plasma obtained from mice infected with S. aureus or injected with PBS was analysed 
for nitric oxide content by Dr Andrew Cowburn, University of Cambridge. In brief, plasma was 
defrosted and passed over a 10 kDa filter column.  Samples were then analysed on a Sievers 
Nitric Oxide Analyser NOA 280i (GE Water & Process Technologies, Boulder, USA) following 
manufacturer instructions.  The analyser uses a reducing agent (vanadium chloride in 1M 
hydrochloric acid) heated to 95 ˚C to convert nitrite, nitrate and S-nitroso compounds into 
nitric oxide. In the gas phase NO will react with oxygen to form nitric dioxide producing a 
chemiluminescent signal emitted from electronically excited NO2.  Total NOx concentration was 
determined from a calibration curve constructed with readings obtained from serially diluted 
nitrate solutions.   
2.21.9 Malondialdehyde measurements 
Malondialdehyde (MDA) is a product of lipid peroxidation, a process that occurs in vivo in 
response to oxidative stress (Ortolani et al., 2000).  The reaction of MDA with thiobarbituric 
acid reactive substances (TBARS) produces an adduct that can be quantified fluorometrically.   
I used a MDA quantitation kit (OxiSelect™, TBARS assay kit, Cell Biolabs Inc., San Diego, USA) to 
determine the amount of lipid peroxidation in plasma from mice infected with S. aureus and 
maintained in normoxic or hypoxic conditions for 12 hours.  A calibration curve was generated 
using serial dilutions of MDA in water.  Samples and standards (100 µl) were transferred into 
eppendorf tubes and 100 µl of SDS lysis solution (OxiSelect™ kit) was added.  Samples and 
standards were incubated at room temperature for 5 minutes before 250 µl of TBA reagent 
was added.  The tubes were then heated to 95 ˚C for 60 minutes before being cooled in ice for 
5 minutes.  Samples were then centrifuged at 3000 rpm for 15 minutes and the supernatant 
removed for analysis.  For fluorimetric analysis, 150 µl of samples and standards were 
transferred to a black fluorescence microplate (Nunc MicroWell™ plates, Nalge Nunc 
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International, Rochester, USA) and read using a wavelength of 540 nm for excitation and 590 
nm for emission (FLUOstar Galaxy, BMG Labtech Ltd., Aylesbury, UK).  
 
2.22 Statistical analysis 
Data were analysed using Prism 5.0 software (GraphPad Software Inc, San Diego, CA). For 
comparison of two sample means when cells from the same subject were used, paired t tests 
were performed. Unpaired t tests were used for comparisons between control and patient or 
wild type and transgenic sample means. If multiple time points or concentrations were used, 
repeated measures ANOVA with Tukey post tests were performed and if comparisons between 
normoxia and hypoxia, controls and patients or wild type and transgenic mice were required in 
these experiments, two-way ANOVA with Bonferonni post tests were performed. Statistical 
significance was accepted when p < 0.05. 
  
88 
3 The role of HIF-2α in neutrophilic inflammation 
3.1 Introduction 
Neutrophils are key mediators of tissue injury in acute and chronic inflammatory diseases 
(Barnes, 2007; Quint and Wedzicha, 2007). Effective treatments to limit the toxic effects of 
neutrophilic inflammation are currently lacking and thus represent a major unmet clinical 
need.  The therapeutic challenge is to simultaneously preserve key neutrophil anti-microbial 
effector functions, whilst maximising efficient neutrophil removal to limit persistent and 
inappropriate inflammation.  Timely neutrophil apoptosis, with effective macrophage 
efferocytosis, ensures resolution of inflammation and protects against the cytotoxic effects of 
neutrophils (Rossi et al., 2006; Savill et al., 1989; Whyte et al., 1993). As such, targeting 
neutrophil apoptosis represents an attractive therapeutic strategy.  
Recent evidence has revealed the importance of oxygen-sensing pathways in innate immune 
biology.  Accumulation of HIF-α subunits in myeloid cells occurs in hypoxic conditions, as in 
other cell types, but also in response to bacteria and bacterial products irrespective of the 
ambient oxygen tension (Peyssonnaux et al., 2005).  These recent data demonstrate complex 
roles for the HIF pathway that go beyond the regulation of hypoxic signalling and implicate HIF 
in host responses to bacteria (Imtiyaz et al., 2010; Peyssonnaux et al., 2007; Peyssonnaux et 
al., 2005).  Indeed, myeloid-specific deficiency of HIF-1α not only abolished the prolonged 
survival of neutrophils in hypoxia but also resulted in depletion of intracellular ATP levels and 
impairment of neutrophil granule protease production, macrophage motility and invasion, and 
bacterial killing (Cramer et al., 2003; Peyssonnaux et al., 2005; Walmsley et al., 2005).  These in 
vitro findings translated into reduced inflammatory cell infiltrates in acute models of 
inflammation and more severe bacterial skin infections (Cramer et al., 2003; Peyssonnaux et 
al., 2005).  With such profound effects on innate immune cell function, HIF-1α itself is not an 
attractive therapeutic target for the many inflammatory diseases, e.g. chronic obstructive 
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pulmonary disease (COPD) and inflammatory bowel disease (IBD), where inflammation and 
bacteria frequently co-exist. In marked contrast to deficiency of HIF-1α, deficiency of the HIF 
hydroxylase PHD3 had minimal consequences for the functional status of neutrophils prior to 
their apoptosis (Walmsley et al., 2011).  This raises the possibility that specific targeting of 
individual components of the HIF hydroxylase pathway, independent of HIF-1α itself, may 
result in selective regulation of neutrophil survival pathways independent of key host-
pathogen responses. 
As discussed in Chapter 1, distinct biological roles for HIF-1α and HIF-2α have recently 
emerged, with HIF-2α regulating a distinct but overlapping set of target genes to HIF-1α and 
importantly playing a less significant role in regulating glycolytic enzyme expression (Hu et al., 
2003; Warnecke et al., 2008).  Furthermore, evidence has shown that differential 
transcriptional activation of HIF-1α and HIF-2α can result in co-ordinated cellular responses, 
dependent upon the relative abundance of each isoform, with for example HIF-1α and HIF-2α 
having opposing effects on macrophage nitric oxide formation (Takeda et al., 2010).  HIF-2α 
has also been implicated in the regulation of other macrophage functions, with myeloid-
specific HIF-2α deficient mice having reduced macrophage-mediated inflammatory responses 
to endotoxemia, and reduced tumour-associated macrophage (TAM) infiltration with an 
associated reduction in tumour cell proliferation and progression (Imtiyaz et al., 2010).   Given 
this evidence of differential functions for HIF-1α and HIF-2α in myeloid cells, and the known 
dominance of HIF-1α over HIF-2α in the regulation of glycolysis and ATP generation, I 
hypothesised that HIF-2α deficiency may have a more selective immunomodulatory phenotype 
than that of HIF-1α deficiency in neutrophils.  
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Results 
3.2 Human neutrophils express HIF2A mRNA. 
To confirm expression of HIF2A in neutrophils, human peripheral blood neutrophils were 
isolated, purified by negative magnetic selection and HIF2A mRNA expression assessed by non 
quantitative PCR (Figure 3.2-1).  Expression of HIF2A mRNA was confirmed by sequencing of 
the PCR products (Figure 3.2-1). Subsequently, using real time PCR, I showed that expression of 
HIF2A mRNA is not significantly altered over time in normoxic or hypoxic culture or with 
stimulation by heat-killed S. aureus or peptidoglycan although some trends were visible that 
suggested differential expression of HIF1A and HIF2A (Figure 3.2-2).   
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HIF2A
N Ht0
400 bp
A
B
NM_001430.3 Homo sapiens endothelial PAS domain protein 1 (EPAS1), mRNA 
Identities = 341/349 (98%), Gaps = 0/349 (0%) 
 
Query  19    CTNAAGCGNCNGCTGGAGTANGAAGAGCAAGCCTTCCNGGACCTGA GCGGGGGGGANCCA  78 
             || ||||| | ||||||||| |||||||||||||||| |||||||||||||||||| |||  
Sbjct  2610  CTGAAGCGACAGCTGGAGTATGAAGAGCAAGCCTTCCAGGACCTGAGCGGGGGGGACCCA  2669  
 
Query  79    CCTGGTGGCAGCACCTCACATTTGATGTGGAAACGGATGAANAACCTCAGGGGTGGGAGC  138  
             ||||||||||||||||||||||||||||||||||||||||| ||||||||||||||||||  
Sbjct  2670  CCTGGTGGCAGCACCTCACATTTGATGTGGAAACGGATGAAGAACCTCAGGGGTGGGAGC  2729  
 
Query  139   TGCCCTTTGATGCCGGACAAGCCACTGAGCGCAAATGTACCCAATGATAAGTTCACCCAA  198  
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  2730  TGCCCTTTGATGCCGGACAAGCCACTGAGCGCAAATGTACCCAATGATAAGTTCACCCAA  2789  
 
Query  199   AACCCCATGAGGGGCCTGGGCCATCCCCTGAGAC ATCTGCCGCTGCCACAGCCTCCATCT  258  
             ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  2790  AACCCCATGAGGGGCCTGGGCCATCCCCTGAGACATCTGCCGCTGCCACAGCCTCCATCT  2849  
 
Query  259   GCCATCAGTCCCGGGGAGAACAGCAAGAGCAGGTTCCCCCCACAGTGCTACNCCAC CCAG  318 
             ||||||||||||||||||||||||||||||||||||||||||||||||||| ||||||||  
Sbjct  2850  GCCATCAGTCCCGGGGAGAACAGCAAGAGCAGGTTCCCCCCACAGTGCTACGCCACCCAG  2909  
 
Query  319   TACCAGGACTACAGCCTGTCGTCAGCCCACAAGGTGTCAGGCAT GGCAA  367 
             |||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  2910  TACCAGGACTACAGCCTGTCGTCAGCCCACAAGGTGTCAGGCATGGCAA  2958  
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Figure 3.2-1. Human neutrophils express HIF2A mRNA. 
 (A) Expression of HIF2A in freshly isolated neutrophils (t0) or cells cultured for 4 hours in 
normoxia (N) or hypoxia (H) was determined by PCR and agarose gel electrophoresis. A 
representative gel image of n=3 is shown. (B) The PCR product obtained in panel A was run on 
1.5% agarose gels, extracted and sequenced. Screenshot from FinchTV showing the sequence 
of this product.  (C) Alignment of the PCR product sequence with that of the HIF2A mRNA 
sequence was verified using NCBI Blast®.   
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Figure 3.2-2. Expression of HIF2A and HIF1A mRNA in hypoxia and following 
stimulation by S. aureus or peptidoglycan.   
(A) Fold change in expression of HIF2A and HIF1A following culture of human neutrophils in 
normoxia (filled bars) or hypoxia (open bars) for 6 or 12 hours. TaqMan analysis of cDNA was 
performed with data normalized to ACTB expression. Data show mean and SEM of fold change 
with respect to normoxic samples at 6 hours, n=3, analysed by ANOVA. (B) Fold change in 
expression of HIF2A and HIF1A following culture with heat killed S. aureus (MOI 10:1) (hatched 
bars) or without (filled bars) for 3 or 5 hours. TaqMan analysis of cDNA was performed with 
data normalized to ACTB expression. Data show mean and SEM fold change with respect to 
unstimulated samples at 3 hours, n=5. (C) Fold change in expression of HIF2A and HIF1A 
following culture with peptidoglycan (10 µg/ml) (shaded bars) or without (filled bars) for 3 or 5 
hours. TaqMan analysis of cDNA was performed with data normalized to ACTB expression. 
Data show fold change with respect to unstimulated samples at 3 hours, n=4. 
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3.3 Human neutrophils express HIF-2α protein. 
In contrast to HIF-1α, low levels of HIF-2α protein were detected in neutrophils that were 
freshly-isolated or cultured in normoxia.  Further induction of HIF-2α was seen in hypoxia, with 
iron chelators or hydroxylase inhibition (Figure 3.3-1). Following culture in the presence of 
heat-killed bacteria, neutrophils showed induction of both HIF-1α and HIF-2α (Figure 3.3-1). 
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Figure 3.3-1. Expression of HIF-2α is upregulated by hypoxia, hydroxylase 
inhibition and heat killed bacteria.   
(A-D) Expression of HIF-1α and HIF-2α is differentially regulated by hydroxylase inhibitors and 
upregulated in response to heat killed bacteria. Neutrophils were cultured in normoxia or 
hypoxia and with (A & C) cobalt chloride [100µM], deferoxamine (DFO) [300µM], 
dimethyloxalylglycine (DMOG) [100µM] or (B & D) heat killed S. aureus or S. pneumoniae 
before being lysed.  Proteins were separated using SDS-PAGE and blots probed for HIF-1α (A & 
B) and HIF-2α (C & D). p38 MAPK was used as a loading control.  Blots are representative of 
n=3.  
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3.4 Inflammatory neutrophils show enhanced HIF-2α expression. 
Peripheral blood neutrophils isolated from patients with active inflammatory arthritis 
displayed enhanced HIF1A and HIF2A mRNA expression (Figure 3.4-1).  HIF-2α protein 
expression was also significantly higher in circulating neutrophils of arthritis patients than of 
healthy controls (Figure 3.4-1).  Interestingly this was selective for HIF-2α, with no increase in 
HIF-1α protein observed in freshly isolated circulating neutrophils from these patients (data 
not shown).  In order to demonstrate whether transmigrated neutrophils also express HIF-2α 
in inflamed tissue, lung biopsy sections from patients with COPD were obtained. Neutrophils 
recruited to the airways in both mild and severe COPD displayed strong HIF-2α staining, in 
marked contrast to epithelium where no HIF-2α expression was demonstrated (Figure 3.4-2). 
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Figure 3.4-1. Expression of HIF-2α is upregulated in neutrophils from 
patients with active inflammatory arthritis.  
(A) Expression of HIF1A and HIF2A in inflammatory arthritis patients (filled bars) and controls 
(open bars) was determined by TaqMan analysis of cDNA from freshly isolated peripheral 
blood neutrophils with data normalized to ACTB expression.  Data are mean and SEM for n=4. 
(B & C) HIF-2α protein expression is significantly higher in neutrophils from patients with 
inflammatory arthritis (IA) than healthy volunteers (HV). Freshly isolated neutrophils were 
lysed and proteins separated by SDS-PAGE. Blots were probed for HIF-2α and densitometry 
data were normalised to p38 MAPK. (B) Data are mean and SEM for n=3. (C) HIF-2α blots of 
circulating neutrophil lysates from 3 healthy volunteers (HV) and 3 patients with inflammatory 
arthritis (IA).  
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Figure 3.4-2. Expression of HIF-2α is seen in neutrophils within lung biopsies 
from patients with COPD.  
(A-E) Immunohistochemistry showing HIF-2α expression in lung biopsies from a non-smoker 
(B) and patients with mild (C) or severe COPD (D & E).  Images are representative of n=2.  Panel 
A is a section stained with an isotype control. Original magnification (A-D) x200, (E) x1000. 
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3.5 Overexpression of HIF-2α delays neutrophil apoptosis but does 
not affect neutrophil function. 
Study of idiopathic cases of erythrocytosis with raised serum erythropoietin has resulted in the 
identification of a rare group of individuals with gain-of-function mutations in the HIF2A gene 
(Percy et al., 2008a; Percy et al., 2008b).  I obtained peripheral blood neutrophils from some of 
these individuals to determine the consequences of HIF-2α overexpression for neutrophil 
survival and function.  Patients with gain-of-function HIF2A mutations had lower rates of 
neutrophil apoptosis compared to controls, but a preserved response to hydroxylase inhibition 
by the pan hydroxylase inhibitor dimethyloxalylglycine (DMOG) (Figure 3.5-1).  Neutrophils 
from these patients also showed enhanced expression of the HIF-2α target genes VEGF, PAI-1 
and PHD3 (Figure 3.5-1).  Functional assays showed preserved phagocytosis and respiratory 
burst (Figure 3.5-2) indicating that HIF-2α overexpression resulted in a selective pro-survival 
phenotype without alteration of key neutrophil functions.    
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Figure 3.5-1. Neutrophils isolated from patients with gain-of-function HIF2A 
mutations have enhanced survival and altered HIF2A target gene expression.  
(A) Neutrophils from patients with HIF2A mutations (closed squares) or healthy controls (open 
squares) were cultured for 20 hours with the hydroxylase inhibitor, dimethyloxalylglycine (0-
100 µM) and apoptosis determined by morphology. Data are mean ± SEM for n=3, analysed by 
2-way ANOVA.  (B) Expression of the HIF targets VEGF, PAI-1 and PHD3.  TaqMan® quantitative 
PCR analysis of cDNA prepared from freshly isolated neutrophils from patients with HIF2A 
mutations (filled bars) or healthy controls (open bars). Data are mean and SEM for n=3.  
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Figure 3.5-2. Neutrophils isolated from patients with gain-of-function HIF2A 
mutations have normal phagocytosis and respiratory burst. 
 (A) Phagocytic index was calculated from cytospin slides of neutrophils from healthy controls 
(open bars) and HIF2A patients (filled bars) prepared after 30 minutes of culture with 
opsonised zymosan (0.2-1 mg/ml). (B) Flow cytometry analysis of intracellular Alexa Fluor® 488 
E. coli was performed after 30 minutes of culture of cells from healthy controls (open bars) and 
HIF2A patients (filled bars). (C) Respiratory burst. Neutrophils from healthy controls (open 
bars) and HIF2A patients (filled bars) were cultured in the presence of DCF only or DCF and 
fMLP (100 nM) or zymosan A (0.2 mg/ml) and analysed by flow cytometry. Data show mean 
and SEM for n=3.  
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3.6 Overexpression of epas1a in zebrafish delays resolution of 
inflammation. 
To explore the significance of the reduced rates of apoptosis seen in humans with gain-of-
function mutations in HIF2A, we mutated the zebrafish orthologue, epas1a, to produce a 
protein with an amino acid substitution at the glycine site corresponding to the mutant human 
protein.  We found that replacing the glycine with either arginine (G487R) or tryptophan 
(G487W), to replicate the HIF2A mutations observed in the patients, did not affect whole body 
neutrophil counts (Figure 3.6-1). In a well-characterised tail injury model of neutrophilic 
inflammation (Renshaw et al., 2006), neutrophil recruitment did not differ between wild-type 
and mutants but the epas1a overexpressing fish showed impaired resolution of inflammation 
(Figure 3.6-1).  The magnitude of neutrophil persistence was equivalent to that seen with 
expression of dominant active hif1ab (Figure 3.6-1) or previously reported with caspase 
inhibition (Renshaw et al., 2006).  The increase in neutrophil number at the site of injury after 
24 hours was associated with a significant reduction in neutrophil apoptosis (Figure 3.6-1).  
Corresponding results were obtained when the PHD target sites were mutated into non-
hydroxylatable amino acids to create a dominant active form of epas1a (Figure 3.6-2).    
Importantly, all three epas1a mutants displayed evidence of upregulation of target genes 
(Figure 3.6-3).   Injection of a morpholino anti-sense oligonucleotide to achieve knock-down of 
the epas1a binding partner, arnt (Prasch et al., 2006) restored resolution of inflammation in 
epas1a overexpressing fish, confirming that the phenotype of neutrophil persistence required 
intact epas1a signalling (3.6-2).   
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Figure 3.6-1. Gain-of-function mutations in the zebrafish HIF2A orthologue 
epas1a delay resolution of neutrophilic inflammation.  
epas1a G487R or G487W RNA (177pg) or dominant active (da) hif1ab control was injected into 
1 cell stage zebrafish mpx:GFP embryos. (A) Wholebody total neutrophil numbers at 2 days 
post fertilization (dpf) were not altered by injection of epas1a G487 variants. n=44 performed 
as 3 independent experiments. (B-D) Tailfin transection was performed at 2dpf, and 
neutrophils counted at 6 and 24 hours post injury (hpi). Data shown are mean ± SEM. (B) 
Injection of dominant active epas1a variants did not alter the recruitment of neutrophils to the 
tailfin injury site after 6hpi. n=24 performed as 3 independent experiments. (C & D) epas1a 
G487 mutations caused a significant increase in neutrophil number at 24hpi compared to 
phenol red injected negative controls. (C) Representative overlaid fluorescence and bright field 
micrographs (x 4 magnifications).  (D) Neutrophil numbers at 24hpi. n=24 performed as 3 
independent experiments. (E) Injection of epas1a G487 mutations significantly decreased the 
percentage of neutrophils at the injury site co-labelled with TUNEL apoptosis staining at 12hpi. 
n=3 performed as independent experiments containing 17-36 embryos per injection group per 
repeat.  These experiments were performed by Dr Phil Elks. 
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Figure 3.6-2. Dominant active epas1a delays resolution of neutrophilic 
inflammation.  
Dominant active (da) forms of epas1 RNA (177pg) were injected into the 1 cell stage zebrafish 
mpx:GFP embryos, tailfin transection performed at 2dpf, and neutrophils counted at 6 and 
24hpi. Data shown are mean and SEM. (A) Injection of individual dominant active epas1a 
variants did not alter wholebody neutrophil numbers at 2dpf. However, injection of dominant 
active epas1 variants led to a significant increase in total neutrophil numbers if they were co-
injected. n=14-17, performed as 2 independent experiments. (B) The recruitment of 
neutrophils to the injury site after 6hpi when the tail was transected at 2dpf. Treatment with 
100µM DMOG (filled bar) or DMSO vehicle control (open bars) was performed 2 hours before 
injury. n=14-17, performed as 2 independent experiments. (C) Dominant active epas1a caused 
a significant increase in neutrophil number at 24hpi in the absence of DMOG treatment 
compared to phenol red injected negative controls. Treatment with 100µM DMOG (filled bar) 
or DMSO vehicle control (open bars) was performed at 4 hpi. Dominant active epas1a alone 
was able to recapitulate the DMOG phenotype, whilst dominant active epas1b homologue did 
not. n=24, performed as 2 independent experiments. (D) 24hpi neutrophil counts in the 
epas1a+b overexpressing fish at 2dpf following co-injection with control (open bars) and arnt-1 
morpholinos (filled bars). n=8 performed as 2 independent experiments. These experiments 
were performed by Dr Phil Elks.  
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Figure 3.6-3. Gain-of-function mutations in the zebrafish HIF2A orthologue 
epas1a upregulate expression of the target genes, phd3 and atf4.  
Evidence of epas1a target gene activation in zebrafish embryos with overexpressed G487 
mutant constructs. Photomicrographs of 24hpf embryos after injection of dominant active 
forms of epas1a RNA (177pg) or dominant negative (dn) epas1a at the 1 cell stage. Embryos 
were stained for (A) phd3 or (B) atf4 expression by in situ hybridization as representative 
epas1a target genes.  These experiments were performed by Dr Phil Elks. 
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3.7 Neutrophils from mice with myeloid-specific deficiency of HIF-2α 
have maintained LPS and hypoxic survival responses and 
preserved function.   
Next the consequences of HIF-2α deficiency for neutrophil survival and function were 
investigated.  Peripheral blood neutrophils were isolated from wild-type mice and the 
presence of Hif2a confirmed by PCR (Figure 3.7-1). In keeping with previous data I was, 
however, unable to detect Hif2a in bone marrow derived neutrophils from wild-type animals 
(Imtiyaz et al., 2010).  Consistent with my findings in human neutrophils and in contrast to HIF-
1α, murine neutrophils showed basal expression of HIF-2α protein following normoxic culture 
with further expression in hypoxia and following lipopolysaccharide (LPS) or DMOG treatment 
(Figure 3.7-1).  To investigate the consequences of HIF-2α deficiency, I used mice with myeloid-
specific targeted deletion of Hif2a (Hif2aflox/flox;LysMCre+/-)(Takeda et al., 2010). HIF-2α 
deficient neutrophils showed preserved rates of apoptosis in normoxia and, in contrast to HIF-
1α deficient neutrophils (Walmsley et al., 2011), a delay of apoptosis in hypoxia that was 
equivalent to wild-type cells (Figure 3.7-2). The survival response to LPS did not differ between 
wild-type cells and those deficient in HIF-1α or HIF-2α (Figure 3.7-2). Functional assays on HIF-
2α deficient neutrophils revealed no deficits in respiratory burst, chemotaxis or phagocytosis 
(Figure 3.7-3) and these cells also showed preserved changes in receptor expression in 
response to stimulation with LPS (Figure 3.7-4).  Furthermore, an in vivo model of 
pneumococcal pneumonia which is associated with significant neutrophil recruitment to the 
lungs did not reveal a difference in mortality between HIF-2α deficient and wild-type animals 
(Figure 3.7-5) indicating preserved ability to control bacterial infection.   
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Figure 3.7-1. Murine neutrophils express HIF-2α mRNA and protein.   
(A) Expression of Hif2a in murine peripheral blood but not bone marrow neutrophils. 
Neutrophils isolated by magnetic negative selection from peripheral blood (PB) or bone 
marrow (BM) or bone marrow mononuclear cells (MC) were cultured in normoxia (N) or 
hypoxia (H) for 5 hours or lysed when freshly isolated (T0). cDNA was amplified using custom 
Hif2a primers and a representative gel image of n=3 is shown. (B & C) Murine neutrophils 
express HIF-1α (B) and HIF-2α (C). Representative western blots of lysates from neutrophils 
cultured in normoxia (N) or hypoxia (H) or stimulated in normoxia with LPS (10 ng/ml) or 
DMOG (100 µM) for 5 hours.   
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Figure 3.7-2  Myeloid-specific HIF-2α deficiency does not affect in vitro 
apoptosis.  
(A & C) Neutrophils from mice with myeloid-specific deletion of (A) Hif2a (filled bars), (C) Hif1a 
(grey bars), or littermate controls (open bars) were cultured for (A) 10 hours or (C) 6 hours in 
normoxia or hypoxia before apoptosis was assessed by morphology.  Data are mean and SEM 
for n=3.  (D & F)  Neutrophils from mice with myeloid-specific deletion of (D) Hif2a (filled bars), 
(F) Hif1a (grey bars), or littermate controls (open bars) were cultured with 10 ng/ml LPS for 5 
hours.  Apoptosis was assessed by morphology. Data are mean and SEM for n=3 (C) or n=6 (E).  
(B & E) Representative cytospin images of HIF-2α deficient neutrophils cultured (B) in normoxia 
or hypoxia for 9 hours or (E) with 10 ng/ml LPS for 5 hours. Arrowheads indicate apoptotic 
neutrophils. Panel C was redrawn with additional data with permission from S. Walmsley 
(Walmsley et al. 2011)  
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Figure 3.7-3. Murine neutrophils deficient in HIF-2α have normal function 
and preserved receptor expression.  
Functional assays. (A) Respiratory burst: neutrophils from C57BL/6 (open bars), 
Hif1a
flox/flox;LysMCre+/- (hatched bars) and Hif2aflox/flox;LysMCre+/- (filled bars) mice were pre-
incubated with 6 µM DCF (30 mins) and stimulated with heat-inactivated S. pneumoniae (MOI 
10:1) and FL1 geometric mean fluorescence determined by flow cytometry (n=3). (B) 
Phagocytic index was calculated on cytospins of neutrophils from C57BL/6 (open bars), 
Hif1a
flox/flox;LysMCre+/- (hatched bars) and Hif2aflox/flox;LysMCre+/- (filled bars) mice that were 
stimulated with opsonised zymosan A (0.2 mg/ml) for 30 minutes. Data are mean and SEM 
(n=3). (C) Chemotaxis: neutrophil migration to KC (0-10 µM) across a 5 µm filter was assessed 
in neutrophils from Hif2aflox/flox;LysMCre-/- (open bars) and Hif2aflox/flox;LysMCre+/- (filled bars) 
mice.  Data are mean and SEM (n=3).   
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Figure 3.7-4. Murine neutrophils deficient in HIF-2α have preserved receptor 
expression. 
Neutrophils from C57BL/6 (open bars), Hif1aflox/flox;LysMCre+/- (hatched bars) and 
Hif2a
flox/flox;LysMCre+/- (filled bars) mice were cultured in the presence/absence of LPS (10 
ng/ml), stained with PE-anti-CD11b (A) or PE-anti-L-selectin (B) and geometric mean 
fluorescence determined by flow cytometry (n=3).    
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Figure 3.7-5. Mice with myeloid-specific deficiency of HIF-2α have normal 
survival in bacterial pneumonia.  
Mice were challenged with 1 x 107 colony forming units of Streptococcus pneumoniae 
administered via the trachea under anaesthetic.  Mice were observed at least twice daily for 9 
days and those that reached a pre-determined level of morbidity were culled by an observer 
blinded to genotype.  Kaplan Meier survival curves were analysed and plotted for wild-type 
Hif2a
flox/flox
;LysMCre
-/- (solid red line, n=10) and Hif2aflox/flox;LysMCre+/- (broken blue line, n=11). 
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3.8 Loss of HIF-2α enhances resolution of neutrophilic inflammation 
following an acute lung injury. 
 
To determine the effect of HIF-2α deficiency on neutrophilic inflammation in vivo, I utilised a 
neutrophil-mediated LPS-induced model of acute lung injury.  Mice with myeloid-specific 
deletion of Hif2a had normal recruitment of neutrophils to the lung, but enhanced 
inflammation resolution, with significantly lower bronchoalveolar lavage neutrophil counts 
than controls at 48 hours, associated with increased neutrophil apoptosis in the HIF-2α 
deficient mice (Figure 3.8-1).  Immunohistochemistry confirmed HIF-2α expression in 
neutrophils of LPS treated wild-type mice with no staining seen in myeloid cells of HIF-2α 
deficient mice (Figure 3.8-2).     Cytokine and chemokine profiles in plasma and lavage fluid 
showed no deficit in pro-inflammatory cytokine production between strains, in keeping with 
their equivalent neutrophil recruitment (Figure 3.8-3).  Differential regulation of Hif1a and 
Hif2a was also observed in wild type LPS treated animals, with downregulation Hif1a mRNA in 
bronchoalveolar lavage samples over time following LPS challenge (Figure 3.8-4), in marked 
contrast to Hif2a which was maintained during the resolution phase of the acute lung injury 
(Figure 3.8-4).  This also reflected in the selective induction of Hif2a but not Hif1a mRNA in 
cells harvested from the bronchoalveolar lavage fluid at 24 hours compared with circulating 
neutrophil expression (figure 3.8-4), and was subsequently confirmed on flow sorted 
bronchoalveolar neutrophils (data not shown).  
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Figure 3.8-1. Enhanced resolution of acute lung inflammation in mice with 
myeloid-specific deficiency of HIF-2α.  
Hif2a
flox/flox;LysMCre+/- mice, littermate Hif2aflox/flox;LysMCre-/- controls or C57BL/6 mice were 
instilled with intratracheal LPS (0.3 µg).  Bronchoalveolar lavage (BAL) was performed at 6, 24 
and 48 hours and (A) total cell counts and (B) neutrophil counts were determined by 
haemocytometer. (C) Neutrophil apoptosis was assessed by morphology.  Data are mean and 
SEM for controls (open bars), HIF-2α deficient mice (filled bars), n=6.   (D) Representative 
cytospins of BAL from Hif2aflox/flox;LysMCre-/- (WT) or Hif2aflox/flox;LysMCre+/- (KO) mice at 48 
hours post instillation.  
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Figure 3.8-2. Expression of HIF-2α in inflammatory murine neutrophils 
recruited to the lung after intratracheal LPS instillation.  
Immunohistochemistry showing expression of HIF-2α in neutrophils of WT (A & C) mice 
challenged with intratracheal LPS, while in HIF-2α deficient mice (B) no staining was observed. 
Original magnification (A & B) x400, (C) x1000.   
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Figure 3.8-3. Mice with myeloid-specific deficiency of HIF-2α have preserved 
cytokine production following LPS-induced acute lung injury. 
Hif2a
flox/flox;LysMCre+/- mice or littermate Hif2aflox/flox;LysMCre-/- controls were instilled with 
intratracheal LPS (0.3 µg).  Bronchoalveolar lavage was performed at 6, 24 and 48 hours. 
Cytokines in plasma and bronchoalveolar lavage fluid were assessed using a multiplex cytokine 
kit.  Levels of (A) IL-10, (B) IL-6, (C) KC, (D) TNF-α and (E) IL-12 are shown for control (open 
bars) and Hif-2α deficient mice (filled bars) as mean ± SEM for a minimum n=4.  
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Figure 3.8-4. Expression of Hif1a and Hif2a in peripheral blood and 
bronchoalveolar lavage cells during LPS-induced acute lung injury.  
C57BL/6 mice were instilled with intratracheal LPS (0.3 µg).  Bronchoalveolar lavage (BAL) was 
performed at 6, 24 and 48 hours. (A) Hif1a and (B) Hif2a expression in BAL cell lysates from 
C57BL/6 mice determined by Taqman® and normalised to Actb.  Data are mean and SEM for 
n=3. (C) Hif1a and (D) Hif2a expression in peripheral blood neutrophils (PB) or BAL cells from 
C57BL/6 mice at 24 hours post LPS instillation.  Data are mean and SEM for n=3. 
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Given the finding of reduced neutrophil counts after 48 hours in mice with myeloid-cell 
deficiency of HIF-2α, I wished to determine whether this enhanced resolution was associated 
with a reduction in lung injury.  Acute lung injury is characterised by neutrophil-mediated 
damage to the pulmonary vascular endothelium and alveolar epithelium leading to leak of 
plasma components into the airspaces (Matthay and Zemans, 2011).  I challenged mice with a 
high dose of nebulised LPS which has been shown to cause significant elevation in IgM in 
bronchoalveolar lavage fluid.  In this model I confirmed the finding of enhanced resolution of 
inflammation in the HIF-2α deficient animals at 48 and 72 hours following LPS administration 
(Figure 3.8-5).  Associated with the reductions in neutrophil counts in BAL, I found evidence of 
reduced lung injury with significantly lower levels of IgM in the lavage fluid from HIF-2α 
deficient mice (Figure 3.8-5).   
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Figure 3.8-5. Reduced lung injury in mice with myeloid cell deficiency of HIF-
2α.  
C57BL/6 (WT) and Hif2aflox/flox;LysMCre+/- (KO) mice were challenged with nebulised LPS (3 mg).  
Bronchoalveolar lavage (BAL) was performed at 48 and 72 hours. (A & E) Total cell counts and 
(B & F) neutrophil counts were performed by haemocytometer. (C & G) Neutrophil apoptosis 
was determined by morphology. (D & H) IgM levels were determined in BAL fluid by ELISA.  
Data are mean and SEM for n=5.  
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3.9 Discussion 
Innate immune cells must function competently in the hypoxic microenvironment of infected 
and inflamed tissues and they utilise oxygen sensing transcription factors, notably HIF, to 
adapt to these conditions. In addition to its key role in cellular oxygen sensing and metabolic 
adaptation to hypoxia, HIF-1α has been shown to regulate neutrophil survival in hypoxia as 
well as regulating myeloid cell motility, invasiveness and bacterial killing, in part through its 
ability to regulate intracellular ATP levels and, in neutrophils, granule protease production 
(Cramer et al., 2003; Peyssonnaux et al., 2005; Walmsley et al., 2005).  HIF-1α expression is 
itself induced in response to microbial products, even in normoxic conditions (Peyssonnaux et 
al., 2005). In vivo myeloid-specific HIF-1α deficiency therefore results in reduced myeloid cell 
mediated inflammation, but also increased susceptibility to bacterial infections both locally 
and systemically (Cramer et al., 2003; Peyssonnaux et al., 2005).  Consequently, direct 
targeting of HIF-1α would not appear to be a desirable anti-inflammatory approach given the 
potential for rendering the host more susceptible to uncontrolled bacterial infection.  This has 
resulted in the search for more selective regulators of neutrophil function and fate.  The data 
presented in this thesis implicate HIF-2α as a regulator of longevity in inflammatory 
neutrophils; with conservation of its role across species, and show that overexpression of HIF-
2α promotes neutrophil survival in humans and zebrafish whilst its deletion results in 
enhanced resolution of neutrophilic inflammation in mice.  These data imply that upregulation 
of HIF-2α mediates a distinct survival mechanism in neutrophils at inflamed sites and that this 
occurs independently of local oxygen availability.  
Whilst HIF-1α and HIF-2α display significant sequence homology, a number of unique functions 
have been ascribed to each protein with HIF-1α exclusively regulating glycolytic enzyme 
abundance and intracellular ATP generation, and HIF-2α determining the transcription of 
erythropoietin and the stem cell transcription regulator, Oct4 (Covello et al., 2006; Gruber et 
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al., 2007; Hu et al., 2003).  More recently, HIF-2α has been shown to directly regulate 
macrophage expression of pro-inflammatory cytokines and receptors M-CSFR and CXCR4, with 
myeloid-specific loss of HIF-2α resulting in resistance to LPS-induced endotoxemia, reduced 
tumour-associated macrophage infiltration, and reduced hepatocellular tumour progression, 
but no associated change in intracellular ATP levels (Imtiyaz et al., 2010).  Although these data 
clearly implicate HIF-2α in myeloid cell mediated inflammatory responses and begin to 
dissociate HIF-1α and HIF-2α functional responses, the work also highlights responses common 
to both, given the previously described role for HIF-1α in the regulation of LPS-mediated 
systemic inflammatory response syndrome.  I therefore proposed that HIF-2α would also play 
a critical role in neutrophil biology, and more specifically regulate neutrophil apoptosis in the 
context of acute inflammation.  
In keeping with previous findings from bone marrow derived neutrophils and murine 
neutrophil cell lines (MPRO) (Imtiyaz et al., 2010), I was unable to detect HIF-2α mRNA or 
protein in immature murine bone marrow neutrophils.  Importantly, however, detectable 
levels of HIF2A mRNA were found in highly pure peripheral blood neutrophils, although 
previous work had failed to detect it by less sensitive RNase protection assay (Walmsley et al., 
2005).  Marked differential expression between bone marrow and circulating neutrophils has 
previously been described for numerous other genes, including BCL-2, which is only detected 
in immature bone marrow derived cells (Andina et al., 2009; Theilgaard-Monch et al., 2005).  
Interestingly other transcription factors, for example c-fos, c-jun and members of the C/EBP 
family, are also induced during late granulopoesis (Bjerregaard et al., 2003).  I speculate that 
Hif2a expression is activated upon exit from the bone marrow but the functional 
consequences of delayed expression remain the subject for future work.  Nonetheless, HIF-2α 
is unlikely to influence neutrophil release from the marrow, given myeloid-specific HIF-2α 
deficient animals have normal circulating neutrophil numbers, equivalent proportions of 
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neutrophils in the spleen and bone marrow (Imtiyaz et al., 2010) and that epas1a 
overexpression in zebrafish did not alter whole body neutrophil numbers. 
In marked contrast to HIF-1α, constitutive expression of HIF-2α was detected in normoxic 
culture.  Detectable levels of HIF-2α in normoxic macrophages are widely reported but the 
mechanism by which it evades degradation in myeloid cells is unknown (Fang et al., 2009; 
Imtiyaz et al., 2010; Rius et al., 2008; Takeda et al., 2010).  One proposed mechanism may be 
through dynamic changes in HIF mRNA expression, as evidenced by work from Takeda et al. 
(Takeda et al., 2010).  They showed HIF1A and HIF2A mRNA to be differentially expressed in 
M1- and M2-polarised macrophages, with labile HIF1A mRNA displaying a relatively short half-
life and conversely HIF2A mRNA being much more stable with a lower rate of turnover.  Of 
note, these changes in mRNA expression occurred independently of oxygen availability, and 
were themselves a strong predictor of protein abundance.  In this context, I observed no 
significant acute changes in mRNA expression of either HIF1A or HIF2A in healthy volunteer 
neutrophils but, in neutrophils isolated from patients with an ongoing chronic inflammatory 
arthritis, a 20-fold induction in HIF2A mRNA expression was observed suggesting 
transcriptional regulation of HIF-2α can occur in a disease context. 
 
While HIF-1α protein was dramatically induced by hypoxia, hydroxylase inhibition and heat 
killed bacteria, the further modulation of HIF-2α protein expression above constitutive levels 
was less pronounced in vitro. However, much higher levels of expression in freshly isolated 
neutrophils from patients with inflammatory arthritis were observed compared to healthy 
control neutrophils and I demonstrated neutrophil expression of HIF-2α protein following 
recruitment to the lung in patients with mild and severe COPD. This was subsequently 
mirrored in a more acute setting in a murine model of LPS mediated acute lung injury.  In 
contrast, no HIF-1α expression was detected in circulating inflammatory neutrophils.  The 
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importance of HIF-2α accumulation with respect to disease outcomes is unknown but, through 
access to three patients with known gain-of-function mutations in the HIF2A gene, I was able 
to assess the functional consequences of HIF-2α overexpression in neutrophils.   Baseline rates 
of constitutive apoptosis were consistently lower in neutrophils from the patients than 
controls, although further reduction in apoptosis was achieved by stimulation with DMOG.  
This is consistent with experimental evidence showing only partial activation of HIF-2α in these 
patients, thus permitting further stabilisation through hydroxylase inhibition, and also the 
consequent additional stabilisation of HIF-1α (Percy et al., 2008b). Interestingly, neutrophils 
derived from patients with gain-of-function mutations in HIF2A also showed increased target 
gene expression namely VEGF, PAI-1 and PHD-3.  Whilst modulation of target gene mRNA 
expression by both HIF-1α and HIF-2α cannot be excluded, changes were observed in the 
specific HIF-2α target gene, PAI-1.  Unfortunately, this did not reach statistical significance, but 
this is likely to reflect the limited sample size, given the small number of patients available to 
study.   
Whilst delayed apoptosis has been implicated in animal models of inflammation (Jonsson et 
al., 2005; Rossi et al., 2006), it is not known whether the increase in HIF-2α expression and 
associated intrinsic delay of neutrophil apoptosis might predispose these patients to 
inflammatory disease, not least because of the rarity of the condition and the dominant clinical 
phenotype of erythrocytosis and its consequences.  To address directly the importance of 
selective HIF-2α stabilisation in the regulation of neutrophil survival and resolution of 
inflammation the human gain-of-function HIF2A mutations were replicated in the genetically 
tractable zebrafish (Elks et al., 2011; Renshaw et al., 2006).  The hydroxylation sites of HIF-α 
subunits are highly conserved across species (Elks et al., 2011) with an overall amino acid 
homology of 58% between zebrafish epas1a and human HIF-2α.  Using zebrafish RNA, the 
same glycine residues as are altered in the patients with gain-of-function HIF2A mutations 
were mutated, and these mutant constructs were injected into zebrafish at the one cell stage.   
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The resulting overexpression of mutant epas1a led to impaired resolution of inflammation in a 
tail injury model that was equivalent to overexpression of dominant active hif1ab and of a 
similar magnitude to previously reported results using the pan-caspase inhibitor, zVD.fmk 
(Renshaw et al., 2006).  These findings highlight that in vivo epas1a can modulate neutrophil 
survival to the same order of magnitude as hif1ab.  
 
Given the possibility that HIF-2α may represent a more selective and therefore potentially 
attractive anti-inflammatory target, I investigated the consequences of HIF-2α deficiency using 
mice with myeloid-specific deletion of Hif2a, as previously described (Takeda et al., 2010).  In 
marked contrast to HIF-1α deficiency (Cramer et al., 2003), I found no impairment of 
neutrophil chemotaxis, phagocytosis or respiratory burst in HIF-2α deficient neutrophils.  The 
expression profiles of the adhesion molecules CD11b and L-selectin were also preserved 
following LPS stimulation as was neutrophil trafficking into the lung in response to 
intratracheal LPS.  This highlights important differences in the consequences of HIF-2α 
deficiency within myeloid cell populations, given myeloid-specific Hif2a deletion resulted in 
reduced macrophage trafficking into tumours and reduced expression of CXCR4 and the 
extracellular protein, fibronectin-1, in these cells (Imtiyaz et al., 2010).  Consistent with my 
findings of preserved neutrophil function in vitro and normal recruitment in vivo, I also 
demonstrated no impairment of host defence against bacterial infection in animals with HIF-
2α deficiency in myeloid cells.  This was assessed using a pneumococcal pneumonia model at a 
dose sufficient to overwhelm the defence provided by resident macrophages and result in 
marked neutrophil infiltration into the lungs (Dockrell et al., 2003).  This model produces 
established pneumonia with a significant mortality rate but the mice with neutrophils deficient 
in HIF-2α had equivalent rates of survival compared to wild-type controls.   
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In the light of my findings with HIF-2α overexpression in human and zebrafish neutrophils, it 
was surprising to find no differences in murine neutrophil apoptosis, either constitutively or in 
response to hypoxia or LPS in vitro.  My data, together with previously published data, suggest 
that while HIF-2α is unable to compensate for loss of HIF-1α and maintain survival in hypoxia 
the survival response to LPS may be mediated by either transcription factor, or an independent 
pathway.  Nonetheless, evidence suggests that the in vivo response to LPS involves both 
transcription factors given that myeloid-specific loss of either HIF-1α or HIF-2α results in 
reduced systemic inflammatory responses and mortality following intravenous or 
intraperitoneal challenges (Imtiyaz et al., 2010; Peyssonnaux et al., 2007). Despite the 
preserved survival response in vitro, in LPS-mediated in vivo models of acute lung injury HIF-2α 
deficiency was associated with enhanced inflammation resolution, with fewer neutrophils in 
BAL samples at 48 and 72 hours, in association with an increase in morphological neutrophil 
apoptosis.  Neutrophils recruited from the circulation to the lung and the airways following LPS 
stimulation significantly up-regulated Hif2a mRNA but not Hif1a mRNA, with persistence of 
Hif2a mRNA in bronchoalveolar lavage cells during inflammation resolution when Hif1a mRNA 
expression had substantially reduced.  This would suggest, in a model of neutrophilic 
inflammation in which oxygen availability is not limited, it is HIF-2α expression that dictates 
the resolution of the inflammatory process.  Importantly the consequences of enhanced 
resolution of inflammation were evident in the high dose nebulised LPS model, with the 
reduction in neutrophil count being associated with evidence of reduced lung injury, as 
assessed by levels of IgM in the bronchoalveolar lavage fluid.   
 
The preservation of neutrophil function in vitro and recruitment in vivo dissociates HIF-2α 
neutrophil phenotypes from deficiency of HIF-1α (Cramer et al., 2003).  Furthermore the 
phenotype of enhanced resolution in LPS-mediated acute lung injury contrasts with findings in 
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PHD3 deficient animals, in which a specific role was demonstrated for PHD3 in regulating 
inflammation resolution in the context of both whole animal hypoxia in a hypoxic LPS acute 
lung injury model, and localised tissue hypoxia in a DSS model of colitis (Walmsley et al., 2011).  
While PHD3 is essential therefore for neutrophil survival and inflammatory responses in 
hypoxia, I propose that the effects of HIF-2α deficiency in inflammatory neutrophils occur 
independently of oxygen tension and targeting HIF-2α may therefore be of greater clinical 
utility in inflammation in tissues such as the lung where oxygen tension may vary widely 
(Hamedani et al., 2011). 
 
Interestingly, cytokine responses were preserved in myeloid-specific HIF-2α deficient mice 
when challenged with intratracheal LPS.  My data contrast with findings from an 
intraperitoneal LPS-induced endotoxemia in which HIF-2α deficiency resulted in reduced 
serum levels of pro-inflammatory cytokines and increased levels of IL-10 (Imtiyaz et al., 2010).  
However, the two models differ in magnitude of cytokine release and outcome, with lethality 
in the intraperitoneal model within 48 hours.  Furthermore, although in vitro data supported a 
role for HIF-2α mediated regulation of IL-6 in macrophages (Imtiyaz et al., 2010), no 
differences were seen in serum in either model.  These results may reflect differences in the 
mechanisms by which neutrophils and macrophages upregulate cytokine production or the in 
vivo production of cytokines from non-myeloid cells.  Indeed alveolar epithelial cells are a 
major source of chemokines and IL-6 in the lung (Thorley et al., 2007).  During resolution, 
cytokine levels fell dramatically in both BAL and plasma and there were no differences with 
HIF-2α deficiency (data not shown), reinforcing that the phenotype of increased neutrophil 
apoptosis seen in Hif2aflox/flox;LysMCre+/- mice at 48 hours is independent of a defect in 
macrophage cytokine production.    
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In summary, I have described expression of HIF-2α in human and murine neutrophils and 
showed upregulation in inflammatory neutrophils.  I have shown that HIF-2α overexpression 
leads to an intrinsic delay of neutrophil apoptosis in patients with gain-of-function HIF2A 
mutations and impaired resolution of inflammation in a zebrafish tailfin injury model.  
Importantly, and in marked contrast to HIF-1α, deficiency of HIF-2α had no effect on 
neutrophil function but did enhance apoptosis of inflammatory neutrophils in vivo.  Through 
modulation of tumour cell apoptosis, HIF-2α has emerged as a potential therapeutic target in 
cancer biology (Bertout et al., 2008; Raval et al., 2005).  I now implicate HIF-2α in neutrophilic 
inflammation and propose that selective inhibition of HIF-2α may allow effective control of 
neutrophil-mediated inflammation without compromising host defences.  
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4 Hypoxia induces hypothermia and sickness behaviour in mice 
following subcutaneous injection of live Staphylococcus aureus 
4.1 Introduction 
Bacterial infections frequently occur in the context of local and systemic hypoxia.  Hypoxaemic 
patients on critical care commonly succumb to bacterial infections and have a high mortality 
(Alberti et al., 2003).  The acute respiratory distress syndrome, defined by arterial hypoxaemia, 
has a mortality rate of 40% and the majority of cases are due to infection (Matthay et al., 
2003; Sheu et al., 2010).  At a tissue level, oxygen tensions measured in healthy subcutaneous 
tissue of perioperative patients had average values of 7.8 kPa compared to values of less than 
3 kPa when infected and inflamed (Hopf et al., 1997; Silver, 1977).  The influence of hypoxia on 
the interaction between host and pathogen, and in particular the host immune response, is 
therefore of considerable interest.   
Outcomes of infection are often worsened by hypoxia.  In animal models, infected wound flaps 
were larger and more necrotic if animals breathed hypoxic gas (12% oxygen) than if they 
breathed air or were given supplementary oxygen (45% oxygen)(Jonsson et al., 1988).  In 
humans, wound infection rate was inversely proportional to subcutaneous oxygen tension 
during surgery (Hopf et al., 1997).  Furthermore, several randomised controlled clinical trials in 
patients having surgery under general anaesthetic have shown reduced frequency of surgical 
wound infection if 80% oxygen rather than 30% oxygen was administered during the 
perioperative period (Belda et al., 2005; Greif et al., 2000).  These observations are consistent 
with the finding that limitation of molecular oxygen impairs neutrophils’ capacity to generate 
reactive oxygen species (ROS) and reduces neutrophil killing of Staphylococcus aureus in vitro 
(McGovern et al., 2011).  Hypoxia, on the other hand, does not impair the ability of S. aureus 
to subvert the host response as it is capable of killing neutrophils in hypoxic culture media 
(McGovern et al., 2011). 
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Although hypoxia may compromise elements of the immune response to infection, there is 
also good evidence that components of cellular oxygen sensing pathways are key regulators of 
the host’s innate immune response. HIF-1α, a master regulator of cellular adaptation to 
hypoxia and of innate immune function, is stabilised not only by hypoxia but also by bacteria 
and endotoxin independent of oxygen tension (Peyssonnaux et al., 2005).  Studies of bone 
marrow-derived macrophages from HIF-1α deficient mice showed that killing of both gram 
positive and gram negative bacteria was reduced (Peyssonnaux et al., 2005). Conversely, 
macrophages from mice with myeloid cell specific deletion of the VHL gene, and thus 
activation of HIF-pathways, had increased bactericidal action (Peyssonnaux et al., 2005).  
Moreover stabilisation of HIF-1α by the HIF-hydroxylase inhibitor, mimosine, enhanced killing 
of S. aureus by neutrophils and monocytes in vitro and reduced lesion size when injected 
locally in a mouse model of S. aureus infection skin (Zinkernagel et al., 2008).   
The HIF pathway also has a critical role in the development of endotoxin-induced sepsis.  
Despite the evidence discussed earlier in this thesis of distinct roles for HIF-1α and HIF-2α 
regulating neutrophil and macrophage phenotypes, deletion of either HIF-1α or HIF-2α in 
myeloid cells protected mice from the effects of high dose intraperitoneal LPS injection 
(Imtiyaz et al., 2010; Peyssonnaux et al., 2007).  Temperature, haemodynamic indices and 
overall mortality were improved with myeloid cell deficiency of either HIF-α subunit.  
Interestingly, in a similar model pre-treatment of mice with the hydroxylase inhibitor, DMOG, 
improved outcome in endotoxaemic mice in an NF-ĸB dependent manner but DMOG pre-
treatment worsened outcome in response to polymicrobial sepsis (Hams et al., 2011).  
Therefore, despite the ability of both hypoxia and bacteria to activate the HIF-pathway, the 
effects of local versus systemic HIF activation appear to be crucial in determining outcome in 
sepsis and localised infection.  I used a model of subcutaneous S. aureus infection with the 
added insult of reduced ambient oxygen tension to investigate the interaction between 
hypoxia and the host response to bacterial infection in vivo.   
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S. aureus is an important cause of morbidity and mortality in humans (Boucher and Corey, 
2008; Laupland et al., 2003).  Although 30%-50% of the population may have skin or mucosal 
colonisation, S. aureus has the potential to cause diverse and devastating infections, even in 
immunocompetent individuals (Lowy, 1998; van Belkum et al., 2009). Local infections include 
impetigo, folliculitis and cellulitis. Moreover, S. aureus is the most common pathogen in 
community acquired skin and soft tissue infections requiring hospital admission (Dryden, 2010; 
Zervos et al., 2012).  Invasive infections, defined as S. aureus isolated from blood, 
cerebrospinal fluid, pleural fluid, synovial fluid or aseptically obtained tissue samples, had an 
incidence of 28.4 cases per 100,000 population with a mortality of 19% (Laupland et al., 2003). 
While certain populations are known to be at high risk of developing invasive infections, for 
example patients on haemodialysis (Laupland et al., 2003), virulent forms of S. aureus 
expressing the Panton-Valentine leukocidin toxin are responsible for necrotizing pneumonia in 
previously healthy children and young adults (Gillet et al., 2002).   
An important problem for clinicians treating S. aureus infections is the emergence of antibiotic 
resistance.  Methicillin resistance is no longer only a feature of nosocomial infection but is 
increasingly found in community acquired S. aureus infections (Boucher and Corey, 2008; 
Fridkin et al., 2005). Resistance to other antibiotics is also emerging with vancomycin and 
linezolid resistant strains reported (Rivera and Boucher, 2011)   To improve strategies for 
combating S. aureus infection in the face of increasing antibiotic resistance (Hiramatsu, 2001; 
Rivera and Boucher, 2011) a greater understanding of host-pathogen interactions is required.  
S. aureus is a major pathogen in critical care where patients may have profound hypoxaemia 
(Alberti et al., 2003; Guidet et al., 2005) and at a tissue level, S. aureus frequently infects 
ischaemic wounds  (Galkowska et al., 2009).   S. aureus is therefore a useful tool to model the 
interaction between pathogens and host responses to infection in the context of hypoxia.  I 
hypothesised that systemic hypoxia might alter the host immune response to a local S. aureus 
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(strain SH1000) infection.  Additionally, in this setting of combined systemic hypoxia and 
bacterial infection which both stabilise HIF-α subunits, I aimed to explore whether myeloid cell 
deficiency of HIF-1α or HIF-2α would alter the host response. 
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Results 
4.2 Subcutaneous injection of live S. aureus induces hypothermia and 
sickness behaviour in hypoxia but not normoxia. 
Injection of 5 x 107 cfu SH1000 bacteria into the subcutaneous tissue of normoxic mice 
consistently produced a skin lesion which increased in size over 7 days (see Figure 4.2-1). Mice 
had lost weight at 24 hours post-injection but this was regained by day 7 (Figure 4.2-1).  
As I wished to determine the interaction between hypoxia and S. aureus in vivo, I challenged 
mice with subcutaneous SH1000 or PBS and placed them in a hypoxic incubator, reducing the 
oxygen level to 10% (approximately 50% of atmospheric oxygen tension) over 1 hour.  This 
level of oxygen tension is frequently used in mouse models and is normally well tolerated but 
if mice are maintained in hypoxia for more than 1 week, they develop right ventricular 
hypertrophy and pulmonary arterial hypertension (Hancher and Smith, 1975; James and 
Thomas, 1968; Naeye, 1967; Yu et al., 1999).  After 6 hours in hypoxia, I observed a slight but 
significant reduction in control mouse body temperature (39.1˚C +/- 0.56 vs. 37.2˚C +/- 0.43, 
n=6, p<0.05) consistent with previous studies (Bhatia et al., 1969; Gellhorn and Janus, 1936; 
Gordon and Fogelson, 1991).  There was no evidence of sickness behaviour in these animals.  
However, after 12 hours I found no difference in temperature between control mice but 
profound hypothermia in infected hypoxic animals compared to those maintained in normoxia 
(see Figure 4.2-2). Furthermore the mice appeared clinically unwell and I developed 
assessment tools to objectively score the sickness behaviour of the mice. Clinical assessment 
of the mice by independent observers revealed marked sickness behaviour in hypoxic mice 
injected with SH1000 which was not observed in mice maintained in normoxia or in hypoxic 
mice injected with PBS (see Figure 4.2-2).  On one occasion the time point was extended to 18 
hours, but by this time 1 out of 3 hypoxic infected mice was dead and 2 out of 3 were 
moribund.  
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Figure 4.2-1. Subcutaneous injection of 5x107 cfu Staphylococcus aureus 
produces a skin lesion in normoxic mice.  
C57BL/6 mice were injected with 5x107 cfu S. aureus (SH1000) then photographed and 
weighed daily for 7 days. (A) A representative photograph of a skin lesion 7 days post-injection.  
(B) Skin lesion area calculated using ImageJ software. (C) Mouse body weight in grams.  Data 
are mean +/- SEM n=5. *** p < 0.001 versus starting weight analysed by repeated measures 
ANOVA and Bonferroni’s post-test.  
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Figure 4.2-2. Hypoxia induces hypothermia and sickness behaviour in mice 
infected subcutaneously with Staphylococcus aureus.  
Mice were injected subcutaneously with 5x107 colony forming units of SH1000 S. aureus or PBS 
vehicle control and placed in normoxia or hypoxia (10% O2) for 12 hours.  (A & B) Scatter plots 
of mouse sickness scores assessed by independent observers blinded to experimental 
condition. (B) Rectal temperatures were also recorded 12 hours following injection. Data are 
mean +/- SEM. n=10 or n=5 (vehicle). ***p<0.0001 by ANOVA. 
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To establish whether live bacteria were required to produce the phenotype of hypothermia 
and sickness behaviour in hypoxic mice, 5 x 107 cfu of heat-killed SH1000 were injected 
subcutaneously.  Unlike live SH1000, the heat-killed bacteria did not lead to a significant 
increase in sickness score or reduction in body temperature (see Figure 4.2-3).  
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Figure 4.2-3. Live bacteria are required to produce the phenotype of 
hypothermia and sickness behaviour in hypoxic animals.  
Mice were injected with 5x107 cfu of live or heat killed SH1000. (A & B) Sickness scores and (C) 
rectal temperature were recorded after 12 hours. Data are mean +/- SEM n=5. ***p<0.0001, 
**p<0.01 by ANOVA. N=normoxia, H=hypoxia.  
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4.3 Hypoxia does not alter inflammatory cell recruitment or bacterial 
burden. 
To investigate whether hypoxia impaired the local immune response to the subcutaneous 
bacterial challenge, the skin around the injection site was biopsied 12 hours after injection.  
Histological sections revealed an inflammatory infiltrate in both normoxic and hypoxic skin but 
no differences were detected in counts of myeloperoxidase expressing cells (see Figure 4.3-1). 
Further objective quantification of inflammatory infiltration was performed using an assay of 
myeloperoxidase activity in homogenised biopsy specimens. No difference in myeloperoxidase 
activity was detected between infected hypoxic or normoxic skin.   
Bacterial counts in the skin were equivalent between normoxic and hypoxic mice in keeping 
with the evidence of preserved inflammatory cell recruitment in hypoxia (see Figure 4.3-2).   
 
  
136 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3-1. No differences in local host response to subcutaneous injection 
of SH1000 bacteria after 12 hours.   
Mice were injected subcutaneously with 5x107 cfu of SH1000 S. aureus or PBS control and 
placed in hypoxia or normoxia for 12 hours.  (A & B) Representative photomicrographs of 
infected skin biopsy sections stained with (A) haematoxylin and eosin or (B) anti-
myeloperoxidase antibody. Original magnification x200. (C) Counts of myeloperoxidase 
positive cells per high powered field in skin tissue. (D) Skin biopsies were homogenized in HTAB 
buffer.  Myeloperoxidase activity was analysed and normalised per gram of skin tissue.  Data 
are mean +/- SEM for n=5.    
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Figure 4.3-2. No differences in bacterial count in skin after 12 hours.   
Mice were injected subcutaneously with 5x107 cfu of SH1000 S. aureus and placed in hypoxia 
or normoxia for 12 hours.  (A)  A photomicrograph of a section of skin tissue stained using a 
Gram stain kit showing gram positive bacteria within the subcutaneous tissue. The arrowhead 
marks one example. Original magnification x400.  (B) Skin biopsies were weighed and 
homogenized in PBS before colony forming unit counts were obtained using the Miles and 
Misra method.  
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4.4 No detectable bacteraemia in infected animals 
Using blood drawn from mice 12 hours following injection of SH1000 I performed serial 
dilutions and cultured these overnight on blood agar plates.  No bacteria were evident in the 
blood from normoxic or hypoxic animals (n=5). To determine whether a transient bacteraemia 
had seeded vital organs, as occurs following intravenous injection of S. aureus (Jonsson et al., 
2004), I isolated kidneys, liver and spleen from animals 12 hours after subcutaneous infection.  
Again, I observed no detectable gram positive bacteria.   
 
4.5 Cytokine responses in mice infected with SH1000. 
Cytokine release was measured in plasma at 3, 6 and 12 hours following injection of S. aureus.  
I found decreased levels of MCP-1 and KC at 3 hours in infected hypoxic mice compared to 
infected normoxic mice (see Figure 4.5-1). Levels of KC and IL-6 were higher 6 hours after 
injection but there were no significant differences in levels of these cytokines between hypoxic 
and normoxic animals at this time point.  Twelve hours following injection cytokine levels had 
reduced from those seen at 6 hours and there were no significant differences between the 
animals maintained in normoxia versus infected hypoxic animals. At none of the time points 
was I able to detect IL-1β, TNF-α, IFN-γ, IL-10, IL-4 or IL-13 by cytometric bead array.  
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Figure 4.5-1. Circulating cytokine concentrations in normoxic and hypoxic 
animals infected with S. aureus.  
Mice were placed in hypoxia or normoxia following infection with SH1000 and sacrificed at 
either 3, 6 or 12 hours.  Plasma was obtained and analysed by cytokine bead array for (A) IL-6, 
(B) KC and (C) MCP-1.  IL-1 and TNF were also analysed but were below the limit of detection 
at these times. Data are mean +/- SEM of a minimum n=4.   
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4.6 No evidence of multi-organ dysfunction. 
In order to try to establish the cause of the sickness behaviour and hypothermia in infected 
hypoxic mice, a series of investigations were performed assessing the function of vital organs. 
Analysis of serum revealed no evidence of either pancreatic or liver dysfunction but there was 
a significant elevation in serum creatinine (see Figure 4.6-1).   
To assess for acute lung injury, bronchoalveolar lavage was performed 12 hours following S. 
aureus injection and this recovered low numbers of cells with no difference in counts between 
infected hypoxic or normoxic mice (see Figure 4.6-2). Notably there was no evidence of 
neutrophilic inflammation. Histological samples confirmed the lack of inflammatory infiltration 
in infected animals (see Figure 4.6-2).  There was also no evidence of increased pulmonary 
oedema in hypoxic animals compared to normoxic mice determined by wet to dry lung weight 
ratios. Consistent with these findings, the infected mice had similar respiratory rates in hypoxia 
and normoxia (see Figure 4.6-3).   
Given the precedent of cerebral oedema in the context of hypobaric hypoxia (Houston and 
Dickinson, 1975; Schoch et al., 2002), I analysed wet and dry brain weights and found no 
evidence of cerebral oedema in either normoxic or hypoxic infected mice (see Figure 4.6-4).  In 
a separate experiment, mice were injected with Evan’s blue dye to assess for fluid leak across 
the blood brain barrier. This method has been used to show cerebral oedema following 
ischaemic tissue injury (Aoki et al., 2002; Manaenko et al., 2011).  I did not detect any dye in 
the brain tissue of hypoxic or normoxic mice.   
To investigate for evidence of significant acidosis or hypoglycaemia contributing to the 
phenotype of hypothermia and sickness behaviour in hypoxic mice, blood glucose and 
bicarbonate levels were measured, but no differences were detected compared to normoxic 
infected mice (see Figure 4.6-5). 
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Figure 4.6-1. Elevated serum creatinine in hypoxic mice infected with S. 
aureus but no evidence of pancreatic or liver dysfunction. 
Mice were injected subcutaneously with 5x107 cfu of SH1000 S. aureus and placed in hypoxia 
or normoxia for 12 hours.  Serum was obtained and analysed for (A) aspartate transaminase, 
(B) lipase and (C) creatinine.  Data are mean +/- SEM, n=5. *** p < 0.001 by unpaired t test.  
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Figure 4.6-2. Injection of subcutaneous S. aureus does not induce acute lung 
injury. 
 Mice were placed in hypoxia or normoxia for 12 hours following infection with SH1000.  
Bronchoalveolar lavage was performed in anaesthetised animals and (A) total cell count and 
(B) neutrophil counts were calculated.  Data are mean and SEM, n=5. (C) Representative 
photographs of lung tissue sections from infected normoxic and hypoxic mice stained with 
haematoxylin and eosin. Original magnification x200.  
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Figure 4.6-3. No evidence of increased pulmonary oedema or respiratory 
distress in hypoxic animals infected with S. aureus.  
Mice were placed in hypoxia or normoxia for 12 hours following infection with SH1000.  (A) 
Lung oedema was assessed by wet to dry lung weight ratio. (B) Respiratory rate of infected 
animals was counted. Data are mean and SEM, n=5.  
  
Normoxia Hypoxia
0
1
2
3
4
5
W
e
t/
d
ry
 r
a
ti
o
Normoxia Hypoxia
0
50
100
150
200
R
e
s
p
ir
a
to
ry
 r
a
te
b
re
a
th
s
 p
e
r 
m
in
A
B
144 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6-4. Injection of subcutaneous S. aureus does not precipitate 
cerebral oedema in hypoxia.  
Mice were placed in hypoxia or normoxia for 12 hours following infection with SH1000.  Brain 
oedema was assessed by wet to dry brain weight ratio.  Data are mean and SEM, n=3.  
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Figure 4.6-5. Blood glucose levels and venous bicarbonate are not 
significantly altered in infected hypoxic mice.  
Mice were placed in hypoxia or normoxia for 12 hours following subcutaneous injection with S. 
aureus.  (A) Blood glucose levels were measured using an Optium Xceed blood glucose meter. 
Animals were not fasted during this experiment. (B) Venous bicarbonate was obtained with a 
blood gas analyser. Data are from a minimum n=4 and are mean and SEM.     
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4.7 Evidence of circulatory dysfunction. 
Further non-invasive assessment of awake mice displaying sickness behaviour revealed 
significant systolic hypotension and bradycardia (see Figure 4.7-1).  Echocardiographic 
assessment of infected hypoxic and normoxic animals was therefore performed under light 
anaesthetic 12 hours after injection of bacteria.   
Several markers of left ventricular contractility were assessed.  For comparison, data from non-
infected normoxic mice of equivalent weight but assessed at a different time are shown 
alongside infected animals. Representative M-mode images of the left ventricle in the short 
axis view are shown in Figure 4.7-2.  These M-mode images revealed fractional shortening, 
calculated from the change in diameter of the left ventricle between diastole and systole, was 
reduced in hypoxic infected animals (see Figure 4.7-3). 2-dimensional measurements of left 
ventricular area were used to calculate fractional area change (see Figure 4.7-3).  This was 
significantly reduced in infected hypoxic animals compared to normoxic animals. Furthermore, 
tissue doppler measurements of left ventricular anterior wall velocity provided additional 
evidence of reduced left ventricular contractility in the hypoxic infected mice (see Figure 4.7-
3).  
Left ventricular volumes were estimated from the internal diameter of the left ventricle 
measured in M-mode.  End-systolic volume was significantly greater in the injected hypoxic 
mice, with no significant change in diastolic volume (see Figure 4.7-4).  Using these volumes to 
calculate ejection fraction, stroke volume index and cardiac index revealed a significant 
reduction in left ventricular function in hypoxic infected mice (see Figure 4.7-4).   
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Figure 4.7-1. Hypoxic mice infected with S. aureus are hypotensive and 
bradycardic.  
Mice were trained to undergo non-invasive measurement of blood pressure and heart rate. 12 
hours following subcutaneous injection of SH1000 or PBS control, animals maintained in either 
hypoxic or normoxic conditions had measurements of (A) rectal temperature, (B) systolic blood 
pressure, (C) diastolic blood pressure and (D) heart rate performed.  Data are mean and SEM 
of a minimum n=3. * p<0.05, ** p<0.01 
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Figure 4.7-2. M mode images of the left ventricle showing impaired left 
ventricular function.   
Echocardiography was performed by Dr Abdul Hameed on anaesthetised mice 12 hours after 
infection with SH1000. Representative M mode images were captured in the short axis view of 
mice maintained in (A) normoxia or (B) hypoxia.   These images were used to measure left 
ventricular diameters in systole (LVID;s) and diastole (LVID;d).   
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Figure 4.7-3. Measurements of left ventricular contractility in mice 12 hours 
after subcutaneous S. aureus injection.  
Echocardiography was performed by Dr Abdul Hameed on anaesthetised mice 12 hours after 
infection with SH1000. Data from non-infected normoxic mice are shown for comparison.  (A) 
Fractional shortening, calculated from the change in left ventricular internal diameter between 
end-diastole and end-systole. (B) Fractional area change, calculated from the 2-dimensional 
measurement of left ventricular area in systole and diastole.  (C) Left ventricular anterior wall 
velocity measured by tissue doppler.  Data are mean and SEM of n=3 or 4. * p <0.05, ** p 
<0.01, *** p<0.001 by ANOVA.  
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Figure 4.7-4. Impaired left ventricular function in hypoxic mice 12 hours 
after subcutaneous S. aureus injection.   
Echocardiography was performed by Dr Abdul Hameed on anaesthetised mice 12 hours after 
infection with SH1000. Data from non-injected normoxic mice are shown for comparison.  (A) 
Left ventricular end-systolic volumes calculated from left ventricular internal diameter.  (B) 
Ejection fraction calculated from the measurements of left ventricular volume at end-systole 
and end-diastole.  (C) Stroke volume index calculated as the change in left ventricular volume 
between systole and diastole and corrected for mouse body weight.  (D) Cardiac index.  
Cardiac output was calculated as the product of stroke volume and heart rate then corrected 
for size by dividing by the body weight of each animal.  Data are mean and SEM of n=4. * p < 
0.05, ** p <0.01, *** p < 0.001 by ANOVA.  
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4.8 No significant increases in oxidative stress or plasma nitric oxide 
levels in infected hypoxic animals. 
Nitric oxide has been implicated as a cause of both hypotension and cardiac dysfunction in the 
context of sepsis (Boyle et al., 2000; Flierl et al., 2008). Nitric oxide in plasma samples were 
kindly analysed by Dr Andrew Cowburn, University of Cambridge. No significant differences 
were found between infected hypoxic animals and normoxic animals (Figure 4.8-1).   
Hypoxia paradoxically leads to increased levels of oxidative stress, potentially contributing to 
cardiac dysfunction (Fink, 2002; Flierl et al., 2008). Malondialdehyde (MDA), a marker of lipid 
peroxidation, was measured in plasma but there were no differences between levels in 
normoxic infected and hypoxic infected mice (Figure 4.8-1).  Grouped analysis using 2-way 
ANOVA revealed higher levels of MDA in hypoxia versus normoxia.   
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Figure 4.8-1. No significant differences in nitric oxide levels or oxidative 
stress in hypoxic infected animals.   
(A) Plasma was harvested from mice injected with S. aureus or PBS (vehicle) and maintained in 
normoxia or hypoxia (10% O2) for 6 hours.  Nitric oxide (NOX) analysis was performed by Dr 
Andrew Cowburn.  Data are mean +/- SEM, minimum n = 3. (B) Mice were infected with live or 
heat killed S. aureus and plasma harvested after 12 hours in normoxia or hypoxia.  
Malondialdehyde levels were measured using the OxiSelectTM TBARS assay kit (Cell Biolabs Inc., 
San Diego).  Data are mean +/- SEM, n = 4. 
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4.9 Myeloid-specific deletion of Hif1a or Hif2a protects infected 
animals from hypoxia-induced hypothermia and sickness 
behaviour. 
In order to assess whether host innate immune responses played an important role in the 
development of sickness behaviour and hypothermia, myeloid-specific knockout mice were 
challenged with subcutaneous S. aureus and exposed to normoxia or hypoxia for 12 hours.  
Deletion of either Hif1a (see Figure 4.9-1) or Hif2a (see Figure 4.9-2) in myeloid cells 
significantly protected mice from the adverse effects of infection in hypoxia.  No significant 
differences were observed in skin bacterial count at 12 hours despite deficiency of HIF-1α or 
HIF-2α (see Figure 4.9-3).      
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Figure 4.9-1. Myeloid-specific deletion of Hif1a protects infected hypoxic 
mice from the phenotype of hypothermia and sickness behaviour.   
Wild-type C57BL/6 and Hif1aflox/flox;LysMCre+/- mice were assessed 12 hours following 
subcutaneous injection of SH1000.  (A & B) Sickness scores and (C) rectal temperature were 
recorded. Data are mean and SEM of a minimum n=5. * p<0.05, ** p<0.01, *** p<0.001 
analysed by 2-way ANOVA. 
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Figure 4.9-2. Myeloid-specific deletion of Hif2a provides protection against 
hypothermia and sickness behaviour in infected hypoxic mice.   
Wild-type Hif2aflox/flox;LysMCre-/- and Hif2aflox/flox;LysMCre+/- mice were assessed 12 hours 
following subcutaneous injection of SH1000.  (A & B) Sickness scores and (C) rectal 
temperature were recorded. Data are mean and SEM of a minimum n=6. * p<0.05, *** 
p<0.001 analysed by 2-way ANOVA. 
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Figure 4.9-3. No significant differences in skin bacterial burden of HIF-
deficient animals 12 hours following subcutaneous injection of SH1000.   
Skin of infected animals was biopsied after 12 hours in normoxia or hypoxia. (A) Bacterial 
colony forming units per gram of skin in wild-type C57BL/6 and Hif1aflox/flox;LysMCre+/- mice. (B) 
Skin bacterial counts in wild type Hif2aflox/flox;LysMCre-/- and Hif2aflox/flox;LysMCre+/- mice.  Data 
are mean and SEM of a minimum n=5 analysed by 2-way ANOVA. 
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4.10 Discussion 
Hypoxia frequently complicates bacterial infection at a tissue or systemic level.  Oxygen 
sensors, particularly HIF-1α, are essential for a normal innate immune response to infection 
(Cramer et al., 2003) yet studies have also shown compromised host defence in hypoxic 
conditions (Belda et al., 2005; McGovern et al., 2011).  I investigated the effects of an ambient 
reduction in oxygen tension on the host response to a local S. aureus infection.  Surprisingly, I 
found that hypoxia modified a low dose subcutaneous S. aureus challenge from a minor to 
severe insult, with severe hypothermia, sickness behaviour, hypotension and impaired cardiac 
function occurring within 12 hours of injection in hypoxic mice.  The mechanism behind this 
phenotype remains unknown but I show that it is independent of acute lung injury, 
bacteraemia or a typical cytokine response to sepsis.  Interestingly, deficiency of either HIF-1α 
or HIF-2α in myeloid cells protected mice from the effects of the challenge strongly implicating 
the host innate immune response in the pathogenesis of the phenotype.  These findings imply 
that subcutaneous bacterial infection may cause severe systemic effects in hypoxic patients 
and that in such a setting modulation of the HIF pathway may be a possible therapeutic option. 
Subcutaneous injection of S. aureus produced a cutaneous lesion in wild-type mice maintained 
in room air for 7 days. No adverse systemic effects, with the exception of transient weight loss, 
were observed.  This model is a good correlate of the commonest manifestations of S. aureus 
in humans, namely soft tissue and skin infections (Lowy, 1998). Similar models using gram-
positive group A Streptococcus and a different strain of S. aureus (ATCC 33591) have been used 
to demonstrate the dependence of the innate immune response on HIF-1α (Peyssonnaux et 
al., 2005; Zinkernagel et al., 2008). Given the data showing impaired immune responses in 
hypoxic wounds and the possibility that S. aureus may infect patients with alveolar hypoxia in 
the setting of lung disease and critical care, I investigated the combined challenge of S. aureus 
and alveolar hypoxia.   
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When mice were infected with S. aureus and placed in a hypoxic chamber with 10% ambient 
oxygen they developed a profound phenotype of sickness behaviour and hypothermia.  
Previous reports suggesting impaired in vitro (McGovern et al., 2011) and in vivo (Jonsson et 
al., 1988) immune responses to S. aureus in hypoxia implicated reduced host defence as the 
likely mechanism behind the phenotype. Indeed, antibody-mediated depletion of myeloid cells 
has previously been shown to lead to bacteraemia, increased skin lesion size and increased 
weight loss in an intradermal S. aureus model (Molne et al., 2000).  Surprisingly, however, I 
was unable to detect evidence of S. aureus bacteraemia from cultures of blood or 
homogenates of tissues which would be seeded by circulating S. aureus (Jonsson et al., 2004).  
Furthermore, despite reduced levels of the chemoattractant cytokines, KC and MCP-1 at 3 
hours post-injection of S. aureus in hypoxic mice, at 12 hours post-injection there were no 
differences in numbers of recruited myeloid cells to the site of infection. There was also no 
increase in bacterial burden, suggesting that host responses to infection were preserved.     
Whilst there was no evidence of bacteraemia or of differences in the local response to 
infection, the systemic effects may have been mediated by circulating factors released by the 
host or pathogen during infection.  Implicating the bacteria in the pathogenesis was the finding 
that live S. aureus were required to produce the hypoxic phenotype. The strain of S. aureus 
used in these experiments was a derivative of the 8325-4 strain, which descends from a clinical 
isolate (Novick, 1967).  SH1000 corrects a mutation in the rsbU gene of the parent strain 
(Horsburgh et al., 2002). Restoration of rsbU function normalized expression of the sigma B 
accessory factor (σB), a regulator of virulence-associated loci such as agr (accessory gene 
regulator) and sarA (staphylococcal accessory regulator)(Giachino et al., 2001; Horsburgh et 
al., 2002). Phenotypically, SH1000 mirrors clinical strains such as UAMS-1 and UAMS-601 
because it produces lower amounts of proteases than the 8325-4 strain and has lower 
expression of the α-haemolysin exotoxin (Blevins et al., 2002; Horsburgh et al., 2002).  
Nonetheless, SH1000 produces a variety of virulence factors in addition to α-haemolysin, 
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including the other pore-forming toxins, β- and γ-haemolysin; enzymes such as catalase, lipase, 
staphylokinase and serine proteases; and the pigment staphyloxanthine (Horsburgh et al., 
2002; Ziebandt et al., 2004).  The surface proteins, protein A and fibronectin binding proteins, 
FnBPA and FnBPB are also expressed, but notably the parent strain 8325-4 does not produce 
enterotoxins or toxic shock syndrome toxin-1 (Nilsson et al., 1999; Shinji et al., 2011; Tamber 
et al., 2010).  However, it is possible that hypoxia altered the virulence profile of SH1000. In 
order to adapt to its surroundings, S. aureus is capable of sensing changes in nutrient 
availability, including the capacity to respond to changes in oxygen tension (Fuchs et al., 2007; 
Novick, 1967). Importantly S. aureus possesses the metabolic machinery to respire both 
aerobically and anaerobically although it predominantly uses glycolysis to metabolise 
carbohydrates (Somerville and Proctor, 2009). Several two-component oxygen-sensing 
systems have been described which subsequently regulate virulence factor expression (Schlag 
et al., 2008; Somerville and Proctor, 2009; Sun et al., 2012; Worlitzsch et al., 2002).  For 
example, AirS is a sensor kinase containing a 2Fe-2S cluster that is sensitive to oxidation and 
reduction.  In aerobic conditions, AirS has an oxidised [2Fe-2S]2+ cluster, the kinase is active 
and phosphorylates AirR while in anaerobic conditions the [2Fe-2S]+ form is inactive. The 
consequences of reduced AirR activity in anaerobic conditions were examined using a strain 
with a mutation of the airR gene.  These studies revealed that AirR regulates expression of 
numerous virulence factors and surface proteins (Sun et al., 2012).  
Given the phenotype of hypotension and sickness behaviour, secreted mediators from S. 
aureus might be involved in the pathogenesis and pyrogenic-toxin superantigens are plausible 
candidates. Toxic shock syndrome toxin-1 (TSST-1) typically causes fever, hypotension and 
multiple organ failure in humans, usually in the absence of bacteraemia (Lin and Peterson, 
2010). In a rabbit model of toxic shock syndrome, subcutaneous infusion of TSST-1 produced a 
transient fever, sickness behaviour and hypothermia preceding death (Parsonnet et al., 1987).  
However, mice are resistant to the effects of gram-positive exotoxins unless sensitised with, 
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for example, endotoxin (Lavoie et al., 1999; Miethke et al., 1992).  Furthermore, studies have 
suggested that TSST-1 production is downregulated in hypoxia (Pragman et al., 2004; Wong 
and Bergdoll, 1990).   
Although it is possible that bacterial virulence may have been altered in hypoxia, using mice 
deficient in HIF-1α and HIF-2α I was able to demonstrate that the host immune response is 
critical to the development of the sickness phenotype.  With selective deficiency of HIF-1α or 
HIF-2α in myeloid cells, mice were protected from the adverse effects of the subcutaneous 
bacterial challenge in hypoxia.   Whilst surprising that deficiency of either HIF-α subunit 
protected the mice, this finding is consistent with the protection conferred by HIF deficiency in 
response to lethal doses of LPS or gram-positive stimuli (Imtiyaz et al., 2010; Mahabeleshwar 
et al., 2012; Peyssonnaux et al., 2007).  The putative mechanism proposed in those studies was 
a dampening of the exaggerated inflammatory response and shock that occurs in severe 
sepsis.  Mediators produced by myeloid cells may therefore be important in the infected 
hypoxic phenotype. 
Numerous studies have demonstrated the importance of cytokines on outcome in models of 
sepsis (Leon, 2002). For example, 6 hours following caecal ligation and puncture plasma levels 
of IL-6 over 3000 pg/ml were associated with higher mortality (Stearns-Kurosawa et al., 2011). 
Although IL-6 was significantly elevated at 6 hours following S. aureus injection, I found no 
significant difference between infected normoxic and hypoxic mice.  Studies have implicated 
TNF-α in the pathology of severe sepsis, particularly with reference to the hypothermic 
response of mice, with injection of TNF-α exacerbating hypothermia and antagonism using 
soluble TNF receptor attenuating hypothermia (Kozak et al., 1995).  Furthermore, mice lacking 
TNF receptors had a blunted hypothermic response in a caecal ligation and puncture sepsis 
model (Leon et al., 1998).  Interestingly, the male TNF receptor knockout mice had improved 
survival compared to wild-type controls. However, consistent with the lack of evidence of 
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circulating bacteraemia, I observed no detectable TNF-α in plasma in either normoxia or 
hypoxia.  Indeed, the lower levels of IL-6 and complete lack of detectable IL-1β, TNF-α and IL-
10 distinguish the cytokine profile in this model from that of a typical sepsis response (Cohen, 
2002; Dinarello, 1997).    
Nitric oxide (NO) is a potent bactericidal agent produced by macrophages and necessary for 
normal immune responses in mice (Wei et al., 1995). NO has been implicated in local 
vasodilatory responses to intradermal LPS and is released from macrophages in response to 
gram positive stimuli (Cunha et al., 1993; Pons et al., 1993).  Peripheral vasodilation is an 
important regulator of heat loss and NO is a key regulator of vessel tone in this setting 
(Bertuglia and Giusti, 2005; Kottke et al., 1948; Simmons et al., 2011; Taylor and Bishop, 1993).  
Thus increases in NO production due to the combination of hypoxia and S. aureus infection 
could exacerbate heat loss through the skin, leading to the observed hypothermic phenotype.  
However, whilst alveolar hypoxia is a global stimulus resulting in systemic alterations in vessel 
tone, the local injection of S. aureus may not have provoked a body-wide alteration in the 
peripheral vascular tone. Indeed plasma levels of NO were not different between infected and 
non-infected hypoxic animals.   Furthermore, the fact that HIF-1α and HIF-2α differentially 
regulate macrophage NO production in response to LPS would argue against it being the 
mediator of the hypoxic phenotype (Takeda et al., 2010).   
In the setting of severe sepsis or lethal endotoxaemia, acute lung injury may occur (Reutershan 
and Ley, 2004). Given the combined stimulus of alveolar hypoxia, the consequences of such 
injury would be exacerbated, plausibly causing sickness behaviour and eventual death.  
However, I did not observe any evidence of respiratory distress, lung oedema or inflammatory 
cell infiltration in the lungs of hypoxic animals.  Despite evidence of systemic hypotension, 
organ function was also remarkably preserved, with only a slight increase in creatinine 
differentiating renal, liver and pancreatic plasma markers between hypoxic and normoxic 
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mice.  Severe sepsis or endotoxaemia tend to lead to more profound organ damage and are 
assumed to be the cause of death in those conditions (Cohen, 2002).  Therefore, the 
mechanism behind sickness behaviour in hypoxic infected animals appears to be distinct from 
that of sepsis.   
A further potential cause of sickness behaviour that I examined was that of cerebral oedema. 
As discussed in Chapter 1, alveolar hypoxia can lead to life-threatening pathology in previously 
healthy humans at high altitude through cerebral oedema (Hackett and Roach, 2001).  
Interestingly, previous studies have suggested that hypoxia may induce vascular permeability 
and lead to a degree of oedema in the brain and other organs (Eltzschig et al., 2005; Schoch et 
al., 2002).  However, I observed no evidence of vascular leak in the brains of infected mice as 
assessed by extravasation of Evan’s blue dye and no evidence of brain oedema as assessed by 
wet/dry weight ratio.   
Notably, in the absence of other major organ dysfunction, I found evidence of significantly 
impaired cardiac function. Cardiac dysfunction is an important feature of sepsis (Parker et al., 
1984).  The haemodynamic changes observed in the hypoxic infected mice mirror the sepsis 
phenotype prior to volume resuscitation with reduced ejection fraction and increased left-
ventricular end-systolic volume (Buys et al., 2009; Jianhui et al., 2010).  Both gram negative 
(LPS) and gram positive (lipoteichoic acid) stimuli may induce cardiac suppression, mediated at 
least in part by cytokines and NO (Kumar et al., 1996; Natanson et al., 1989; Ullrich et al., 
2000).  The lack of plasma cytokines or elevation in plasma NO levels in hypoxic animals count 
against these factors as the mechanism.  Importantly, I observed no infiltration of 
inflammatory cells in the myocardium, but it would be interesting to assess local expression of 
cytokines and NO within the heart to exclude autocrine and paracrine-mediated effects.  Other 
potential mechanisms of cardiac dysfunction require consideration. First, coronary 
vasoconstriction has been observed in isolated perfused rat heats in response to purified 
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staphylococcal α-haemolysin (Sibelius et al., 2000). Whether this occurs in the hypoxic infected 
mice requires further examination. Secondly, myocardial metabolism may also be impaired.  In 
sepsis, glucose and fatty acid uptake may be reduced, plasma lactate rises and abnormalities in 
myocardial oxygen extraction have also been described (Dhainaut et al., 1987; Herbertson et 
al., 1995). I found no reduction in plasma bicarbonate levels making a significant lactic acidosis 
unlikely but have not examined myocardial oxygen or glucose uptake.  Finally, related to 
impaired metabolism, mitochondrial dysfunction in human skeletal muscle is associated with 
mortality and severity of sepsis (Brealey et al., 2002).  The putative mediators of mitochondrial 
dysfunction in this context are nitric oxide and reactive oxygen species (Brealey et al., 2002; 
Flierl et al., 2008).  Indeed, anti-oxidants targeted to the mitochondria alleviate cardiac 
dysfunction in a rat endotoxin model (Supinski et al., 2009). Hypoxia could exacerbate 
mitochondrial dysfunction as it is known to provoke oxidative stress at cellular and systemic 
levels (Baillie et al., 2007; Guzy and Schumacker, 2006).  However, I found no evidence of 
increased oxidative stress in hypoxic infected animals compared to hypoxic vehicle controls.  
A further factor which may have contributed to impaired cardiac function is hypothermia. 
Hypothermia was profound in hypoxic infected mice and is known to induce bradycardia and 
hypotension (Goodyer, 1965; Prec et al., 1949).  The mechanisms behind temperature 
regulation in mammals are complex and changes in body temperature are highly dependent 
on the stimulus and ambient temperature.  Below the thermoneutral ambient temperature 
(31°C for C57BL/6 mice, (Rudaya et al., 2005)), animals employ thermogenic mechanisms to 
maintain body temperature (Tb). Involuntary or autonomic mechanisms include piloerection 
and peripheral vasoconstriction to minimise heat loss and an increase in metabolic rate and 
shivering to generate heat (IUPS, 1987; Landsberg et al., 1984).  In hypoxia, experimental 
evidence suggests that these mechanisms are blunted (Kottke et al., 1948; Mortola et al., 
1999; Rohlicek et al., 1998). Indeed, consistent with published studies conducted on mice and 
other mammals, there was a slight but significant reduction in Tb in non-infected mice placed 
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in hypoxia after 6 hours (Bhatia et al., 1969; Gellhorn and Janus, 1936; Gordon and Fogelson, 
1991; Wood and Stabenau, 1998).  This phenomenon, known as anapyrexia, is a regulated 
reduction in Tb and has been proposed to be an adaptive response reducing the oxygen 
requirements of tissues sensitive to hypoxia and facilitating oxygen uptake in the lungs by 
shifting the oxyhaemoglobin dissociation curve leftwards (Buchan and Pulsinelli, 1990; Busto et 
al., 1987; Wood, 1991). Animals also display behavioural temperature regulation, moving to 
warmer or cooler thermal ambience, wetting body surfaces and huddling (IUPS, 1987). 
Consistent with the hypoxic reduction in Tb being adaptive is the observation that hypoxic 
animals permitted to regulate temperature through behaviour surprisingly seek lower ambient 
temperatures to facilitate the reduction in body temperature (Gordon and Fogelson, 1991).  In 
more extreme hypoxia (2-5%), data from rodents showed that a reduction in Tb is associated 
with longer survival (Artru and Michenfelder, 1981; Minard and Grant, 1982; Wood and 
Stabenau, 1998).   
Outwith the context of hypoxia, there is debate as to whether hypothermia in severe sepsis 
may also constitute a protective host response. Lui et al. found that rats challenged with either 
a sub-lethal dose of LPS or E. coli, had higher survival rates in cool environments (with a 
hypothermic response) compared to those in a warm environment that responded with fever 
(Liu et al., 2012). Nonetheless, other studies have shown that reductions in Tb, in sepsis and 
lethal endotoxaemia are highly predictive of poor outcome (Leon et al., 1998; Vlach et al., 
2000). Furthermore, hypothermia (<36°C) in humans admitted to critical care with sepsis is 
associated with higher risk of mortality (Brun-Buisson et al., 1995; Peres Bota et al., 2004).  The 
development of hypothermia described here occurred in response to a low dose of 
subcutaneous S. aureus that did not induce any temperature change in normoxic animals. 
Furthermore the hypoxic infected animals displayed sickness behaviour with lack of interest in 
their surroundings, hunched postures, reduced and uncoordinated movements and often 
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exudative accumulation around the eyes, strongly suggesting that the response observed in 
infected hypoxic mice is dysregulated and pathological.   
By 12 hours Tb in control, PBS-injected mice was not significantly lower in hypoxia than 
normoxia but profound differences were detected between infected groups.  These data 
contrast with those of Kozak et al. who found that 12% hypoxia led to persistent hypothermia 
in mice without any additional stimuli (Kozak et al., 1995).  In that particular model, hypoxia 
was induced aggressively by reducing the ambient oxygen tension to 11% in 15 minutes and 
the nadir in Tb was reached at 4 hours. Although Tb then increased and diurnal variation was 
restored the mice remained mildly hypothermic, with body temperatures around 2°C lower 
than normoxic mice, for the duration of the 7 day hypoxic exposure. A notable difference 
between the experimental findings was the elevation in IL-6 detected in plasma which 
contrasts with my finding of undetectable levels in non-infected hypoxic mice (Kozak et al., 
1995). Surprisingly, given data showing the direct relationship between ambient temperature 
and the reduction in body temperature in hypoxic rats (Bhatia et al., 1969), the ambient 
temperature was higher (28°C) in Kozak et al’s model compared to 21°C in my experiments. 
However, the temperature within the hypoxic chamber was not reported (Kozak et al., 1995).  
Interestingly, intraperitoneal injection of low dose LPS (80 μg/kg) led to a fever in normoxic 
mice but exacerbated the hypoxia-induced hypothermia whereas I observed no pyrexia in 
infected mice maintained in normoxia compared to control mice, but profound hypothermia 
was induced in the infected hypoxic mice.  These data suggest that either the difference in 
ambient temperature between the two protocols may have influenced the thermoregulatory 
response or the mechanisms of temperature regulation involved in the response to LPS are 
distinct from those in subcutaneous S. aureus infection.        
Several other potential mechanisms for the phenotype observed in hypoxia deserve mention.  
Spontaneous activity can contribute to thermogenesis in mice (Humphries and Careau, 2011; 
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Mount and Willmott, 1967). Diurnal variations in temperature correlate with fluctuations in 
activity (Mount and Willmott, 1967; Nautiyal et al., 2009). However, following either injection 
of inflammatory stimuli or a reduction in ambient oxygen tension, activity is depressed (Kozak 
et al., 1995; Nautiyal et al., 2009). However, studies have demonstrated dissociation between 
temperature responses and activity, with reduced activity evident despite normalization of 
body temperature and in the presence of fever (Kozak et al., 1995; Nautiyal et al., 2009).  
Therefore, although I have not yet formally monitored activity counts, I believe that the 
hypothermia observed in hypoxia is not simply due to reduced activity.   
Finally, alveolar hypoxia results in a reduction in oxygen consumption in small mammals and 
this has been linked to hypoxic inhibition of thermogenic responses (Gautier, 1996).  This is not 
thought to be solely due to a reduction in oxygen availability because oxygen consumption in 
hypoxic conditions can be increased in response to cold stress or pharmacologically (Mortola 
et al., 1999; Rohlicek et al., 1998).  However, it is possible that the added stimulus of bacterial 
infection reduced the potential to increase oxygen consumption leading to a further 
impairment of thermogenesis in infected mice.  Indeed in the setting of sepsis, as discussed 
above, utilisation of oxygen is compromised due to impaired mitochondrial respiration 
(Brealey et al., 2002; Singer et al., 2004).  Therefore, measurements of oxygen consumption or 
other markers of global metabolism may provide insight into the mechanism behind the 
phenotype of hypothermia and sickness behaviour. 
 
In conclusion, hypoxic mice infected with S. aureus develop a phenotype of sickness behaviour, 
hypothermia and cardiac dysfunction. The data suggest that even localised S. aureus infection 
could have multiple and profound adverse systemic effects in hypoxaemic patients.  Indeed, in 
the setting of invasive S. aureus infection in humans, underlying lung disease increased the 
relative risk of infection by nearly 4 times and patients with a respiratory focus were over 3 
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times more likely to die (Laupland et al., 2003).  These data suggest that this murine model is 
relevant in human disease and could provide insight into why hypoxia may potentiate the 
virulence of S. aureus infection.        
The cause of the hypoxic phenotype is not yet known but I have shown that it is not due to 
excessive cytokine production, impaired local immune responses, or early multi-organ failure.  
Although bacterial viability is required for the development of hypothermia and sickness 
behaviour, I also showed that the host myeloid cell response is critical to this mechanism.  
Animals with myeloid-cell deficiency of either HIF-1α or HIF-2α were protected from the 
adverse consequences of bacterial infection in hypoxia and therefore these transcription 
factors may represent future therapeutic targets.  Interestingly, given that myeloid cell HIF-1α 
deficiency has been shown to impair immune responses and bacterial killing (Cramer et al., 
2003; Peyssonnaux et al., 2005), I observed no increase in local bacterial burden.  However, 
this assessment was made at an early time point, before the development of a visible skin 
lesion.   Crucially, consistent with my data from Chapter 3 suggesting that HIF-2α deficient 
neutrophils have preserved bactericidal activity, there was also no increase in skin bacterial 
counts in the HIF-2α deficient animals.  Therefore, to avoid potential compromise of host 
defences, HIF-2α may be the preferred target for potential therapeutic intervention in this 
model.    
S. aureus is a common pathogen leading to diverse and life-threatening illnesses.  
Understanding the interaction between pathogen and host is vital to develop new treatments. 
This model reveals a novel role for hypoxia in promoting virulence of S. aureus infection in a 
manner dependent upon the host response.  While further work is needed to explore whether 
the phenotype observed is precipitated by other pathogens, I identify host myeloid-cell oxygen 
sensing pathways as key mediators of the adverse response to subcutaneous infection in 
hypoxia.    
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5 Discussion 
Responses to injury and infection necessitate highly regulated and co-ordinated machinery to 
limit damage, resolve inflammation and repair tissue.  The host immune system, 
microenvironment and pathogens all influence such responses.  I have shown that HIF-2α plays 
a key role in neutrophils as they respond to infection or to inflammatory stimuli and that 
hypoxia may profoundly alter the host response to a minor subcutaneous bacterial challenge.   
 
5.1 Summary of key findings 
Neutrophils are vital effector cells, critical for defence against bacterial and fungal infections, 
but their antimicrobial arsenal is capable of damaging healthy tissue.  Neutrophil-mediated 
damage is implicated in both acute and chronic inflammatory settings, with inhibition of 
neutrophil apoptosis contributing to pathology by preventing timely resolution of the 
inflammatory response.  Neutrophil survival at sites of inflammation is promoted not only by 
inflammatory stimuli but also by hypoxia, a feature of inflamed tissue.  Hypoxic survival of 
neutrophils is dependent upon HIF-1α which has emerged as a master regulator of innate 
immune cell function.  Myeloid cells lacking HIF-1α have impaired function probably due to the 
important role HIF-1α plays in regulating glycolytic enzymes, utilised in neutrophils as the 
predominant pathway for energy production. Thus the finding that HIF-2α plays a role in 
neutrophil persistence at sites of inflammation is important for future development of 
therapeutic anti-inflammatory strategies.  Importantly, I have shown that HIF-2α is expressed 
in neutrophils in the setting of human chronic inflammatory diseases and is upregulated in a 
murine model of acute lung injury.  Overexpression of HIF-2α was associated with reduced 
rates of constitutive apoptosis in human neutrophils and delayed resolution of inflammation in 
a zebrafish tail injury model.  On the other hand myeloid-cell deficiency of HIF-2α enhanced 
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resolution of inflammation and reduced tissue injury in a neutrophil-mediated model of acute 
lung injury without any evidence of host defences being compromised.  
Whilst targeting HIF-2α may be a possibility for treating inflammatory diseases, work 
demonstrating that local HIF-α stabilisation improved anti-bacterial defences raised the 
question of what effect systemic hypoxia would have on host-pathogen interactions.  My work 
begins to dissect this by using a murine model of subcutaneous S. aureus infection in the 
setting of ambient hypoxia.  Surprisingly hypoxia transformed this local bacterial challenge into 
a phenotype of sickness behaviour and hypothermia.  The mechanism responsible for this 
phenotype remains unknown but I found no evidence of bacteraemia, excessive cytokine 
production or lung injury in the hypoxic infected mice.  However, there was significant 
circulatory dysfunction, with hypotension, bradycardia and impaired left ventricular function.  
These findings imply that in a hypoxic host, minor bacterial challenges may result in systemic 
pathology.   
 
5.2 Limitations  
Although I have demonstrated a role for HIF-2α in neutrophils that is conserved across three 
species, a number of limitations require discussion.  First, the purity of peripheral blood 
murine neutrophils used for in vitro experiments was not 100 %.  Contaminating mononuclear 
cells are known to influence human neutrophil responses to lipopolysaccharide (Sabroe et al., 
2002). However, I did not attempt to quantify the cytokine production of these cells and purity 
was sufficiently high to accept protein and RNA expression data.  The influence of 
contaminating cells was less important in assessing in vitro apoptosis as I was primarily 
interested in whether known survival signals remained intact in HIF-2α deficient neutrophils. 
Secondly, the lysozyme M-driven Cre recombinase results in deletion of Hif2a in all myeloid 
cells.  Therefore it could be argued that the in vivo responses observed in HIF-2α deficient mice 
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were at least in part mediated by monocytes and macrophages. To minimize this potential 
issue, I chose models that depended principally on neutrophil function.  For example, the LPS-
induced acute lung injury is characterized by an intense neutrophil infiltration, often with 
neutrophils constituting 90% of cells in BAL 24 hours following LPS administration.  Similarly, 
the model of pneumococcal infection was one in which the initial macrophage containment of 
infection has been overwhelmed and recruited neutrophils are required to prevent excessive 
mortality (Dockrell et al., 2003).  Thirdly, recapitulation of the human gain-of-function HIF2A 
mutations was possible in the zebrafish but was achieved through injection of mutant 
constructs at the one cell stage.  Therefore, epas1a was overexpressed in all cells in the fish 
and therefore it may have been overexpression of the gene in other cells that contributed to 
delayed resolution of inflammation and reduced neutrophil apoptosis.  This issue can be 
addressed by generating a zebrafish line with neutrophil-specific upregulation of epas1a.  
Furthermore, I cannot exclude that the effects on neutrophil constitutive apoptosis were not 
due to the expression of the protein during granulopoesis.  The data from immature bone 
marrow neutrophils suggests that expression during the early stages of maturation would be 
abnormal.  However, in the patients with gain-of-function mutations in the HIF2A gene I 
observed the same phenotype of reduced apoptosis. In these neutrophils, upregulation of HIF-
2α expression reflects impaired post-translational degradation; mRNA expression should not 
have been altered during cell development.  Finally, the data showing impaired resolution of 
inflammation in the zebrafish with epas1a overexpression would be strengthened if there was 
evidence that patients with gain-of-function mutations in the HIF2A gene were more prone to 
developing chronic inflammatory conditions.  Unfortunately such evidence does not exist 
because of the extreme rarity of the mutation and the fact that patients may die prematurely 
from other complications of their polycythaemia.   
The limitations of the work using S. aureus relate mainly to how widely applicable the findings 
are.  This is a murine model and the phenotype may not translate into human disease.  For 
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example, the experiments were performed outside the thermoneutral zone for C57BL/6 mice 
and impairment of thermogenesis by the combined stimuli of hypoxia and bacteria may be the 
primary mediator of the phenotype.  Given species differences in temperature control, this 
phenomenon may not occur in humans.  However, the cardiac dysfunction observed may be 
independent of body temperature and is not only a common finding in humans in the context 
of sepsis but could also be exacerbated by hypoxia.  Nonetheless, even in the mouse it remains 
to be shown that this phenotype would be recapitulated in other settings, for example with 
different bacteria or with systemic hypoxaemia due to underlying lung disease rather than 
normobaric hypoxia.   
 
5.3 Future work 
Multiple avenues of future work can be pursued in light of the findings described in this thesis.  
Regarding the role of HIF-2α in neutrophils further work is needed on how HIF-2α regulates 
neutrophil apoptosis at sites of inflammation.  As HIF-2α deficient neutrophils showed no loss 
of enhanced survival in response to LPS, impaired responses to other mediators of neutrophil 
survival (e.g. GM-CSF) or enhanced pro-apoptotic (e.g. TNF-α) signalling compared to wild type 
cells must have contributed to the enhanced resolution of inflammation in the mouse acute 
lung injury model.  Future work could examine the effects of modulators of apoptosis on HIF-
2α deficient neutrophils.  For example, the survival pathways that may operate in response to 
stimuli present in the inflammatory microenvironment, such as damage associated molecular 
patterns (DAMPS), could be explored by microarray analysis of key apoptotic pathway 
components in wild type and HIF-2α deficient neutrophils.   
The mechanism by which HIF-2α is upregulated also deserves further investigation.  I have 
shown upregulation of Hif2a mRNA in neutrophils as they transmigrate into the lungs from the 
circulation in mice, but I also found upregulation of HIF-2α expression in circulating neutrophils 
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of patients with inflammatory arthritis.  These data suggest that upregulation could occur in 
response to either a circulating mediator or a signal during the process of endothelial 
transmigration.  Identifying such factors may provide potential targets for preventing 
inappropriate upregulation of HIF-2α expression.   These questions may be answered by 
investigating the regulation of HIF-2α expression in COPD patients from whom it would be 
possible to obtain neutrophils from the circulation, bronchoalveolar lavage and sputum.  It 
would be of great interest to discover whether HIF-2α expression correlates with disease 
severity and whether alterations in expression occur during infective exacerbations.   
 The work in this thesis would be strengthened by investigating the role of HIF-2α in other 
models of neutrophil-mediated inflammatory disease.  For example, whether the enhanced 
resolution of inflammation seen in the models of acute lung injury in HIF-2α deficient mice was 
evident in models of chronic inflammation could be investigated.  Chronic models in which 
neutrophil apoptosis has been implicated include bleomycin induced lung inflammation and 
passively induced arthritis (Jonsson et al., 2005; Rossi et al., 2006).   
 
Further work is also required to elucidate the mechanism behind the phenotype of 
hypothermia and sickness behaviour in the S. aureus infected hypoxic mice.  Both host and 
pathogen have been implicated in the phenotype and both require further investigation.  Host 
factors to explore include other circulating mediators and the neuroendocrine response to 
inflammation.  Several circulating factors implicated in sepsis have not been measured.  One 
example is macrophage inhibitory factor (MIF), a pro-inflammatory cytokine implicated in 
cardiac dysfunction and mortality in sepsis models (Calandra et al., 2000; Chagnon et al., 
2005).  Interestingly, inhibition of MIF in TNF-α knockout mice improved survival in a model of 
lethal peritonitis suggesting that it may play a role in pathogenic host responses independently 
of TNF-α (Calandra et al., 2000), which I did not detect in plasma.   
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The neuroendocrine system not only encompasses autonomic control of temperature, heart, 
vasculature and inflammation, but includes hormonal modulators of stress responses (Tracey, 
2002).  In response to stress or inflammatory stimuli, catecholamines and glucocorticoids are 
released and these regulate vessel tone as well as inflammatory cell production of cytokines 
(Rittirsch et al., 2008).  Autonomic responses are also vital in the context of sepsis with vagal 
tone contributing to the control cytokine production and disease severity (Borovikova et al., 
2000; Huston et al., 2007).  Hypoxia also impacts upon autonomic tone, with many of the 
cardiovascular responses to acute and chronic hypoxia mediated through sympathetic 
activation (Morrison, 2001).  However, dampening of responses to catecholamines in hypoxia 
has also been demonstrated in the context of thermogenesis and cardiac rate control (Bicego 
et al., 2007; Richalet et al., 1988).  Therefore, dysregulation of neuroendocrine responses to 
the inflammatory stimulus in hypoxia could provoke systemic consequences contributing to 
the phenotype of sickness behaviour, cardiac dysfunction and hypothermia. Indeed, loss of 
sympathetic tone leading to reduced thermogenesis in brown adipose tissue and skeletal 
muscle, inappropriate cutaneous vasodilation and reduced heart rate and contractility would 
be in keeping with the observed phenotypic changes in hypoxic infected animals. Thus, it 
would be interesting to assess autonomic tone and adrenal hormone levels.  Furthermore as 
phagocytes are known to produce catecholamines (Flierl et al., 2007), if it could be 
demonstrated that myeloid cell production of catecholamines was regulated by HIF, impaired 
production would constitute a potential mechanism by which deficiency of HIF-1α or HIF-2α 
conferred protection in the model.  Counting against this hypothesis is the evidence that 
stimuli known to induce macrophage secretion of catecholamines and upregulate 
thermogenesis would differentially activate HIF-2α (Nguyen et al., 2011).  However, one could 
argue that in view of their distinct roles, it remains possible that different mechanisms are 
responsible for protection observed with deficiency of either HIF-1α or HIF-2α subunits in the 
model of S. aureus infection.  
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Given that live bacteria were required to invoke the hypoxic phenotype, it is possible that 
bacterial virulence was altered in the hypoxic conditions.  However, it may be that the effect 
was mediated by the host response to a critical threshold of bacterial burden and that the 
dose of injected heat-killed bacteria was not a sufficient stimulus.  Further studies could 
therefore involve different doses of bacteria and the use of different S. aureus strains to 
establish which virulence factors are involved in mediating the phenotype.    As mentioned 
above, use of alternative bacterial species would also be interesting to determine the wider 
applicability of this phenotype.  Equally, performing this infection when animals are 
hypoxaemic due to a lung injury will be important to more closely recapitulate a situation that 
may occur in human patients.   
Monitoring of activity and temperature using telemetry would potentially provide useful and 
more detailed information regarding the time course of the sickness phenotype.  Additionally, 
extending the protocol to document mortality and confirm the level of protection conferred by 
myeloid-specific deficiency of HIF-1α and HIF-2α will be important.   
 
5.4 Therapeutic targeting of the HIF pathway 
To date, the majority of work to modify HIF pathways therapeutically has focussed on 
enhancing HIF signalling. Clinical trials using hydroxylase inhibitors are already underway for 
the treatment of anaemia in renal patients (Semenza, 2009). Upregulation of HIF-2α in this 
context will not only promote EPO production but increase iron absorption through its actions 
on DMT1 (Gruber et al., 2007; Mastrogiannaki et al., 2009). Activation of the HIF pathway may 
also benefit inflammatory bowel disease, where HIF-1α is involved in protecting the barrier 
function of the gut epithelium (Cummins et al., 2008). Furthermore, the study by Zinkernagel 
et al. provided evidence that HIF stabilisation could reduce tissue damage caused by bacterial 
infection (Zinkernagel et al., 2008).  
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However, studies on patients with Chuvash polycythaemia, who have systemic HIF activation, 
revealed potentially detrimental effects on cardiopulmonary physiology and metabolism 
during exercise (Formenti et al., 2010; Smith et al., 2008). Furthermore given the evidence, 
presented here and elsewhere, that targeting HIF-2α in myeloid cells may be of benefit in the 
context of chronic inflammation and maladaptive host responses such as those observed in the 
models of hypoxic S. aureus infection or high-dose endotoxaemia (Imtiyaz et al., 2010), the 
potential adverse consequences of activating HIF signalling need to be considered. Indeed the 
model of infected hypoxic mice may be a useful platform on which to test the effects of both 
activators and inhibitors of HIF signalling on host responses to infection.   
A number of challenges exist with regard to the development of HIF-2α inhibitors. Currently 
available HIF pathway inhibitors lack target specificity (Kung et al., 2004).  With the potential 
for disruption of HIF-1α signalling to compromise myeloid cell function it will be important to 
identify more selective HIF-2α inhibitors.  As HIF-1α and HIF-2α are structurally and biologically 
similar, understanding the mechanisms by which they can differentially regulate target genes 
will be important in the process of identifying potential candidate molecules for indirect 
therapeutic manipulation. Given the widespread expression of HIF-2α and its important 
function in non-myeloid cell types, targeting such inhibition to neutrophils is also challenging.  
However, it may be feasible to develop drugs that could be applied locally, for example to 
lungs or skin, to minimise the potential for systemic side-effects.   
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5.5 Conclusions 
The balance of maintaining host defence while suppressing inappropriate persistent 
inflammation presents a therapeutic conundrum.  Therefore understanding of the pathways 
involved in controlling inflammation and infection has obvious potential benefits for patients. 
Oxygen sensing pathways have now been heavily implicated in the control of the innate 
immune system but work is needed to dissect out specific roles for the key members of these 
pathways.  This work provides evidence of a role for HIF-2α in persistent neutrophilic 
inflammation and of an adverse host response to bacterial infection in hypoxia, which may also 
be ameliorated by targeting HIF-2α.  Further investigation of this transcription factor may lead 
to the identification of therapeutic targets that may regulate host responses in inflammatory 
sites and in the context of systemic hypoxaemia.  
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7 Appendices 
7.1 Appendix I – Mastermix constituents by application  
7.1.1  cDNA synthesis 
All reagents were from Promega (Promega UK, Southampton).  For every 1 µg of human RNA 
or 500 ng of murine RNA in water, made up to a total volume of 12.4 µl, the following 
mastermix was added to generate cDNA: 
8µl   5x AMV RT buffer 
16µl  10mM dNTPs 
1.2µl  RNasin® 
1.2µl  random primers 
1.2µl  AMV reverse transcriptase 
7.1.2 Polymerase chain reaction – human and murine cDNA samples 
All reagents were from Promega with the exception of the primers (see Appendix II).  2 µl of 
each sample was added to the following mastermix giving a total volume of 25 µl per reaction: 
 5 µl   5x GoTaq® flexi green buffer     
1.5 µl   magnesium chloride  
1 µl   10 mM dNTPs  
0.7 µl  10 µM forward primer  
0.7 µl   10 µM reverse primer  
0.25 µl   GoTaq® flexi DNA polymerase 
13.85 µl dH2O   
 
7.1.3 Real time polymerase chain reaction – human and murine cDNA 
For Applied Biosystems primer/probe sets, 1 µl of cDNA was added to 19 µl of mastermix per 
reaction.  The real time PCR mastermix consisted of: 
10 µl   2x qPCR MasterMix Plus (Eurogentec Ltd.)      
8 µl   H2O  
1 µl   primer/probe mix  
 
Mastermix for Sigma-Aldrich custom made primers and probes per reaction using 1 µl of cDNA: 
 10 µl   2x 1PCR MasterMix Plus 
0.1 µl   sense primer  
0.1 µl   anti-sense primer  
 0.02 µl  probe 
 8.78 µl  H2O 
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7.2 Appendix II - Primer and probe sequences 
7.2.1 Primers for standard polymerase chain reaction – Human  
Custom primers were designed for the following targets and supplied by Eurogentec 
(Eurogentec Ltd., Southampton, UK): 
 
Target gene name Sequence (5'->3') Product size 
 
Hypoxia inducible factor 2 (HIF2A) 
 
F- CCAGACGTGCTGAGTCCGGC  
R- GGCTTGCCATGCCTGACACCTT 
 
400 bp 
Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) 
F- ACTTTGGTATCGTGGAAGGAC 
R- TGGTCGTTGAGGGCAATG 
418 bp 
   
 
7.2.2 Primers for standard polymerase chain reaction – Murine  
Custom primers were designed for the following targets and supplied by Eurogentec 
(Eurogentec Ltd., Southampton, UK): 
 
Target gene name Sequence (5'->3') Product size 
 
Hypoxia inducible factor 2 (Hif2a) 
 
F- TAAAGCGGCAGCTGGAGTAT 
R- AGCTCCTGGAGGACCGTAGT 
 
326 bp 
Beta-actin (Actb) F- TTCTTTGCAGCTCCTTCGTTGCCG 
R- TGGATGGCTACGTACATGGCTGGG 
457 bp 
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7.2.3 Primers for real time polymerase chain reaction - Human 
Commercially available primer probe sets were obtained from Applied Biosystems (Applied 
Biosystems, Foster, USA) for the following target transcripts:  
 
Target gene name TaqMan assay ID 
 
Hypoxia inducible factor 1, alpha subunit (HIF1A)  
 
HS00153153_m1 
Plasminogen activator inhibitor type 1 (PAI-1) HS01126606_m1 
Vascular endothelial growth factor A (VEGF)  HS00900054_m1 
Beta-actin (ACTB) HS99999903_m1 
 
Primers and 6-FAM labelled probes were designed for the following targets and obtained from 
Sigma-Aldrich (Sigma-Aldrich Company Ltd., Gillingham, UK): 
 
Target gene name  Sequence 
 
Prolyl hydroxylase 3  
 
Sense 
 
5’ AGTCCGGAAACGGGTCGTGGAG 3 
(PHD3) Antisense 5’ AGCGTCGGGGACAAGGGAAAGTT 3’ 
 Probe 5’ TCCGCACCACTCCCGCTGGTTCCCGAAG 3’ 
Hypoxia inducible factor 2  Sense 5’ CTCCCACGGCTGTACGGACAC 3’ 
(HIF2A) Antisense 5’ AGTGCTCCCGCTGAATGACTCCACT 3’ 
 Probe 5’CTCGGATTGTCACACCTATGGCAT 3’ 
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7.2.4 Primers for real time polymerase chain reaction - Murine 
Commercially available primer probe sets were obtained from Applied Biosystems (Applied 
Biosystems, Foster, USA) for the following target transcripts:  
 
Target gene name TaqMan assay ID 
 
Hypoxia inducible factor 1, alpha subunit (Hif1a)  
 
Mm00468869_m1 
Hypoxia inducible factor 2, alpha subunit (Hif2a) Mm00438717_m1 
Beta actin (Actb) Mm00607939_s1 
 
7.3 Appendix III - Polymerase chain reaction cycling conditions 
Polymerase chain reactions were carried out using a DNA Engine™(PTC-200, MJ Research, 
Watertown, USA).  Conditions were as follows: 
Step 1   94˚C    for 5 minutes 
  
Step 2 35 cycles of  
94˚C      for 30 seconds 
  *Annealing temperature for 60 seconds 
  72˚C    for 30 seconds 
 
Step 3  72˚C    for 2 minutes 
 
 
*Optimal annealing temperatures for the primers in Appendix II are shown below: 
 
HIF2A  57˚C 
GAPDH   50˚C 
Hif2a  50˚C 
Actb  50˚C 
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7.4 Appendix IV – Cell lysis buffers 
7.4.1  Sonication lysis buffer (made up in water) 
Ingredient Molarity 
1M Tris-HCl pH 7.8  
(Bio-Rad Laboratories, Hemel Hempstead, UK) 
0.1 
EDTA 
(Sigma-Aldrich Company Ltd., Gillingham, UK) 
0.0015 
Potassium Chloride 
(Sigma-Aldrich Company Ltd., Gillingham, UK) 
0.01 
1,4-Dithio-DL-threitol  (DTT) 
(Fluka Chemie, Buchs, Switzerland) 
0.0005 
Sodium orthovanadate 
(Sigma-Aldrich Company Ltd., Gillingham, UK) 
0.001 
Tetramisole 
(Sigma-Aldrich Company Ltd., Gillingham, UK) 
0.002 
 
Immediately before use the following were added: 
Complete mini EDTA-free protease inhibitor cocktail tablets 
(1 tablet in 1 ml water) 
(Roche Applied Science, Mannheim, Germany) 
1:20 
Phenylmethanesulfonyl fluoride (PMSF) 
(Sigma-Aldrich Company Ltd., Gillingham, UK) 
1:100 
 
7.4.2 2X SDS lysis buffer (made up in water) 
Ingredient Concentration 
1,4-Dithio-DL-threitol  (DTT) 0.2 M 
20% Sodium dodecyl sulphate (SDS) solution 
(Fisher Bioreagents®, Fisher Scientific) 4% 
Glycerol bi-distilled 
(AnalaR NORMAPUR, VWR International, Leuven, Belgium) 20% 
0.5 M Tris-HCl buffer pH 6.8 
(Bio-Rad Laboratories, Hemel Hempstead, UK) 0.1 M 
Bromophenol Blue 
(Fissons scientific equipment, Loughborough, UK) 0.04% 
Complete mini EDTA-free protease inhibitor cocktail 
tablets (1 tablet in 1 ml water) 2%  
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7.5 Appendix V – Western blot buffers 
7.5.1  Resolving Gel – 8% (makes 2 x 1.5 mm gels) 
 
Water 12ml 
40% Acrylamide 
(AccuGel™ 29:1, Geneflow Ltd, Fradley, UK) 
4.5ml 
1.5 M Tris-HCl buffer pH 8.0 
(Bio-Rad Laboratories, Hemel Hempstead, UK) 
5.7ml 
20% Sodium dodecyl sulphate (SDS) solution 112.5µl 
20% Ammonium persulphate (APS) 
(Fisher Bioreagents®, Fisher Scientific) 
225µl 
Tetramethyl-ethylenediamine (TEMED) 
(Fisher Bioreagents®, Fisher Scientific) 
 
9µl 
 
7.5.2  Stacking Gel (makes 2 x 1.5 mm gels) 
 
Water 
 
6ml 
40% Acrylamide 1240µl 
0.5 M Tris-HCl buffer pH 6.8 
(Bio-Rad Laboratories, Hemel Hempstead, UK) 
2520µl 
20% SDS 50µl 
20% APS 100µl 
TEMED 10µl 
 
7.5.3  Running buffer (10 X) 
 
Glycine 
(AnalaR NORMAPUR VWR International, Leuven, Belgium) 
190g 
TRIS-(hydroxymethyl) aminomethane 
(AnalaR NORMAPUR, VWR International, Leuven, Belgium) 
30.3g 
20% SDS 50ml 
Water to 1 litre 
 
7.5.4 Transfer buffer (10 X) 
 
Glycine 14.5g 
TRIS-(hydroxymethyl) aminomethane 29g 
20% SDS 9.25ml 
Water to 400ml 
 
7.5.5 Transfer Buffer (1 X) 
 
Made immediately before use 
10 X Transfer Buffer 10ml 
Methanol 20ml 
Water 70ml 
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7.5.6 Tris-buffered saline (TBS) (10 X) 
  
1M Tris-HCl  pH 8.0 
(Bio-Rad Laboratories, Hemel Hempstead, UK) 
  
 100ml 
 Sodium Chloride 
(Sigma-Aldrich Company Ltd., Gillingham, UK) 
  97.3g 
 Water to 1000ml 
 
7.5.7 TBS with Tween (10 X) 
 
As for TBS with 5 ml Electran Tween®-20  
(VWR International, Haasrode Belgium) 
 
7.5.8 Blocking Solution 
 
Skimmed Milk Powder (Marvel) 
(Premier International Foods, Spalding, UK) 
 
5g 
TBS 100ml 
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7.6 Appendix VI - Antibody concentrations used for Western blotting  
Target Size 
(kDa) 
Dilution Secondary Dilution 
     
HIF-1α  
Mouse monoclonal  
Clone 54, 250 µg/ml 
(BD transduction laboratories™) 
 
120 1:200 Horse anti-mouse IgG,  
HRP-linked antibody 
(#7076, Cell Signaling 
Technology®, New England 
Biolabs UK Ltd, Hitchin, UK) 
1:2000 
HIF-2α  
Mouse monoclonal 
Clone ep190b, 1.6 mg/ml 
(Novus biologicals, Cambridge, UK) 
 
120 1:200 Horse anti-mouse IgG,  
HRP-linked antibody 
 
1:2000 
Anti-p38 MAPK 
Rabbit polyclonal 
(Cell signalling 
 Technology®) 
 
40 1:1000 Goat anti-rabbit  
HRP-linked antibody 
(P0448, Dako UK Ltd, Ely, UK) 
1:2000 
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7.7 Appendix VII – Zebrafish primer and probe sequences 
 
Primers used to PCR amplify zebrafish epas1a, epas1b and the dominant constructs.  
Product Sequence (5'->3') 
epas1a F- CACACCTGGACAAAGCCTCT 
R- CTGATTGCTCACCCCTGTTT 
epas1b F- AGAGCGGCGTAAGGAGAAAT 
R- GGATGAAGAGGGTGAATGGA 
epas1a ∆330 F- TCATGAGACTGGCTATCAGC 
R- ATCGATTCAGGAGTTGCGGCTGTTGTA 
epas1b ∆330 F- TCATGAGACTGGCTATCAGC 
R- ATCGATTCAGGAGTTGCGGCTGTTGTA 
epas1a P347A F- TAGCGCAGTTAGCGGCTATGCCAGGAGAC 
R- GTCTCCTGGCATAGCCGCTAACTGCGCTA 
epas1a P481G F- CCTGGAGACTCTCGCTGGATACATCCCAATGGAC 
R- GTCCATTGGGATGTATCCAGCGAGAGTCTCCAGG 
epas1a N753A F- GCGATATGACTGTGAGGTAGCCATGCCTCTACAAGGAAAC 
R- GTTTCCTTGTAGAGGCATGGCTACCTCACAGTCATATCGC 
epas1b P343A F- ACGCAGCTGGCAGCTACACCTGGGG 
R- CCCCAGGTGTAGCTGCCAGCTGCGT 
epas1b P469G F- ACTTGGAGACACTGGCTGGCTATATCCCCATGGATG 
R- CATCCATGGGGATATAGCCAGCCAGTGTCTCCAAGT 
epas1b N755A F- TTACGACTGCGAGGTCGCTGTCCCGTTGCAAGGC 
R- GCCTTGCAACGGGACAGCGACCTCGCAGTCGTAA 
epas1a G487R F- ACATCCCAATGGACCGCGAGGACTTCCAG 
R- CTGGAAGTCCTCGCGGTCCATTGGGATGT 
epas1a G487W F- ATACATCCCAATGGACTGGGAGGACTTCCAGCTGC 
R- GCAGCTGGAAGTCCTCCCAGTCCATTGGGATGTAT 
 
  
213 
7.8 Appendix VIII – Murine genotyping 
7.8.1 Primers used to genotype transgenic murine colonies. 
Target Sequence (5'->3') Product sizes 
 
Hif1a
flox/flox 
 
F- GCAAAGAGCACTAGTTG 
R- GGAGCTATCTCTCTAGACC 
 
200 bp (wild type allele)   
250 bp (floxed allele) 
 
LysMCre 
recombinase 
 
F- TGCAAGTTGAATAACCGGAAA 
R- CTAGAGCCTGTTTTGCACGTT C 
 
250 bp 
 
Hif2a
flox/flox 
 
 
1- CAGGCAGTATGCCTGGCTAATTCCAGTT 
2- CTTCTTCCATCATCTGGGATCTGGGACT 
3- GCTAACACTGTACTGTCTGAAAGAGTAGC 
 
410 bp (wild type allele) 
444 bp (2-loxP band) 
340 bp (1-loxP band) 
   
 
7.8.2 Mastermix for PCR reaction – murine genomic DNA. 
1 µl of cDNA was diluted in 4 µl H2O. This was added to 15 µl of the following mastermix: 
 2 µl   10x PCR buffer (Bioline reagents Ltd., London, UK) 
0.8 µl   50 mM magnesium chloride  
0.16 µl   25 mM dNTP mix (Bioline reagents Ltd.) 
0.4 µl  10 µM forward primer  
0.4 µl   10 µM reverse primer  
0.3 µl   5u/µl Taq DNA polymerase (Bioline reagents Ltd.) 
10.54 µl dH2O  
 
7.8.3  PCR cycling conditions. 
94°C 5 min 
94°C 30 sec 
58°C 30 sec  x 35 cycles 
72°C 1 min 
72°C 10 min 
4°C hold 
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7.9 Appendix IX – Primary antibodies used for immunohistochemistry  
Target  Tissues Dilution 
    
HIF-2α  
Mouse monoclonal 
Clone ep190b, 1.6 mg/ml 
(Novus biologicals, Cambridge, UK) 
 
 Human lung 
Mouse lung 
 
1:50 
1:50 
Myeloperoxidase 
Rabbit polyclonal 
(Abcam, Cambridge, UK) 
 Mouse skin 
Mouse lung 
 
1:50 
1:50 
 
Ly6G 
Rat monoclonal 
Clone RB6-8C5, 0.5mg/ml 
(BB Pharmingen, Oxford, UK) 
  
Mouse heart 
 
1:150 
 
7.10 Appendix X – Mouse IgM ELISA buffers 
7.10.1  Coating buffer 
 
0.05 M Carbonate-Bicarbonate, pH 9.6 
(Sigma-Aldrich Company Ltd., Gillingham, UK) 
 
7.10.2 Wash solution 
 
50 mM Tris HCl, pH 8.0 
(Bio-Rad Laboratories, Hemel Hempstead, UK) 
0.14 M NaCl 
0.05% Tween 20 
 
7.10.3  Blocking solution 
 
50 mM Tris HCl, pH 8.0 
0.14 M NaCl 
1% bovine serum albumin 
(Sigma-Aldrich Company Ltd., Gillingham, UK) 
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7.11 Appendix XI – Mouse sickness scoring 
7.11.1 Sickness score 1 
A single score was applied to each animal as follows: 
 
A normal and unremarkable condition     = 0  
 
Slight illness, defined as lethargy and ruffled fur   = 1 
 
Moderate illness, defined as severe lethargy, ruffled fur,  
and hunched back      = 2 
 
Severe illness, with the above signs plus exudative  
accumulation around partially closed eyes   = 3  
 
Moribund state       = 4  
 
Death         = 5  
 
7.11.2 Sickness score 2 
Several aspects of appearance and behaviour were assessed and the scores for each category 
totalled to provide the final value. 
Score 0 1 2 3 
Coat Normal 
Rough/Lack of 
grooming 
Unkempt, thin, 
wounds 
Staring coat 
Loss of fur 
Activity Normal 
Isolated, 
abnormal 
posture 
Huddled/inactive 
OR overactive 
Moribund or 
fitting 
Breathing Normal Rapid, shallow Rapid, abdominal Laboured, blue 
Dehydration Nil 
Skin less 
elastic 
Skin tents 
Skin tents, 
eyes sunken 
Movement Normal 
Slight 
uncoordination
/ abnormality 
Uncoordinated, 
reluctant to move 
Staggering, 
paralysis, limb 
dragging 
